Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.55 |
| ▸ | CA12 | O43570 | 2/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.51 |
| ▸ | CA2 | P00918 | 2/20 | 0.51 |
| ▸ | CA9 | Q16790 | 2/20 | 0.51 |
| ▸ | PLCD1 | P51178 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 3/20 | 0.49 |
| ▸ | CNR2 | P34972 | 2/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.48 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.47 |
| ▸ | FGF1 | P05230 | 1/20 | 0.47 |
| ▸ | FGF2 | P09038 | 1/20 | 0.47 |
| ▸ | VEGFA | P15692 | 1/20 | 0.47 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.47 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.47 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14417100 | 1.00 | TDP1 (0.55) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL12569327 | 1.00 | TDP1 (0.55) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL4455260 | 1.00 | TDP1 (0.55) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL18780618 | 1.00 | TDP1 (0.55) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL6033324 | 1.00 | TDP1 (0.55) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL3622089 | 0.99 | TDP1 (0.54) | TDP1CA12CA1CA2CA9 | |
| Biotin SCHEMBL1039790 | 0.97 | TDP1 (0.54) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL20537344 | 0.93 | TDP1 (0.55) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL1693977 | 0.93 | TDP1 (0.53) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL565520 | 0.93 | TDP1 (0.53) | TDP1CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1392 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122017231-A | Chemiluminescent immunoassay kit for quantitatively detecting tPAI.C and detection method thereof | 杭州隆基生物技术有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-119881306-A | Preparation of natural alternaria alternata antigen and allergen specific IgE antibody detection kit thereof | 江苏浩欧博生物医药股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119492873-A | Cell surface to-be-detected cytokine enrichment system and method based on biological coupling strategy | 吉林大学 | 2025-02-21 | — | — | CN | claimed |
| CN-118995693-A | Development and application of cell marking improved electrofusion method based on SA-Biotin bridge | 赣南创新与转化医学研究院 | 2024-11-22 | — | — | CN | claimed |
| CN-117801092-A | Aquaporin antibody AQP4 detection kit | 上海柏慧康生物科技有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-117647652-A | Reagent and kit for detecting mould mixed allergen specific IgE antibody | 江苏浩欧博生物医药股份有限公司 | 2024-03-05 | — | — | CN | claimed |
| CN-116660527-A | Helicobacter pylori magnetic particle chemiluminescence detection reagent, kit, preparation method and application | 重庆新赛亚生物科技有限公司 | 2023-08-29 | — | — | CN | claimed |
| CN-116243004-A | Reagent and kit for quantitative detection of chicken protein allergen specific IgE | 江苏浩欧博生物医药股份有限公司 | 2023-06-09 | — | — | CN | claimed |
| CN-116143865-A | Method for enriching cell surface mediated tau protein diffusion receptor | 中国科学院大连化学物理研究所 | 2023-05-23 | — | — | CN | claimed |
| CN-115290883-A | Synchronous detection method for multiple exosome proteins | 郑州大学 | 2022-11-04 | — | — | CN | claimed |
| CN-115184621-A | Immunity layer analysis-based copeptin detection reagent and preparation method thereof | 长春恒晓生物科技有限责任公司 | 2022-10-14 | — | — | CN | claimed |
| CN-112485233-B | Nano sensor for detecting deacetylase and detection method and application thereof | 山东师范大学 | 2022-08-26 | — | — | CN | claimed |
| CN-114878840-A | Kit and method for measuring triiodothyronine by magnetic particle chemiluminescence | 昆明思安生物科技有限公司 | 2022-08-09 | — | — | CN | claimed |
| CN-112180102-B | Peanut allergen specificity IgE quantitative detection reagent, kit and application thereof | 郑州安图生物工程股份有限公司 | 2022-06-14 | — | — | CN | claimed |
| CN-112748248-B | Milk allergen specificity IgE detect reagent box | 郑州安图生物工程股份有限公司 | 2022-06-14 | — | — | CN | claimed |
| US-20130029428-A1 | PREPARATION METHOD OF ANTIGEN-IMMOBILIZED IMMUNO- FLUORESCENCE SLIDE AND IMMUNO-FLUOROSCENCE SLIDE PREPARED THEREBY | KOREA FOOD RESEARCH INSTITUTE (KR) | 2013-01-31 | — | — | US | claimed |
| EP-2541248-A2 | PREPARATION METHOD OF ANTIGEN-IMMOBILIZED IMMUNOFLUORESCENCE SLIDE, AND IMMUNOFLUORESCENCE SLIDE PREPARED THEREBY | Korea Food Research Institute (KR) | 2013-01-02 | — | — | EP | claimed |
| US-7799526-B2 | Phosphoprotein detection reagent and methods of making and using the same | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2010-09-21 | — | — | US | claimed |
| US-20040146950-A1 | Phosphoprotein detection reagent and methods of making and using the same | THE UNIVERSITY OF NORTH CAROLINA | 2004-07-29 | — | — | US | claimed |
| US-20260146087-A1 | REAGENTS AND METHODS FOR TREATING CANCER AND AUTOIMMUNE DISEASE | UNIVERSITY OF CONNECTICUT (US) | 2026-05-28 | — | — | US | disclosed |
| CN-116496249-B | Salt form and crystal form of complement factor B inhibitor, and preparation methods and applications thereof | SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO.,LTD. (CN) | 2026-05-26 | — | — | CN | disclosed |
| US-12636594-B2 | Continuous purification device | STAMM VEGH CORPORATION (US) | 2026-05-26 | — | — | US | disclosed |
| US-12636307-B2 | In vitro heparin and heparan sulfate compositions and methods of making and using | TEGA THERAPEUTICS, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| US-12630609-B2 | Techniques for predicting, detecting and reducing a specific protein interference in assays involving immunoglobulin single variable domains | ABLYNX NV (BE) | 2026-05-19 | — | — | US | disclosed |
| CN-122060040-A | Polar aprotic organic solvent for dissociating streptavidin-biotin conjugate, screening method and application thereof | 上海交通大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-122056862-A | Application of dibutyl phthalate in construction of testicle injury model | 重庆医科大学附属第二医院 | 2026-05-19 | — | — | CN | disclosed |
| US-12631645-B2 | Detection of BCL-2 family heterodimer complexes and use thereof | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2026-05-19 | — | — | US | disclosed |
| CN-119529103-B | Monoclonal antibody against TSLP monoclonal antibody, kit comprising same and detection method using same | 江苏荃信生物医药股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| WO-2026101398-A1 | BARCODE FREE LIBRARY SCREEN | UNIVERSITEIT LEIDEN (NL) | 2026-05-15 | — | — | WO | disclosed |
| CN-122017231-A | Chemiluminescent immunoassay kit for quantitatively detecting tPAI.C and detection method thereof | 杭州隆基生物技术有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12624378-B2 | Cell-free protein synthesis | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260124312-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2 | BICYCLETX LIMITED (GB) | 2026-05-07 | — | — | US | disclosed |
| EP-4735053-A1 | REGULATORY ELEMENTS | Purespring Therapeutics Limited (GB) | 2026-05-06 | — | — | EP | disclosed |
| US-20260116914-A1 | METHODS OF GENERATING NANOARRAYS AND MICROARRAYS | NAUTILUS SUBSIDIARY INC (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4731198-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF NAPE-PLD RELATED DISEASES AND METHODS OF IDENTIFICATION THEREOF | Fondazione Istituto Italiano di Tecnologia (IT) | 2026-04-29 | — | — | EP | disclosed |
| EP-4049674-B1 | TRUNCATED EPIDERMAL GROWTH FACTOR RECEPTOR (EGFRT) FOR TRANSDUCED T CELL SELECTION | HOPE CITY (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12606594-B2 | Heterotandem bicyclic peptide complexes | BICYCLETX LIMITED (GB) | 2026-04-21 | — | — | US | disclosed |
| US-20260103533-A1 | ANTI-OPG ANTIBODIES | KYMAB LTD (GB) | 2026-04-16 | — | — | US | disclosed |
| EP-4724460-A1 | RECOMBINANT CD16A BINDING PROTEINS AND THEIR USE | Molecular Partners AG (CH) | 2026-04-15 | — | — | EP | disclosed |
| US-12600767-B2 | Compounds and methods targeting epiregulin | ELI LILLY AND COMPANY (US) | 2026-04-14 | — | — | US | disclosed |
| EP-4719437-A1 | CONNECTOR MODIFIED SYNTHETIC RIG-I AGONISTS AND METHODS OF USING THE SAME | RIGImmune Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-12594346-B2 | Crosslinked hydrogel for immune checkpoint blockade delivery | GEORGIA TECH RESEARCH CORPORATION (US) | 2026-04-07 | — | — | US | disclosed |
| US-20260092929-A1 | ANTIBODY AGAINST COATOMER PROTEIN COMPLEX SUBUNIT BETA 2 | ISM CO., LTD. (JP) | 2026-04-02 | — | — | US | disclosed |
| US-12590166-B2 | CD20 binding molecules and uses thereof | LEGEND BIOTECH IRELAND LIMITED (IE) | 2026-03-31 | — | — | US | disclosed |
| EP-3471753-B1 | ANTI-PD-L1 AND IL-2 CYTOKINES | KYMAB LTD (GB) | 2026-03-25 | — | — | EP | disclosed |
| EP-4713108-A2 | CONTINUOUS PURIFICATION DEVICE | Stamm Vegh Corporation (US) | 2026-03-25 | — | — | EP | disclosed |
| US-12583928-B2 | Antibodies against IGFR-like receptor and uses thereof | Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) | 2026-03-24 | — | — | US | disclosed |
| EP-4372378-B1 | METHOD FOR DETECTING HEPATITIS E VIRUS INFECTION, AND ANTIGEN POLYPEPTIDE AND KIT FOR DETECTING HEPATITIS E VIRUS INFECTION | ADVANCED LIFE SCIENCE INST INC (JP) | 2026-03-18 | — | — | EP | disclosed |
| EP-4709759-A1 | IMMUNOTHERAPEUTIC PROTEINS | Macfarlane Burnet Institute for Medical Research and Public Health Limited (AU) | 2026-03-18 | — | — | EP | disclosed |
| US-20260070979-A1 | TIGIT ANTIBODIES, ENCODING NUCLEIC ACIDS AND METHODS OF USING SAID ANTIBODIES IN VIVO | KYMAB LTD (GB) | 2026-03-12 | — | — | US | disclosed |
| US-20260070972-A1 | MODULATORS | XOMA US LLC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260062481-A1 | NOVEL ANTI-NECTIN-4 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES | LILLY CO ELI (US) | 2026-03-05 | — | — | US | disclosed |
| US-20260062493-A1 | Antibody Targeting BCMA, Bispecific Antibody, And Use Thereof | HARBOUR BIOMED SHANGHAI CO LTD (CN) | 2026-03-05 | — | — | US | disclosed |
| US-20260063630-A1 | CAPTURE, PURIFICATION, AND RELEASE OF BIOLOGICAL SUBSTANCES USING A SURFACE COATING | ACADEMIA SINICA (TW) | 2026-03-05 | — | — | US | disclosed |
| EP-3287143-B1 | CKAP4-TARGETED ANTITUMOR AGENT | UNIV OSAKA (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4703381-A1 | ANTIBODIES AGAINST ICAM-1 AND APPLICATIONS THEREOF | Institució Catalana de Recerca i Estudis Avançats (ES) | 2026-03-04 | — | — | EP | disclosed |
| CN-121574248-A | Canine IL-31 specific antibody and application thereof | 广东蓝玉生物科技有限公司 | 2026-02-27 | — | — | CN | disclosed |
| EP-4694930-A1 | COMBINATION THERAPIES INVOLVING GREM1 ANTAGONISTS FOR TREATMENT OF CANCER | Suzhou Transcenta Therapeutics Co., Ltd. (CN) | 2026-02-18 | — | — | EP | disclosed |
| US-12552868-B2 | Antibodies that bind to AXL proteins | AGENSYS, INC. (US) | 2026-02-17 | — | — | US | disclosed |
| US-12552873-B2 | Anti-PSGL-1 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof | VERSEAU THERAPEUTICS, INC. (US) | 2026-02-17 | — | — | US | disclosed |
| US-20260043816-A1 | Anti-TDP-43 Binding Molecules | AC IMMUNE SA (CH) | 2026-02-12 | — | — | US | disclosed |
| EP-4689651-A2 | CAPTURE REAGENT FOR LATERAL FLOW IMMUNOASSAY | IDEXX Laboratories, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-4688850-A1 | DISCERNIBLE CELL SURFACE PROTEIN VARIANTS OF CD33 FOR USE IN CELL THERAPY | Universität Basel (CH) | 2026-02-11 | — | — | EP | disclosed |
| US-12545737-B2 | Antibodies that bind to AXL proteins | AGENSYS, INC. (US) | 2026-02-10 | — | — | US | disclosed |
| EP-4151785-B1 | FIBRONECTIN TYPE III REPEAT BASED PROTEIN SCAFFOLDS WITH ALTERNATIVE BINDING SURFACES | JANSSEN BIOTECH INC (US) | 2026-01-28 | — | — | EP | disclosed |
| US-12534718-B2 | Separating polynucleotide fragments | ILLUMINA, INC. (US) | 2026-01-27 | — | — | US | disclosed |
| EP-4679095-A2 | ANTIBODIES THAT BIND TO AXL PROTEINS | Agensys, Inc. (US) | 2026-01-14 | — | — | EP | disclosed |
| US-20260007657-A1 | PHARMACEUTICAL COMPOSITION FOR KERATOSIS AND USE THEREOF | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2026-01-08 | — | — | US | disclosed |
| US-12516107-B2 | Potent neutralizing antibodies for prevention and treatment of COVID-19 | ACADEMIA SINICA (TW) | 2026-01-06 | — | — | US | disclosed |
| US-12516105-B2 | Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains | ABLYNX N.V. (BE) | 2026-01-06 | — | — | US | disclosed |
| US-20260000773-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2 | BICYCLETX LIMITED (GB) | 2026-01-01 | — | — | US | disclosed |
| EP-4662246-A1 | IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS THAT INHIBIT UREASE AND USE THEREOF | Seni-Preps B.V. (NL) | 2025-12-17 | — | — | EP | disclosed |
| US-12493033-B2 | Method for detecting bi-specific antibody complex | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-12-09 | — | — | US | disclosed |
| US-12486317-B2 | Fungal (1,3)-beta-d glucan-directed monoclonal antibody, coding genes thereof, expression thereof and application thereof | HEBEI TELLGEN LIFE SCIENCE CO., LTD. (CN) | 2025-12-02 | — | — | US | disclosed |
| EP-4652458-A1 | SYSTEMS AND METHODS FOR MULTIPLEX DETECTION OF BIOMARKERS | Veravas, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| US-20250354991-A1 | KIT FOR DETECTING GLYCOPROTEIN | UNIVERSITY PUBLIC CORPORATION OSAKA (JP) | 2025-11-20 | — | — | US | disclosed |
| US-12474329-B2 | Immunoassays for high positively charged proteins | ARES TRADING S.A. (CH) | 2025-11-18 | — | — | US | disclosed |
| US-12473371-B2 | Anti-OPG antibodies | KYMAB LIMITED (GB) | 2025-11-18 | — | — | US | disclosed |
| US-12473285-B2 | DCN-1 modulating compounds and methods of use thereof | CELLARITY, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| WO-2025232936-A1 | CONJUGATED ANTIBODIES AGAINST HUMAN MXA PROTEIN, KIT AND METHOD OF DETECTION OF HUMAN MXA PROTEIN | BIOINOVA, A.S. (CZ) | 2025-11-13 | — | — | WO | disclosed |
| US-20250349136-A1 | METHODS AND SYSTEMS FOR COMPUTATIONAL DECODING OF BIOLOGICAL, CHEMICAL, AND PHYSICAL ENTITIES | NAUTILUS SUBSIDIARY INC (US) | 2025-11-13 | — | — | US | disclosed |
| US-20250346654-A1 | ANTI-AP2 ANTIBODIES AND ANTIGEN BINDING AGENTS TO TREAT METABOLIC DISORDERS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2025-11-13 | — | — | US | disclosed |
| US-20250346646-A1 | COMPOUNDS USEFUL TO TREAT METABOLIC DISORDERS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2025-11-13 | — | — | US | disclosed |
| EP-3297663-B1 | ANTIBODIES THAT BIND TO AXL PROTEINS | AGENSYS INC (US) | 2025-11-12 | — | — | EP | disclosed |
| EP-4647770-A1 | CONJUGATED ANTIBODIES AGAINST HUMAN MXA PROTEIN, KIT AND METHOD OF DETECTION OF HUMAN MXA PROTEIN | BIOINOVA, A.S. (CZ) | 2025-11-12 | — | — | EP | disclosed |
| US-12465650-B2 | Methods and compositions for targeting cancer cells in metastases | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-11-11 | — | — | US | disclosed |
| EP-4642801-A1 | ANTI-FGFR2B ANTIBODY AND USES THEREOF | Suzhou Transcenta Therapeutics Co., Ltd. (CN) | 2025-11-05 | — | — | EP | disclosed |
| US-20250334577-A1 | MARKERS FOR CANCER DETECTION (BF7) | MILAGEN INC (US) | 2025-10-30 | — | — | US | disclosed |
| US-20250334576-A1 | MARKER FOR CANCER DETECTION (BC / or BF9) | MILAGEN INC (US) | 2025-10-30 | — | — | US | disclosed |
| US-20250326807-A1 | CALPROTECTIN BINDING PEPTIDES | BUEHLMANN LABORATORIES AG (CH) | 2025-10-23 | — | — | US | disclosed |
| US-20250325660-A1 | IMMUNOMODULATOR COMPOUNDS AND METHODS OF USE | INCYTE CORP (US) | 2025-10-23 | — | — | US | disclosed |
| EP-2974737-B1 | TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING A SPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | ABLYNX NV (BE) | 2025-10-22 | — | — | EP | disclosed |
| US-20250312321-A1 | TRANSIENT SIROLIMUS WITH FASL MICROGELS | ITOLERANCE, INC. | 2025-10-09 | — | — | US | disclosed |
| US-12433956-B2 | Method of administering a nanoparticle | KAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION (JP) | 2025-10-07 | — | — | US | disclosed |
| US-12435087-B2 | Modulators of DCN-1 and methods of use thereof | CELLARITY, INC. (US) | 2025-10-07 | — | — | US | disclosed |
| EP-3309176-B1 | IMMUNOGLOBULIN SINGLE VARIABLE DOMAIN ANTIBODIES AGAINST OX40L, CONSTRUCTS AND THEIR THERAPEUTIC USE | ABLYNX NV (BE) | 2025-10-01 | — | — | EP | disclosed |
| US-20250295767-A1 | ROR1-SPECIFIC ANTIGEN BINDING MOLECULES | ALMAC DISCOVERY LIMITED (GB) | 2025-09-25 | — | — | US | disclosed |
| US-20250297282-A1 | VIRAL-BINDING PROTEIN AND RELATED REAGENTS, ARTICLES, AND METHODS OF USE | JUNO THERAPEUTICS GMBH (DE) | 2025-09-25 | — | — | US | disclosed |
| US-12421294-B2 | Truncated epiderimal growth factor receptor (EGFRt) for transduced t cell selection | CITY OF HOPE (US) | 2025-09-23 | — | — | US | disclosed |
| EP-3717007-B1 | ILDR2 ANTAGONISTS AND COMBINATIONS THEREOF | BAYER AG (DE) | 2025-09-17 | — | — | EP | disclosed |
| EP-4617366-A1 | ANTIBODY AGAINST COATOMER PROTEIN COMPLEX SUBUNIT BETA 2 | ISM Co., Ltd. (JP) | 2025-09-17 | — | — | EP | disclosed |
| US-12416628-B2 | Portable photonic sensor system as an early detection tool for ovarian cancer | WAWRO DEBRA (US) | 2025-09-16 | — | — | US | disclosed |
| US-20250270296-A1 | POTENT NEUTRALIZING ANTIBODIES FOR PREVENTION AND TREATMENT OF COVID-19 | ACADEMIA SINICA (TW) | 2025-08-28 | — | — | US | disclosed |
| US-12394223-B2 | Methods and systems for computational decoding of biological, chemical, and physical entities | NAUTILUS SUBSIDIARY, INC. (US) | 2025-08-19 | — | — | US | disclosed |
| US-20250257063-A1 | DCN-1 MODULATING COMPOUNDS AND METHODS OF USE THEREOF | THAMES PHARMA PARTNERS | 2025-08-14 | — | — | US | disclosed |
| EP-4597115-A2 | PEPTIDE QUANTITATION ASSAY FOR DIFFERENTIATING FULL-LENGTH HIGH MOLECULAR WEIGHT KININOGEN (HMWK) AND CLEAVED HMWK | Takeda Pharmaceutical Company Limited (JP) | 2025-08-06 | — | — | EP | disclosed |
| US-12371488-B2 | Modulators | XOMA (US) LLC (US) | 2025-07-29 | — | — | US | disclosed |
| US-20250228894-A2 | TRUNCATED DOMAIN IV EGFR AND USES THEREOF | HOPE CITY (US) | 2025-07-17 | — | — | US | disclosed |
| EP-4299749-B1 | FASL-ENGINEERED BIOMATERIALS WITH IMMUNOMODULATORY FUNCTION | UNIV LOUISVILLE RES FOUND INC (US) | 2025-07-16 | — | — | EP | disclosed |
| US-20250224398-A1 | GASDERMIN E EXPRESSION IN HUMAN T CELLS AS A MARKER FOR PROINFLAMMATORY T CELL FUNCTIONS | LEIBNIZ INST FUER NATURSTOFF FORSCHUNG UND INFEKTIONSBIOLOGIE E V HANS KNOELL INST HKI (DE) | 2025-07-10 | — | — | US | disclosed |
| US-20250223339-A1 | SARS-COV2 ANTIBODIES AND USES THEREOF | INVIVYD INC (US) | 2025-07-10 | — | — | US | disclosed |
| EP-4582436-A2 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2 | BicycleTX Limited (GB) | 2025-07-09 | — | — | EP | disclosed |
| EP-3727461-B1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2 | BICYCLETX LTD (GB) | 2025-07-09 | — | — | EP | disclosed |
| US-20250215103-A1 | BISPECIFIC ANTIBODIES AND METHODS OF USE | HOFFMANN-LA ROCHE INC. (US) | 2025-07-03 | — | — | US | disclosed |
| EP-4577575-A1 | CHIMERIC ANTIGEN RECEPTORS TARGETING INTERLEUKIN 13 RECEPTOR SUBUNIT ALPHA 2 AND METHODS OF USE THEREOF | Nanjing Legend Biotech Co., Ltd. (CN) | 2025-07-02 | — | — | EP | disclosed |
| US-20250206841-A1 | ANTI-TROPHOBLAST CELL SURFACE ANTIGEN 2 (TROP-2) ANTIBODIES | ADEPT BIOPHARMACEUTICAL AND TECHNOLOGY, LTD. (CN) | 2025-06-26 | — | — | US | disclosed |
| WO-2025137256-A1 | POLYOXAZOLINE-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2025-06-26 | — | — | WO | disclosed |
| EP-4574040-A2 | EVACUATED BLOOD COLLECTION TUBES CONTAINING PROTEASE INHIBITORS FOR THE ASSESSMENT OF CONTACT SYSTEM ACTIVATION | Takeda Pharmaceutical Company Limited (JP) | 2025-06-25 | — | — | EP | disclosed |
| EP-4573123-A1 | HUMANIZED ANTI-NECTIN-4 ANTIBODIES | ELI LILLY AND CO. (US) | 2025-06-25 | — | — | EP | disclosed |
| US-12339282-B2 | Coronavirus antibody detection kit based on magnetic particle chemiluminescence | DYNAMIKER BIOTECHNOLOGY (TIANJIN) CO., LTD. (CN) | 2025-06-24 | — | — | US | disclosed |
| EP-4039812-B1 | REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF NEURAL INJURY CAUSED BY DISRUPTION OF BLOOD FLOW | PENN STATE RES FOUND (US) | 2025-06-11 | — | — | EP | disclosed |
| US-12324837-B2 | ROR1-specific antigen binding molecules | ALMAC DISCOVERY LIMITED (GB) | 2025-06-10 | — | — | US | disclosed |
| CN-120118186-A | Interleukin 10 antibody, application thereof and interleukin 10 detection kit | 天津龙晟生物科技有限公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-120081939-A | Interleukin 1 beta antibody, application thereof and interleukin 1 beta detection kit | 天津龙晟生物科技有限公司 | 2025-06-03 | — | — | CN | disclosed |
| US-20250172567-A1 | PEPTIDE QUANTITATION ASSAY FOR DIFFERENTIATING FULL-LENGTH HIGH MOLECULAR WEIGHT KININOGEN (HMWK) AND CLEAVED HMWK | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2025-05-29 | — | — | US | disclosed |
| US-20250171542-A1 | ANTI-PROGRAMMED DEATH-LIGAND 1 (PD-L1) ANTIBODIES | ADEPT BIOPHARMACEUTICAL AND TECHNOLOGY LTD. (CN) | 2025-05-29 | — | — | US | disclosed |
| EP-4558521-A1 | NOVEL ANTI-NECTIN-4 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES | ELI LILLY AND COMPANY (US) | 2025-05-28 | — | — | EP | disclosed |
| WO-2025103358-A1 | ANTI-FGFR2B IMMUNOCONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER | Suzhou Transcenta Therapeutics Co., Ltd. (CN) | 2025-05-22 | — | — | WO | disclosed |
| US-20250163057-A1 | DCN-1 MODULATING COMPOUNDS AND METHODS OF USE THEREOF | THAMES PHARMA PARTNERS | 2025-05-22 | — | — | US | disclosed |
| US-20250163058-A1 | MODULATORS OF DCN-1 AND METHODS OF USE THEREOF | THAMES PHARMA PARTNERS | 2025-05-22 | — | — | US | disclosed |
| US-12303567-B2 | Compositions of protein complexes and methods of use thereof | BONUM THERAPEUTICS, INC. (US) | 2025-05-20 | — | — | US | disclosed |
| US-12306093-B2 | Methods and systems for integrated on-chip single-molecule detection | NAUTILUS SUBSIDIARY, INC. (US) | 2025-05-20 | — | — | US | disclosed |
| CN-119971026-A | Antibodies to FLT3L and their use for the treatment of autoimmune and inflammatory diseases | 爱尔兰好利恩治疗有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-115639360-B | Preparation of precursor gastrin (PG 80) antibody and establishment of reagent kit for detecting PG80 by CLIA | 武汉市朗典精医生物科技有限公司 | 2025-05-13 | — | — | CN | disclosed |
| US-20250145722-A1 | ANTI-GAL3 ANTIBODIES AND METHODS OF USE | TRUEBINDING, INC. | 2025-05-08 | — | — | US | disclosed |
| WO-2025097062-A1 | METHODS AND PREPARATIONS FOR MODULATING DEFECTIVE IN CULLIN NEDDYLATION 1 (DCN1) | CELLARITY, INC. (US) | 2025-05-08 | — | — | WO | disclosed |
| WO-2025096981-A1 | MODULATORS OF DCN-1 AND METHODS OF USE THEREOF | CELLARITY, INC. (US) | 2025-05-08 | — | — | WO | disclosed |
| WO-2025096956-A1 | DCN-1 MODULATING COMPOUNDS AND METHODS OF USE THEREOF | CELLARITY, INC. (US) | 2025-05-08 | — | — | WO | disclosed |
| US-12291797-B2 | Fibronectin type III domain based scaffold compositions, methods and uses | JANSSEN BIOTECH, INC. (US) | 2025-05-06 | — | — | US | disclosed |
| CN-119948061-A | Humanized anti-Nectin-4 antibodies | 伊莱利利公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-119930824-A | Anti-Gal 3 antibodies and methods of use | 真和制药有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-119915921-A | Method for determining DAR value of antibody-coupled drug | 上海益诺思生物技术股份有限公司 | 2025-05-02 | — | — | CN | disclosed |
| US-20250138009-A1 | OPTIMIZING DIAGNOSTICS FOR GALACTOFURANOSE CONTAINING ANTIGENS | UNIV JOHNS HOPKINS (US) | 2025-05-01 | — | — | US | disclosed |
| CN-119901564-A | Sample diluent, application of sample diluent in bovine paratuberculosis screening kit and product | 天津海关动植物与食品检测中心 | 2025-04-29 | — | — | CN | disclosed |
| US-12287336-B2 | Protein for rapid, efficient capture of antigens | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-04-29 | — | — | US | disclosed |
| CN-119881303-A | Beta amyloid 1-40 chemiluminescence detection kit | 江南大学附属医院 | 2025-04-25 | — | — | CN | disclosed |
| CN-119881306-A | Preparation of natural alternaria alternata antigen and allergen specific IgE antibody detection kit thereof | 江苏浩欧博生物医药股份有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-119874671-A | Difluoroalkyl substituted piperidine compounds, pharmaceutical compositions, preparation method and use thereof | 上海美悦生物科技发展有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-118834299-B | Anti-TSLP shark nanobody fusion protein, production method, detection kit and application thereof | 康立泰生物医药(青岛)有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-119881322-A | Analysis method for detecting FGF21 drug-resistant antibodies in serum based on ELISA | 北京吉源生物科技有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-119881323-A | ELISA-based anti-drug antibody analysis method for detecting GLP-1 in serum | 北京吉源生物科技有限公司 | 2025-04-25 | — | — | CN | disclosed |
| US-20250129164-A1 | ANTI-PD-1 ANTIBODIES AND USES THEREOF | BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. (CN) | 2025-04-24 | — | — | US | disclosed |
| WO-2025080894-A1 | DETECTION OF DISEASE STATE MACROMOLECULES BINDING TO NORMAL MACROMOLECULES AS A BIOMARKER FOR DISEASE IDENTIFICATION | VERAVAS, INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| US-12275882-B2 | Near-infrared-II nanoparticles and related compositions and methods | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-04-15 | — | — | US | disclosed |
| EP-4532542-A1 | ANTI-BMP9 ANTIBODIES AND METHODS OF USE THEREOF | Pfizer Inc. (US) | 2025-04-09 | — | — | EP | disclosed |
| EP-3909509-B1 | EVACUATED BLOOD COLLECTION TUBES CONTAINING PROTEASE INHIBITORS FOR THE ASSESSMENT OF CONTACT SYSTEM ACTIVATION | TAKEDA PHARMACEUTICALS CO (JP) | 2025-04-09 | — | — | EP | disclosed |
| CN-114555626-B | Iso-tandem bicyclic peptide complexes | 拜斯科技术开发有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-119757734-A | Specific latex microsphere, kit and preparation method and application thereof | 广州朗坤生物科技有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119768430-A | Novel anti-Nectin-4 antibodies and antibody drug conjugates | 伊莱利利公司 | 2025-04-04 | — | — | CN | disclosed |
| EP-3817761-B1 | NOVEL THYROID PEROXIDASE AUTOANTIBODY IMMUNOASSAY | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2025-04-02 | — | — | EP | disclosed |
| US-20250099480-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING CANDIDA AURIS IN BLOOD | CORMEDIX INC (US) | 2025-03-27 | — | — | US | disclosed |
| US-20250101091-A1 | COMPOUNDS AND METHODS TARGETING EPIREGULIN | ELI LILLY AND COMPANY | 2025-03-27 | — | — | US | disclosed |
| CN-119684453-A | Human IL-13 antibody, ELISA kit and detection method thereof | 江苏荃信生物医药股份有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-119661707-A | Anti-human interleukin 2 antibody and application thereof | 康立泰生物医药(青岛)有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119661706-A | Anti-human interleukin 2 antibody and application thereof | 康立泰生物医药(青岛)有限公司 | 2025-03-21 | — | — | CN | disclosed |
| EP-4522236-A1 | TRANSIENT SIROLIMUS WITH FASL MICROGELS | Itolerance, Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| CN-119638799-A | Digital coding magnetic bead, kit and method for detecting antibodies of porcine reproductive and respiratory syndrome virus | 北京市动物疫病预防控制中心 | 2025-03-18 | — | — | CN | disclosed |
| CN-119638833-A | Human IL-13 antibody, ELISA kit and detection method thereof | 江苏荃信生物医药股份有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-119654556-A | Method for detecting CEACAM1 | 株式会社先端生命科学研究所 | 2025-03-18 | — | — | CN | disclosed |
| CN-114295841-B | Antibody detection kit of integrin biological agent and preparation method thereof | 苏州和锐生物科技有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-114264814-B | Antibody detection kit of PD-1 biological agent and preparation method thereof | 苏州和锐生物科技有限公司 | 2025-03-14 | — | — | CN | disclosed |
| EP-4519318-A1 | CD3/BCMA/CD38 TRISPECIFIC ANTIBODIES | Ichnos Sciences SA (CH) | 2025-03-12 | — | — | EP | disclosed |
| EP-3390439-B1 | PEPTIDE QUANTITATION ASSAY FOR DIFFERENTIATING FULL-LENGTH HIGH MOLECULAR WEIGHT KININOGEN (HMWK) AND CLEAVED HMWK | TAKEDA PHARMACEUTICALS CO (JP) | 2025-03-12 | — | — | EP | disclosed |
| CN-119604527-A | Anti-programmed death ligand 1 (PD-L1) antibodies | 安得泰医药有限公司 | 2025-03-11 | — | — | CN | disclosed |
| US-12247068-B2 | Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2025-03-11 | — | — | US | disclosed |
| CN-115047182-B | Exosome analysis and cancer diagnosis method | 香港科技大学 | 2025-03-11 | — | — | CN | disclosed |
| CN-119564879-A | Compositions, combinations and related methods for photo-immunotherapy | 乐天医药生技股份有限公司 | 2025-03-07 | — | — | CN | disclosed |
| EP-4517323-A1 | KIT FOR DETECTING GLYCOPROTEIN | University Public Corporation Osaka (JP) | 2025-03-05 | — | — | EP | disclosed |
| CN-119562972-A | Monoclonal antibody against CD20 antibody and use thereof | 上海星湾生物技术有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-119562974-A | Monoclonal antibody for detecting expression level of anti-BCMA CAR and application thereof | 上海星湾生物技术有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-119534854-A | Chitinase 3-like protein 1 detection kit and preparation method thereof | 江南大学附属医院 | 2025-02-28 | — | — | CN | disclosed |
| CN-119529103-A | Monoclonal antibody against TSLP monoclonal antibody, kit comprising same and detection method using same | 江苏荃信生物医药股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119492873-A | Cell surface to-be-detected cytokine enrichment system and method based on biological coupling strategy | 吉林大学 | 2025-02-21 | — | — | CN | disclosed |
| CN-119492873-A | Cell surface to-be-detected cytokine enrichment system and method based on biological coupling strategy | 吉林大学 | 2025-02-21 | — | — | CN | disclosed |
| US-20250059569-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS TO ACCEPTOR CELLS | FLAGSHIP PIONEERING INNOVATIONS VI, LLC | 2025-02-20 | — | — | US | disclosed |
| EP-3620465-B1 | IMPROVED METHODS FOR GENERATION, LABELING AND USE OF MHC MULTIMERS | DAKO DENMARK AS (DK) | 2025-02-19 | — | — | EP | disclosed |
| CN-119470902-A | Peanut allergen specific IgE quantitative detection reagent | 郑州安图生物工程股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-111989117-B | Antibodies to the Mexwell's cat sarcoma (FMS) -like tyrosine kinase 3 receptor ligand (FLT 3L) and their use for the treatment of autoimmune and inflammatory diseases | 爱尔兰好利恩治疗有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119462688-A | Preparation method of biotinylation amino acid derivative | 青岛大学 | 2025-02-18 | — | — | CN | disclosed |
| CN-119431593-A | Monoclonal antibody against TSLP monoclonal antibody, kit comprising same and detection method using same | 江苏荃信生物医药股份有限公司 | 2025-02-14 | — | — | CN | disclosed |
| WO-2025031965-A1 | DISCERNIBLE CELL SURFACE PROTEIN VARIANTS OF CD52 FOR USE IN CELL THERAPY | CIMEIO THERAPEUTICS AG (CH) | 2025-02-13 | — | — | WO | disclosed |
| EP-4504775-A1 | ANTI-TDP-43 BINDING MOLECULES | AC Immune SA (CH) | 2025-02-12 | — | — | EP | disclosed |
| EP-4505179-A2 | SARS-COV2 ANTIBODIES AND USES THEREOF | Invivyd, Inc. (US) | 2025-02-12 | — | — | EP | disclosed |
| CN-119405829-A | Bicyclic peptide ligands specific for conjugated protein-4 | 拜斯科技术开发有限公司 | 2025-02-11 | — | — | CN | disclosed |
| US-20250041762-A1 | CONTINUOUS PURIFICATION DEVICE | STAMM VEGH CORPORATION | 2025-02-06 | — | — | US | disclosed |
| EP-4500176-A1 | GASDERMIN E EXPRESSION IN HUMAN T CELLS AS A MARKER FOR PROINFLAMMATORY T CELL FUNCTIONS | Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. -Hans-Knöll-Institut- (HKI) (DE) | 2025-02-05 | — | — | EP | disclosed |
| US-20250032640-A1 | TARGETED DRUG DELIVERY-RELEASE AND KILLING OF DRUG RESISTANT TUMORS AND PATHOGENS | RUBHU BIOLOGICS INC (US) | 2025-01-30 | — | — | US | disclosed |
| WO-2025021158-A1 | SPIROCYCLICALKENYL OR AZAALKENYL COMPOUND, AND PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF | 上海美悦生物科技发展有限公司 | 2025-01-30 | — | — | WO | disclosed |
| US-12209128-B2 | Anti-PD-L1 antibodies | KYMAB LIMITED (GB) | 2025-01-28 | — | — | US | disclosed |
| US-12209117-B2 | Monoclonal antibodies and cocktails for treatment of Ebola infections | Biopharmaceutical, Inc. (US) | 2025-01-28 | — | — | US | disclosed |
| CN-119371402-A | Spirocyclic alkenyl or aza alkenyl compound, and pharmaceutical composition, preparation method and application thereof | 上海美悦生物科技发展有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-119310289-A | Application of ON detection reagent in auxiliary diagnosis of acute chest pain diseases | 新疆维吾尔自治区人民医院 | 2025-01-14 | — | — | CN | disclosed |
| US-12195512-B2 | Affinity ligands for antibody Fc region | UNIVERZA V LJUBLJANI (SI) | 2025-01-14 | — | — | US | disclosed |
| US-20250009795-A1 | TRUNCATED DOMAIN IV EGFR AND USES THEREOF | HOPE CITY (US) | 2025-01-09 | — | — | US | disclosed |
| US-20250009854-A1 | Antiviral Agent Comprising a Cellular Entry Receptor and Fc Region Component | MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH LIMITED (AU) | 2025-01-09 | — | — | US | disclosed |
| EP-4486783-A2 | ANTI-PROGRAMMED DEATH-LIGAND 1 (PD-L1) ANTIBODIES | Adept Therapeutics Inc. (US) | 2025-01-08 | — | — | EP | disclosed |
| US-12186383-B2 | Antibodies or antibody-fragments thereof targeting alphaviruses, and compositions and methods comprising same | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2025-01-07 | — | — | US | disclosed |
| US-12188059-B2 | Proximity-dependent biotinylation and uses thereof | THE BROAD INSTITUTE, INC. (US) | 2025-01-07 | — | — | US | disclosed |
| WO-2025003709-A1 | REGULATORY ELEMENTS | PURESPRING THERAPEUTICS LIMITED (GB) | 2025-01-02 | — | — | WO | disclosed |
| WO-2025003710-A1 | POLYNUCLEOTIDES, AAV VECTORS, AND PHARMACEUTICAL COMPOSITIONS FOR TREATING NEPHROTIC SYNDROME | PURESPRING THERAPEUTICS LIMITED (GB) | 2025-01-02 | — | — | WO | disclosed |
| CN-119219649-A | Complement factor B inhibitor, pharmaceutical composition, preparation method and application thereof | 武汉朗来科技发展有限公司 | 2024-12-31 | — | — | CN | disclosed |
| US-12180281-B2 | Anti-PD-1 antibodies and methods of treating cancer | BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. | 2024-12-31 | — | — | US | disclosed |
| CN-111655287-B | ILDR2 antagonists and combinations thereof | 拜耳股份公司 | 2024-12-27 | — | — | CN | disclosed |
| WO-2024260920-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF NAPE-PLD RELATED DISEASES AND METHODS OF IDENTIFICATION THEREOF | FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) | 2024-12-26 | — | — | WO | disclosed |
| US-20240425895-A1 | Cell-Free Protein Synthesis | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2024-12-26 | — | — | US | disclosed |
| CN-119158034-A | Bicyclic peptide ligands specific for conjugated protein-4 | 拜斯科技术开发有限公司 | 2024-12-20 | — | — | CN | disclosed |
| CN-119156401-A | Anti-TDP-43 binding molecules | AC免疫有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-119137155-A | CD3/BCMA/CD38 trispecific antibodies | 伊克诺斯科学公司 | 2024-12-13 | — | — | CN | disclosed |
| WO-2024251628-A1 | RECOMBINANT CD16A BINDING PROTEINS AND THEIR USE | MOLECULAR PARTNERS AG (CH) | 2024-12-12 | — | — | WO | disclosed |
| EP-4470553-A2 | NOVEL THYROID PEROXIDASE AUTOANTIBODY IMMUNOASSAY | Siemens Healthcare Diagnostics Inc. (US) | 2024-12-04 | — | — | EP | disclosed |
| EP-4471021-A1 | SALT TYPE AND CRYSTAL FORM OF COMPLEMENT FACTOR B INHIBITOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Shanghai Meiyue Biotech Development Co., Ltd. (CN) | 2024-12-04 | — | — | EP | disclosed |
| CN-119039448-A | Anti-idiotype antibody specifically binding to anti-human TIM-3 antibody and use thereof | 南京维立志博生物科技股份有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-119053615-A | Calprotectin binding peptides | 布尔曼实验室股份公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-119044384-A | Method for measuring serum neutralizing peptide by liquid chromatography tandem mass spectrometry | 中国医学科学院北京协和医院 | 2024-11-29 | — | — | CN | disclosed |
| CN-119039447-A | Anti-idiotype antibody specifically binding to anti-human LAG-3 antibody, preparation method and application thereof | 南京维立志博生物科技股份有限公司 | 2024-11-29 | — | — | CN | disclosed |
| WO-2024243293-A1 | CONNECTOR MODIFIED SYNTHETIC RIG-I AGONISTS AND METHODS OF USING THE SAME | RIGIMMUNE INC. (US) | 2024-11-28 | — | — | WO | disclosed |
| WO-2024243043-A2 | CONTINUOUS PURIFICATION DEVICE | STAMM VEGH CORPORATION (US) | 2024-11-28 | — | — | WO | disclosed |
| US-20240390510-A1 | COMPOSITIONS OF PROTEIN COMPLEXES AND METHODS OF USE THEREOF | BONUM THERAPEUTICS, INC. | 2024-11-28 | — | — | US | disclosed |
| CN-118388645-B | Anti-human interleukin 4 antibody and application thereof | 康立泰生物医药(青岛)有限公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-118986953-A | Application of retinoid as CLCA1 protein expression promoter or inducer in promoting bifidobacterium intestinal colonisation | 上海市第十人民医院 | 2024-11-22 | — | — | CN | disclosed |
| CN-118995693-A | Development and application of cell marking improved electrofusion method based on SA-Biotin bridge | 赣南创新与转化医学研究院 | 2024-11-22 | — | — | CN | disclosed |
| CN-118978591-A | Anti-cryptococcus capsular polysaccharide monoclonal antibody, coding gene thereof, expression and application thereof | 河北康立德生物科技有限公司 | 2024-11-19 | — | — | CN | disclosed |
| CN-118344474-B | Foot-and-mouth disease virus type-O, type-A and Asia1 broad-spectrum neutralization swine monoclonal antibody and application thereof | 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) | 2024-11-15 | — | — | CN | disclosed |
| CN-118955700-A | Foot-and-mouth disease virus A broad-spectrum neutralization swine monoclonal antibody and application thereof | 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) | 2024-11-15 | — | — | CN | disclosed |
| US-20240376225-A1 | CD21 ANTIBODIES AND USES THEREOF | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2024-11-14 | — | — | US | disclosed |
| US-20240376185-A1 | Tetanus prophylaxis | SMIVET B.V. (NL) | 2024-11-14 | — | — | US | disclosed |
| WO-2024229535-A1 | IMMUNOTHERAPEUTIC PROTEINS | MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH LIMITED (AU) | 2024-11-14 | — | — | WO | disclosed |
| CN-118909043-A | Bicyclic peptide ligands specific for EPHA2 | 拜斯科技术开发有限公司 | 2024-11-08 | — | — | CN | disclosed |
| US-12135329-B2 | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-11-05 | — | — | US | disclosed |
| CN-118878672-A | Anti-aspergillus galactomannan monoclonal antibody, kit and application thereof | 河北康立德生物科技有限公司 | 2024-11-01 | — | — | CN | disclosed |
| CN-118598996-B | Anti-human interleukin 8 antibody and application thereof | 康立泰生物医药(青岛)有限公司 | 2024-11-01 | — | — | CN | disclosed |
| US-20240360218-A1 | ANTI-PD-L1 AND IL-2 CYTOKINES | KYMAB LTD (GB) | 2024-10-31 | — | — | US | disclosed |
| EP-4452319-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS TO ACCEPTOR CELLS | Flagship Pioneering Innovations VI, LLC (US) | 2024-10-30 | — | — | EP | disclosed |
| CN-113648426-B | Construction method and application of magnetic nanoparticles capable of being connected in two directions | 浙江大学 | 2024-10-29 | — | — | CN | disclosed |
| CN-118834299-A | Anti-TSLP shark nanobody fusion protein, production method, detection kit and application thereof | 康立泰生物医药(青岛)有限公司 | 2024-10-25 | — | — | CN | disclosed |
| WO-2024218358-A1 | THE LARGE EXTRACELLULAR LOOP (LEL) OF CD9 AS AN IMMUNOGENIC ADJUVANT IN LIPID NANOVESICLES | Universidad Autónoma de Madrid (ES) | 2024-10-24 | — | — | WO | disclosed |
| EP-4450084-A1 | THE LARGE EXTRACELLULAR LOOP (LEL) OF CD9 AS AN IMMUNOGENIC ADJUVANT IN LIPID NANOVESICLES | Universidad Autónoma de Madrid (ES) | 2024-10-23 | — | — | EP | disclosed |
| CN-114217079-B | Capturing antigen for detecting anti-pancreatic acinar antibody and detection method | 苏州和锐生物科技有限公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-118806795-A | Prussian blue nanoparticle-loaded mesenchymal stem cells and preparation method and application thereof | 中山大学 | 2024-10-22 | — | — | CN | disclosed |
| WO-2024213066-A1 | COMBINATION THERAPIES INVOLVING GREM1 ANTAGONISTS FOR TREATMENT OF CANCER | Suzhou Transcenta Therapeutics Co., Ltd. (CN) | 2024-10-17 | — | — | WO | disclosed |
| US-20240345090-A1 | EARLY DETECTION OF INNATE IMMUNE DYSFUNCTION AND TREATMENT OF CONDITIONS ASSOCIATED THEREWITH | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2024-10-17 | — | — | US | disclosed |
| CN-118772270-A | Anti-candida mannan monoclonal antibody, related biological material and application thereof | 河北康立德生物科技有限公司 | 2024-10-15 | — | — | CN | disclosed |
| WO-2024208836-A1 | DISCERNIBLE CELL SURFACE PROTEIN VARIANTS OF CD33 FOR USE IN CELL THERAPY | UNIVERSITÄT BASEL (CH) | 2024-10-10 | — | — | WO | disclosed |
| US-20240337654-A1 | METHOD FOR LATERAL FLOW IMMUNOASSAY | PURDUE RESEARCH FOUNDATION (US) | 2024-10-10 | — | — | US | disclosed |
| WO-2024206497-A2 | CAPTURE REAGENT FOR LATERAL FLOW IMMUNOASSAY | IDEXX LABORATORIES, INC. (US) | 2024-10-03 | — | — | WO | disclosed |
| US-20240329042-A1 | CAPTURE REAGENT FOR LATERAL FLOW IMMUNOASSAY | IDEXX LABORATORIES, INC. | 2024-10-03 | — | — | US | disclosed |
| CN-118725098-A | Method for extracting streptococcus pharyngolaris specific antibodies in serum | 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) | 2024-10-01 | — | — | CN | disclosed |
| CN-118697854-A | FasL engineered biomaterials with immunomodulatory function | 路易斯维尔大学研究基金会有限公司 | 2024-09-27 | — | — | CN | disclosed |
| US-20240317867-A1 | IGFR-LIKE 2 RECEPTOR AND USES THEREOF | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) | 2024-09-26 | — | — | US | disclosed |
| US-20240317847-A1 | INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-09-26 | — | — | US | disclosed |
| WO-2024193575-A1 | SPIRO COMPOUND, AND PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF | 上海美悦生物科技发展有限公司 | 2024-09-26 | — | — | WO | disclosed |
| CN-118684668-A | Spiro compound, pharmaceutical composition, preparation method and application thereof | 上海美悦生物科技发展有限公司 | 2024-09-24 | — | — | CN | disclosed |
| US-20240310377-A1 | EVALUATION, ASSAYS AND TREATMENT OF PKALMEDIATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-09-19 | — | — | US | disclosed |
| EP-4430179-A1 | ANTIVIRAL AGENT COMPRISING A CELLULAR ENTRY RECEPTOR AND FC REGION COMPONENT | The Macfarlane Burnet Institute for Medical Research and Public Health Limited (AU) | 2024-09-18 | — | — | EP | disclosed |
| CN-118652353-A | Recombinant human AMPAR1 fusion protein and preparation method and application thereof | 上海康黎诊断技术有限公司 | 2024-09-17 | — | — | CN | disclosed |
| US-20240299497-A1 | IMMUNOMODULATION FOR THE LONG TERM PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES AND FOREIGN TISSUE REJECTION | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) | 2024-09-12 | — | — | US | disclosed |
| WO-2024182722-A1 | THERAPEUTIC NANOPARTICLES FOR SOLID ORGAN IMMUNE ACCEPTANCE | GEORGIA TECH RESEARCH CORPORATION (US) | 2024-09-06 | — | — | WO | disclosed |
| CN-118598945-A | Bicyclic peptide ligands specific for EphA2 | 拜斯科技术开发有限公司 | 2024-09-06 | — | — | CN | disclosed |
| CN-115656154-B | Anti-RNP antibody chemiluminescence detection kit based on recombinant RNP multiple antigens | 广东优尼德生物科技有限公司 | 2024-09-06 | — | — | CN | disclosed |
| CN-118598996-A | Anti-human interleukin 8 antibody and application thereof | 康立泰生物医药(青岛)有限公司 | 2024-09-06 | — | — | CN | disclosed |
| US-20240294646-A1 | HETERODIMERIC Fc VARIANTS SELECTIVE FOR Fc GAMMA RIIB | ZYMEWORKS BC INC. (CA) | 2024-09-05 | — | — | US | disclosed |
| US-20240287179-A1 | REAGENTS AND METHODS FOR TREATING CANCER AND AUTOIMMUNE DISEASE | UNIVERSITY OF CONNECTICUT | 2024-08-29 | — | — | US | disclosed |
| US-20240287174-A1 | HIDE1 COMPOSITIONS AND METHODS | COMPUGEN LTD (IL) | 2024-08-29 | — | — | US | disclosed |
| WO-2024177998-A2 | HUMAN AGGREGATED TAU BINDING MOLECULES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2024-08-29 | — | — | WO | disclosed |
| WO-2024177999-A2 | HUMAN AGGREGATED ALPHA-SYNUCLEIN BINDING MOLECULES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2024-08-29 | — | — | WO | disclosed |
| US-12071466-B2 | Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use thereof | JANSSEN BIOTECH, INC. (US) | 2024-08-27 | — | — | US | disclosed |
| CN-118515779-A | Anti-HK 2 Chimeric Antigen Receptor (CAR) | 詹森生物科技公司 | 2024-08-20 | — | — | CN | disclosed |
| CN-118108837-B | Foot-and-mouth disease virus Asia1 type neutralization swine monoclonal antibody and application thereof | 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) | 2024-08-16 | — | — | CN | disclosed |
| CN-118510893-A | Antiviral agents comprising a cell entry receptor and an Fc region component | 麦克法兰布奈特医疗研究与公共健康研究所有限公司 | 2024-08-16 | — | — | CN | disclosed |
| WO-2024165710-A1 | IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS THAT INHIBIT UREASE AND USE THEREOF | SENI-PREPS B.V. (NL) | 2024-08-15 | — | — | WO | disclosed |
| CN-112469479-B | Reagents and methods for treating cancer and autoimmune diseases | 康涅狄格大学 | 2024-08-13 | — | — | CN | disclosed |
| CN-118464761-A | Multi-joint inspection kit for measuring six thrombus markers based on flow cytometry and preparation and use methods thereof | 成都达思嘉生物科技有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-116675771-B | Anti-human TSLP monoclonal antibody, kit containing same and inspection method | 江苏荃信生物医药股份有限公司 | 2024-08-06 | — | — | CN | disclosed |
| CN-111741771-B | Bicyclic peptide ligands specific for EPHA2 | 拜斯科技术开发有限公司 | 2024-08-06 | — | — | CN | disclosed |
| US-12054540-B2 | Single domain antibodies binding to tetanus neurotoxin | SMIVET B.V. (NL) | 2024-08-06 | — | — | US | disclosed |
| CN-115656153-B | Anti-nuclear antibody spectrum detection kit based on acridinium ester chemiluminescence | 广东优尼德生物科技有限公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-118384297-A | Regeneration of functional neurons for treatment of nerve damage due to blood flow disruption | 宾州研究基金会 | 2024-07-26 | — | — | CN | disclosed |
| CN-118384296-A | Regeneration of functional neurons for treatment of nerve damage due to blood flow disruption | 宾州研究基金会 | 2024-07-26 | — | — | CN | disclosed |
| CN-118388645-A | Anti-human interleukin 4 antibody and application thereof | 康立泰生物医药(青岛)有限公司 | 2024-07-26 | — | — | CN | disclosed |
| WO-2024155854-A1 | SYSTEMS AND METHODS FOR MULTIPLEX DETECTION OF BIOMARKERS | VERAVAS, INC. (US) | 2024-07-25 | — | — | WO | disclosed |
| US-20240249539-A1 | METHODS AND SYSTEMS FOR COMPUTATIONAL DECODING OF BIOLOGICAL, CHEMICAL, AND PHYSICAL ENTITIES | NAUTILUS SUBSIDIARY, INC. | 2024-07-25 | — | — | US | disclosed |
| US-12037597-B2 | Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells | THE CATHOLIC UNIVERSITY OF AMERICA (US) | 2024-07-16 | — | — | US | disclosed |
| CN-118344474-A | Foot-and-mouth disease virus type-O, type-A and Asia1 broad-spectrum neutralization swine monoclonal antibody and application thereof | 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) | 2024-07-16 | — | — | CN | disclosed |
| US-20240228635-A9 | CCR8 ANTIBODY AND APPLICATION THEREOF | B7 THERAPEUTICS INC. (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240228579-A1 | FC MUTANT WITH ALTERED BINDING TO FC RECEPTOR | INNOVENT BIOLOGICS (SUZHOU) CO., LTD. (CN) | 2024-07-11 | — | — | US | disclosed |
| US-20240228650-A9 | CD3/BCMA/CD38 Trispecific Antibodies | IGI Therapeutics SA (CH) | 2024-07-11 | — | — | US | disclosed |
| US-12031983-B2 | Method for lateral flow immunoassay | PURDUE RESEARCH FOUNDATION (US) | 2024-07-09 | — | — | US | disclosed |
| US-12030923-B2 | Compositions and methods for producing a composition | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-07-09 | — | — | US | disclosed |
| CN-118290576-A | Porcine monoclonal antibody, kit and application thereof | 河南农业大学 | 2024-07-05 | — | — | CN | disclosed |
| WO-2024140834-A1 | ANTI-FGFR2B ANTIBODY AND USES THEREOF | Suzhou Transcenta Therapeutics Co., Ltd. (CN) | 2024-07-04 | — | — | WO | disclosed |
| US-12023367-B2 | Immunomodulation for the long term prevention and treatment of autoimmune diseases and foreign tissue rejection | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) | 2024-07-02 | — | — | US | disclosed |
| CN-116514981-B | Novel anti-human IL-23 monoclonal antibody, kit containing same and detection method thereof | 江苏荃信生物医药股份有限公司 | 2024-06-25 | — | — | CN | disclosed |
| US-12016865-B2 | Methods and pharmaceutical compositions for treating candida auris in blood | CORMEDIX INC. (US) | 2024-06-25 | — | — | US | disclosed |
| CN-110582560-B | FasL engineered biomaterials with immunomodulatory function | 路易斯维尔大学研究基金会有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-115947844-B | Novel anti-human IL-33 monoclonal antibody, kit containing same and detection method thereof | 江苏荃信生物医药股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
| US-20240191259-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS TO ACCEPTOR CELLS | FLAGSHIP PIONEERING INNOVATIONS VI, LLC | 2024-06-13 | — | — | US | disclosed |
| US-20240189436-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2 | BICYCLETX LIMITED (GB) | 2024-06-13 | — | — | US | disclosed |
| EP-4380980-A1 | BISPECIFIC ANTIBODIES AND METHODS OF USE | F. Hoffmann-La Roche AG (CH) | 2024-06-12 | — | — | EP | disclosed |
| US-12006352-B2 | Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains | ABLYNX N.V. (BE) | 2024-06-11 | — | — | US | disclosed |
| US-11999776-B2 | IGFR-like 2 receptor and uses thereof | Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) | 2024-06-04 | — | — | US | disclosed |
| CN-118108700-A | Complement factor B inhibitor, pharmaceutical composition, preparation method and application thereof | 诺华股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-118108837-A | Foot-and-mouth disease virus Asia1 type neutralization swine monoclonal antibody and application thereof | 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) | 2024-05-31 | — | — | CN | disclosed |
| US-20240165214-A1 | COMPOSITIONS AND METHODS FOR STABILIZATION OF ALLOSTERIC PROTEINS | UNIVERSITY OF WASHINGTON (US) | 2024-05-23 | — | — | US | disclosed |
| EP-3584576-B1 | BIS-BIOTIN AND BIS-IMINOBIOTIN DERIVATIVES AS LABELS FOR IDENTIFICATION OF POTENTIAL DRUG TARGET PROTEINS FOR DEVELOPMENT OF ANTIBODY DRUGS | MITSUI CHEMICALS INC (JP) | 2024-05-22 | — | — | EP | disclosed |
| EP-4372378-A1 | METHOD FOR DETECTING HEPATITIS E VIRUS INFECTION, AND ANTIGEN POLYPEPTIDE AND KIT FOR DETECTING HEPATITIS E VIRUS INFECTION | Advanced Life Science Institute, Inc. (JP) | 2024-05-22 | — | — | EP | disclosed |
| US-11987830-B2 | Cell-free protein synthesis systems | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2024-05-21 | — | — | US | disclosed |
| WO-2024101357-A1 | ANTIBODY AGAINST COATOMER PROTEIN COMPLEX SUBUNIT BETA 2 | ＩＳＭ株式会社 | 2024-05-16 | — | — | WO | disclosed |
| CN-114344297-B | Application of riluzole in treating oligospermia | 暨南大学 | 2024-05-14 | — | — | CN | disclosed |
| US-20240150431-A1 | MHC Multimers, Methods for Their Generation, Labeling and Use | DAKO DENMARK APS (DK) | 2024-05-09 | — | — | US | disclosed |
| US-11977084-B2 | Nervous system-specific transmembrane proteasome complex that modulates neuronal signaling through extracellular signaling via brain activity peptides | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-05-07 | — | — | US | disclosed |
| CN-117964751-A | Single domain antibodies that bind to tetanus neurotoxin | 斯米维特公司 | 2024-05-03 | — | — | CN | disclosed |
| US-20240141030-A1 | VEGF-BINDING MOLECULES | BOEHRINGER INGELHEIM INT (DE) | 2024-05-02 | — | — | US | disclosed |
| US-20240142463-A1 | METHODS OF QUANTIFYING ANTI-CD40 ANTIBODIES | SEAGEN INC (US) | 2024-05-02 | — | — | US | disclosed |
| CN-117929719-A | Test paper strip and kit for detecting treponema pallidum antibody | 青岛大学 | 2024-04-26 | — | — | CN | disclosed |
| US-20240132615-A1 | CD3/BCMA/CD38 Trispecific Antibodies | Ichnos Sciences SA (CH) | 2024-04-25 | — | — | US | disclosed |
| US-20240132603-A1 | CCR8 ANTIBODY AND APPLICATION THEREOF | Harbour Biomed US, Inc. (US) | 2024-04-25 | — | — | US | disclosed |
| US-11965026-B2 | Anti-PD-L1 and IL-2 cytokines | KYMAB LIMITED (GB) | 2024-04-23 | — | — | US | disclosed |
| US-20240124572-A1 | INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-04-18 | — | — | US | disclosed |
| US-20240117055-A1 | ANTIBODIES THAT BIND TO AXL PROTEINS | AGENSYS, INC. (US) | 2024-04-11 | — | — | US | disclosed |
| EP-4347657-A1 | METHODS OF QUANTIFYING ANTI-CD40 ANTIBODIES | Seagen Inc. (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-4350345-A2 | TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBIN SINGLE VARIABLE DOMAINS | Ablynx N.V. (BE) | 2024-04-10 | — | — | EP | disclosed |
| US-11952419-B2 | Reagents and methods for treating cancer and autoimmune disease | UNIVERSITY OF CONNECTICUT (US) | 2024-04-09 | — | — | US | disclosed |
| US-20240110909-A1 | BIOANALYTICAL ANALYSIS OF SITE-SPECIFIC ANTIBODY DRUG CONJUGATES | GENENTECH, INC. (US) | 2024-04-04 | — | — | US | disclosed |
| EP-4341288-A1 | COMPOUNDS AND METHODS TARGETING EPIREGULIN | Eli Lilly and Company (US) | 2024-03-27 | — | — | EP | disclosed |
| CN-117731758-A | A composition for cartilage regeneration comprising HAPLN1 as an active ingredient | 哈普赛安思有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117720656-A | Anti-human interleukin 12P70 antibody and application thereof | 康立泰生物医药(青岛)有限公司 | 2024-03-19 | — | — | CN | disclosed |
| CN-117730255-A | Method for detecting hepatitis E virus infection, antigen polypeptide for detecting hepatitis E virus infection, and kit | 株式会社先端生命科学研究所 | 2024-03-19 | — | — | CN | disclosed |
| US-11931465-B2 | Functionalized Prussian blue nanoparticles, combination Prussian blue nanoparticle-based nano-immunotherapy and applications thereof | CHILDREN'S NATIONAL MEDICAL CENTER (US) | 2024-03-19 | — | — | US | disclosed |
| US-11935311-B2 | Methods and systems for computational decoding of biological, chemical, and physical entities | NAUTILUS SUBSIDIARY, INC. (US) | 2024-03-19 | — | — | US | disclosed |
| CN-117720657-A | Anti-human interleukin 12P70 antibody and application thereof | 康立泰生物医药(青岛)有限公司 | 2024-03-19 | — | — | CN | disclosed |
| CN-116217714-B | Full porcine PEDV monoclonal antibody and epitope thereof | 华中农业大学 | 2024-03-15 | — | — | CN | disclosed |
| US-20240083991-A1 | ANTI-BMP9 ANTIBODIES AND METHODS OF USE THEREOF | PFIZER INC. (US) | 2024-03-14 | — | — | US | disclosed |
| US-20240082352-A1 | REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF NEURAL INJURY CAUSED BY DISRUPTION OF BLOOD FLOW | THE PENN STATE RESEARCH FOUNDATION (US) | 2024-03-14 | — | — | US | disclosed |
| EP-4335868-A1 | FC MUTANT WITH ALTERED BINDING TO FC RECEPTOR | Innovent Biologics (Suzhou) Co., Ltd. (CN) | 2024-03-13 | — | — | EP | disclosed |
| CN-116004684-B | Sm fusion antigen and anti-Sm antibody chemiluminescence detection kit | 广东优尼德生物科技有限公司 | 2024-03-08 | — | — | CN | disclosed |
| US-20240076390-A1 | ANTIBODIES THAT BIND TO AXL PROTEINS | AGENSYS, INC. (US) | 2024-03-07 | — | — | US | disclosed |
| CN-117647652-A | Reagent and kit for detecting mould mixed allergen specific IgE antibody | 江苏浩欧博生物医药股份有限公司 | 2024-03-05 | — | — | CN | disclosed |
| CN-117647652-A | Reagent and kit for detecting mould mixed allergen specific IgE antibody | 江苏浩欧博生物医药股份有限公司 | 2024-03-05 | — | — | CN | disclosed |
| US-20240067748-A1 | ANTIBODY CAPABLE OF BINDING TO TROP2, AND USE THEREOF | NONA BIOSCIENCES (SUZHOU) CO., LTD. (CN) | 2024-02-29 | — | — | US | disclosed |
| WO-2024041650-A1 | CHIMERIC ANTIGEN RECEPTORS TARGETING INTERLEUKIN 13 RECEPTOR SUBUNIT ALPHA 2 AND METHODS OF USE THEREOF | NANJING LEGEND BIOTECH CO., LTD. (CN) | 2024-02-29 | — | — | WO | disclosed |
| CN-117589980-A | Multi-index detection device, detection method and application based on micro-fluidic chip | 清华大学深圳国际研究生院 | 2024-02-23 | — | — | CN | disclosed |
| US-20240058454-A1 | BIOLOGICAL DELIVERY SYSTEMS | PARTICELLA INC (US) | 2024-02-22 | — | — | US | disclosed |
| WO-2024038075-A1 | HUMANIZED ANTI-NECTIN-4 ANTIBODIES | EMERGENCE THERAPEUTICS AG (DE) | 2024-02-22 | — | — | WO | disclosed |
| EP-4324849-A1 | HUMANIZED ANTI-NECTIN-4 ANTIBODIES | Emergence Therapeutics AG (DE) | 2024-02-21 | — | — | EP | disclosed |
| WO-2024034580-A1 | METHOD FOR DETECTING CEACAM1 | 株式会社先端生命科学研究所 | 2024-02-15 | — | — | WO | disclosed |
| EP-4320241-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS TO ACCEPTOR CELLS | Flagship Pioneering Innovations VI, LLC (US) | 2024-02-14 | — | — | EP | disclosed |
| US-20240043552-A1 | Methods for Producing Fabs and IgG Bispecific Antibodies | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2024-02-08 | — | — | US | disclosed |
| US-20240044882-A1 | TETHERED DETECTION ASSAYS | FIRST-CITIZENS BANK & TRUST COMPANY | 2024-02-08 | — | — | US | disclosed |
| US-20240043439-A1 | COMPOUNDS AS C5AR INHIBITORS | KIRA PHARMACEUTICALS (SUZHOU) LTD. (CN) | 2024-02-08 | — | — | US | disclosed |
| US-20240043821-A1 | Superior Neutralization of SARS-CoV-2 by Deglycosylated Human Angiotensin Converting Enzyme 2 (ACE2) | INSTITUT FÜR MOLEKULARE BIOTECHNOLOGIE GMBH (AT) | 2024-02-08 | — | — | US | disclosed |
| US-11892450-B2 | Evaluation, assays and treatment of pKal-mediated disorders | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-02-06 | — | — | US | disclosed |
| CN-114107386-B | Method for preparing mouse model with blood brain barrier defect | 中国人民解放军军事科学院军事医学研究院 | 2024-02-02 | — | — | CN | disclosed |
| WO-2024023118-A1 | NOVEL DOSAGES OF ANTI-CD137 ANTIBODY | ALLIGATOR BIOSCIENCE AB (SE) | 2024-02-01 | — | — | WO | disclosed |
| WO-2024023120-A1 | NOVEL DOSAGES OF ANTI-CD137 ANTIBODY | ALLIGATOR BIOSCIENCE AB (SE) | 2024-02-01 | — | — | WO | disclosed |
| US-20240034778-A1 | AMYLOID-SPECIFIC ANTIBODIES AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2024-02-01 | — | — | US | disclosed |
| CN-110725009-B | Protein scaffolds based on fibronectin type III repeats with alternative binding surfaces | 詹森生物科技公司 | 2024-01-30 | — | — | CN | disclosed |
| US-20240024501-A1 | COMPOSITIONS OF PROTEIN COMPLEXES AND METHODS OF USE THEREOF | GOOD THERAPEUTICS, INC. | 2024-01-25 | — | — | US | disclosed |
| US-20240026020-A1 | ANTI-OPG ANTIBODIES | KYMAB LIMITED (GB) | 2024-01-25 | — | — | US | disclosed |
| WO-2024017992-A1 | NOVEL ANTI-NECTIN-4 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES | EMERGENCE THERAPEUTICS AG (DE) | 2024-01-25 | — | — | WO | disclosed |
| US-20240026404-A1 | CELLULAR GLYCOSAMINOGLYCAN COMPOSITIONS AND METHODS OF MAKING AND USING | TEGA THERAPEUTICS, INC. | 2024-01-25 | — | — | US | disclosed |
| EP-4310101-A1 | NOVEL ANTI-NECTIN-4 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES | Emergence Therapeutics AG (DE) | 2024-01-24 | — | — | EP | disclosed |
| CN-117440968-A | Compounds and methods for targeting epidermal modulators | 伊莱利利公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-112135840-B | Single domain antibodies that bind to tetanus neurotoxin | 斯米维特公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-113156134-B | ELISA kit for detecting human interleukin 23 and detection method | 江苏荃信生物医药股份有限公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-113281522-B | Alzheimer related neurofilament protein chemiluminescence immunoassay kit and preparation method thereof | 迪瑞医疗科技股份有限公司 | 2024-01-09 | — | — | CN | disclosed |
| US-20240002437-A1 | COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY LUNG DISEASES | NATIONAL INSTITUTES OF HEALTH | 2024-01-04 | — | — | US | disclosed |
| US-20240000957-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2 | BICYCLETX LIMITED (GB) | 2024-01-04 | — | — | US | disclosed |
| US-20240003877-A1 | DEVICES, SYSTEMS, AND METHODS FOR THE DETECTION OF A TARGET ANALYTE USING MAGNETIC FOCUS LATERAL FLOW IMMUNOASSAY TECHNIQUES | PURDUE RESEARCH FOUNDATION | 2024-01-04 | — | — | US | disclosed |
| EP-4299749-A2 | FASL-ENGINEERED BIOMATERIALS WITH IMMUNOMODULATORY FUNCTION | University Of Louisville Research Foundation, Inc. (US) | 2024-01-03 | — | — | EP | disclosed |
| EP-4298124-A1 | INHIBITORS OF IL-11 OR IL-11RA FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING | Bayer Aktiengesellschaft (DE) | 2024-01-03 | — | — | EP | disclosed |
| EP-4298123-A2 | INHIBITORS OF IL-11 OR IL-11RA FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING | Bayer Aktiengesellschaft (DE) | 2024-01-03 | — | — | EP | disclosed |
| US-11860156-B2 | Bioanalytical analysis of site-specific antibody drug conjugates | GENENTECH, INC. (US) | 2024-01-02 | — | — | US | disclosed |
| WO-2023247731-A1 | ROR1/PTK7 BI-SPECIFIC ANTIGEN BINDING MOLECULES | ALMAC DISCOVERY LIMITED (GB) | 2023-12-28 | — | — | WO | disclosed |
| US-20230408529-A1 | IMMUNOASSAYS FOR HIGH POSITIVELY CHARGED PROTEINS | ARES TRADING S.A. (CH) | 2023-12-21 | — | — | US | disclosed |
| US-20230408528-A1 | PEPTIDE QUANTITATION ASSAY FOR DIFFERENTIATING FULL-LENGTH HIGH MOLECULAR WEIGHT KININOGEN (HMWK) ANDCLEAVED HMWK | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-12-21 | — | — | US | disclosed |
| CN-117247432-A | Coronavirus spike protein receptor binding domain affinity peptide and application thereof | 天津大学 | 2023-12-19 | — | — | CN | disclosed |
| US-20230398225-A1 | PD-L1/STING CONJUGATES AND METHODS OF USE | INCYTE CORPORATION | 2023-12-14 | — | — | US | disclosed |
| WO-2023233330-A1 | ANTI-BMP9 ANTIBODIES AND METHODS OF USE THEREOF | PFIZER INC. (US) | 2023-12-07 | — | — | WO | disclosed |
| US-20230390253-A1 | APPLICATION OF RILUZOLE IN TREATMENT OF OLIGOSPERMIA | JINAN UNIVERSITY (CN) | 2023-12-07 | — | — | US | disclosed |
| US-11833211-B2 | Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2 | BICYCLETX LIMITED (GB) | 2023-12-05 | — | — | US | disclosed |
| CN-110381999-B | Compounds that bind human CD160 and uses thereof | 埃尔萨里斯生物技术公司 | 2023-12-01 | — | — | CN | disclosed |
| US-20230381170-A1 | METHOD FOR TREATING ALS/FTD THROUGH DEGRADATION OF RNA REPEAT EXPANSION | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-11-30 | — | — | US | disclosed |
| US-20230383284-A1 | SEPARATING POLYNUCLEOTIDE FRAGMENTS | ILLUMINA, INC. (US) | 2023-11-30 | — | — | US | disclosed |
| EP-4282486-A2 | COMPLEMENT FACTOR B INHIBITOR, AND PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Meiyue Biotech Development Co., Ltd. (CN) | 2023-11-29 | — | — | EP | disclosed |
| US-11826758-B2 | Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-11-28 | — | — | US | disclosed |
| CN-117106075-A | Nanometer antibody for resisting H7 subtype influenza virus and application thereof | 华南农业大学 | 2023-11-24 | — | — | CN | disclosed |
| WO-2023224100-A1 | KIT FOR DETECTING GLYCOPROTEIN | 公立大学法人大阪 | 2023-11-23 | — | — | WO | disclosed |
| US-20230375531-A1 | A Method Of Detecting an Analyte and Related Systems | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2023-11-23 | — | — | US | disclosed |
| CN-117098561-A | CCR8 antibodies and uses thereof | 和铂医药美国股份有限公司 | 2023-11-21 | — | — | CN | disclosed |
| US-11820828-B2 | Methods for producing fabs and IgG bispecific antibodies | ELI LILLY AND COMPANY (US) | 2023-11-21 | — | — | US | disclosed |
| US-20230365707-A1 | NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A | BioNTech SE (DE) | 2023-11-16 | — | — | US | disclosed |
| US-20230366879-A1 | CAPTURE, PURIFICATION, AND RELEASE OF BIOLOGICAL SUBSTANCES USING A SURFACE COATING | ACADEMIA SINICA (TW) | 2023-11-16 | — | — | US | disclosed |
| WO-2023220690-A1 | TRANSIENT SIROLIMUS WITH FASL MICROGELS | ITOLERANCE, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| CN-117050181-A | Binding molecules specific for fcγriia and uses thereof | 维埃拉生物股份有限公司 | 2023-11-14 | — | — | CN | disclosed |
| WO-2023213998-A1 | CD3/BCMA/CD38 TRISPECIFIC ANTIBODIES | Ichnos Sciences SA (CH) | 2023-11-09 | — | — | WO | disclosed |
| US-20230358760-A1 | APTAMERS THAT TARGET CXCL9 | Rheinische Friedrich-Wilhelms-Universität Bonn (DE) | 2023-11-09 | — | — | US | disclosed |
| WO-2023213969-A1 | VIRAL-BINDING PROTEIN AND RELATED REAGENTS, ARTICLES, AND METHODS OF USE | JUNO THERAPEUTICS GMBH (DE) | 2023-11-09 | — | — | WO | disclosed |
| EP-4273171-A1 | ANTIBODY CAPABLE OF BINDING TO TROP2, AND USE THEREOF | Nona Biosciences (Suzhou) Co., Ltd. (CN) | 2023-11-08 | — | — | EP | disclosed |
| CN-117003861-A | Fully humanized antibody for broad spectrum neutralization of novel coronavirus and preventive spray | 四川省凯瑞华创生物科技股份有限公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-116997357-A | Antibodies against GDF-15 | 免疫医疗有限责任公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-114685652-B | Fully human broad spectrum cross neutralizing antibodies against SARS-CoV-2 and SARS-CoV and uses thereof | 中国科学院分子细胞科学卓越创新中心 | 2023-11-03 | — | — | CN | disclosed |
| CN-107893052-B | Fusion proteins and uses thereof | 科济生物医药（上海）有限公司 | 2023-11-03 | — | — | CN | disclosed |
| US-20230340088-A1 | Fungal (1,3)-Beta-D glucan-directed monoclonal antibody, coding genes thereof, expression thereof and application thereof | Hebei Collead Biotech Co., Ltd. (CN) | 2023-10-26 | — | — | US | disclosed |
| US-20230340014-A1 | METHODS OF GENERATING NANOARRAYS AND MICROARRAYS | NAUTILUS SUBSIDIARY, INC. | 2023-10-26 | — | — | US | disclosed |
| US-20230338590-A1 | MATERIALS AND METHODS FOR TREATING CORONAVIRUS | MONOPAR THERAPEUTICS, INC. | 2023-10-26 | — | — | US | disclosed |
| US-20230331710-A1 | HETEROCYCLIC COMPOUND, PREPARATION METHOD AND USE THEREOF | SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO. LTD (CN) | 2023-10-19 | — | — | US | disclosed |
| EP-4259099-A1 | BIOLOGICAL DELIVERY SYSTEMS | Particella, Inc. (US) | 2023-10-18 | — | — | EP | disclosed |
| EP-4259182-A1 | SUPERIOR NEUTRALIZATION OF SARS-COV-2 BY DEGLYCOSYLATED HUMAN ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) | IMBA-Institut für Molekulare Biotechnologie GmbH (AT) | 2023-10-18 | — | — | EP | disclosed |
| CN-116879544-A | Extended range immunoassay device using immunosensor and magnetic immunosensor | 雅培医护站股份有限公司 | 2023-10-13 | — | — | CN | disclosed |
| WO-2023194565-A1 | ANTI-TDP-43 BINDING MOLECULES | AC IMMUNE SA (CH) | 2023-10-12 | — | — | WO | disclosed |
| US-20230310510-A1 | FASL-ENGINEERED BIOMATERIALS WITH IMMUNOMODULATORY FUNCTION | GEORGIA TECH RESEARCH CORPORATION | 2023-10-05 | — | — | US | disclosed |
| WO-2023193017-A2 | SARS-COV2 ANTIBODIES AND USES THEREOF | Invivyd, Inc. (US) | 2023-10-05 | — | — | WO | disclosed |
| WO-2023187184-A1 | GASDERMIN E EXPRESSION IN HUMAN T CELLS AS A MARKER FOR PROINFLAMMATORY T CELL FUNCTIONS | LEIBNIZ-INSTITUT FÜR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE E. V. HANS-KNÖLL-INSTITUT (HKI) (DE) | 2023-10-05 | — | — | WO | disclosed |
| WO-2023192289-A2 | ANTI-TROPHOBLAST CELL SURFACE ANTIGEN 2 (TROP-2) ANTIBODIES | ADEPT THERAPEUTICS INC. (US) | 2023-10-05 | — | — | WO | disclosed |
| US-11773159-B2 | Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same | MERCK PATENT GMBH (DE) | 2023-10-03 | — | — | US | disclosed |
| CN-114423868-B | Prokaryotic-eukaryotic hybrid viral vectors for delivery of high-load genes and proteins into human cells | 美国天主教大学 | 2023-10-03 | — | — | CN | disclosed |
| CN-116840489-A | Detection kit for house dust mite allergen specific IgE antibody and application thereof | 郑州安图生物工程股份有限公司 | 2023-10-03 | — | — | CN | disclosed |
| US-20230305002-A1 | PROTEIN FOR RAPID, EFFICIENT CAPTURE OF ANTIGENS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-09-28 | — | — | US | disclosed |
| US-20230296601-A1 | NOVEL CORONAVIRUS ANTIBODY DETECTION KIT BASED ON MAGNETIC PARTICLE CHEMILUMINESCENCE | DYNAMIKER BIOTECHNOLOGY (TIANJIN) CO., LTD. (CN) | 2023-09-21 | — | — | US | disclosed |
| US-11760994-B2 | Separating polynucleotide fragments | ILLUMINA, INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-11761958-B2 | Devices, systems, and methods for the detection of a target analyte using magnetic focus lateral flow immunoassay techniques | PURDUE RESEARCH FOUNDATION (US) | 2023-09-19 | — | — | US | disclosed |
| CN-111458520-B | Novel coronavirus alpha LISA antigen rapid detection kit | 中国人民解放军军事科学院军事医学研究院 | 2023-09-15 | — | — | CN | disclosed |
| US-20230286947-A1 | COMPLEMENT FACTOR B INHIBITOR, AND PHARMACEUTICAL COMPOSITION, PREPARATION METHOD AND USE THEREOF | SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO. LTD. (CN) | 2023-09-14 | — | — | US | disclosed |
| EP-3592392-B1 | FASL-ENGINEERED BIOMATERIALS WITH IMMUNOMODULATORY FUNCTION | UNIV LOUISVILLE RES FOUND INC (US) | 2023-09-13 | — | — | EP | disclosed |
| US-11753624-B2 | Methods for generating functional therapeutic B cells ex-vivo | GEORGIA TECH RESEARCH CORPORATION (US) | 2023-09-12 | — | — | US | disclosed |
| CN-114685653-B | Neutralizing antibodies against epitopes of novel coronavirus receptor binding region and uses thereof | 中国科学院分子细胞科学卓越创新中心 | 2023-09-12 | — | — | CN | disclosed |
| CN-114163528-B | CD47 binding molecules and uses thereof | 东曜药业有限公司 | 2023-09-12 | — | — | CN | disclosed |
| WO-2023165465-A1 | USE OF RILUZOLE IN TREATMENT OF OLIGOSPERMIA | 暨南大学 | 2023-09-07 | — | — | WO | disclosed |
| CN-116675771-A | Anti-human TSLP monoclonal antibody, kit containing same and inspection method | 江苏荃信生物医药股份有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-116685685-A | TIGIT single domain antibodies and bispecific antibodies based thereon | 南京维立志博生物科技有限公司 | 2023-09-01 | — | — | CN | disclosed |
| US-20230272104-A1 | CD20 BINDING MOLECULES AND USES THEREOF | LEGEND BIOTECH USA INC. | 2023-08-31 | — | — | US | disclosed |
| WO-2023164277-A2 | ANTI-PROGRAMMED DEATH-LIGAND 1 (PD-L1) ANTIBODIES | ADEPT THERAPEUTICS INC. (US) | 2023-08-31 | — | — | WO | disclosed |
| CN-114773466-B | Anti-human interleukin 23, kit containing same and detection method thereof | 江苏荃信生物医药股份有限公司 | 2023-08-29 | — | — | CN | disclosed |
| US-11739155-B2 | Antibodies that bind to AXL proteins | AGENSYS, INC. (US) | 2023-08-29 | — | — | US | disclosed |
| US-11740236-B2 | Protein for rapid, efficient capture of antigens | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-08-29 | — | — | US | disclosed |
| CN-116660527-A | Helicobacter pylori magnetic particle chemiluminescence detection reagent, kit, preparation method and application | 重庆新赛亚生物科技有限公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-116640729-A | Memory type B lymphocyte screening method aiming at single antigen specificity and application thereof | 中国人民解放军陆军军医大学 | 2023-08-25 | — | — | CN | disclosed |
| CN-108802360-B | Kit capable of exchanging copper and ceruloplasmin in serum and used for one-step simultaneous detection, preparation method and application | 首都医科大学 | 2023-08-25 | — | — | CN | disclosed |
| EP-4231174-A2 | METHODS AND SYSTEMS FOR COMPUTATIONAL DECODING OF BIOLOGICAL, CHEMICAL, AND PHYSICAL ENTITIES | Nautilus Subsidiary, Inc. (US) | 2023-08-23 | — | — | EP | disclosed |
| US-20230257416-A1 | METHODS OF GENERATING NANOARRAYS AND MICROARRAYS | NAUTILUS SUBSIDIARY, INC. | 2023-08-17 | — | — | US | disclosed |
| US-20230257475-A1 | MULTISPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | LEGEND BIOTECH USA INC. | 2023-08-17 | — | — | US | disclosed |
| US-20230256115-A1 | CROSSLINKED HYDROGEL FOR IMMUNE CHECKPOINT BLOCKADE DELIVERY | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. | 2023-08-17 | — | — | US | disclosed |
| CN-110178032-B | Combined immunoassay and magnetic immunoassay methods for extended range sensitivity | 雅培医护站股份有限公司 | 2023-08-11 | — | — | CN | disclosed |
| US-20230250184-A1 | CD22 BINDING MOLECULES AND USES THEREOF | LEGEND BIOTECH USA INC. | 2023-08-10 | — | — | US | disclosed |
| EP-4223369-A1 | IMMUNOMODULATOR COMPOUNDS AND METHODS OF USE | Incyte Corporation (US) | 2023-08-09 | — | — | EP | disclosed |
| US-11718677-B2 | Antibodies that bind to AXL proteins | AGENSYS, INC. (US) | 2023-08-08 | — | — | US | disclosed |
| CN-112494659-B | Process for producing phthalocyanine dye conjugate and stable conjugate | 乐天医药生技股份有限公司 | 2023-08-08 | — | — | CN | disclosed |
| US-20230242620-A1 | TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | ABLYNX N.V. (BE) | 2023-08-03 | — | — | US | disclosed |
| WO-2023143293-A1 | SALT TYPE AND CRYSTAL FORM OF COMPLEMENT FACTOR B INHIBITOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 上海美悦生物科技发展有限公司 | 2023-08-03 | — | — | WO | disclosed |
| EP-2206517-B1 | Immunopotentiating compositions comprising anti-PD-L1 antibodies | ONO PHARMACEUTICAL CO (JP) | 2023-08-02 | — | — | EP | disclosed |
| CN-116514981-A | Novel anti-human IL-23 monoclonal antibody, kit containing same and detection method thereof | 江苏荃信生物医药股份有限公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-107249636-B | Antitumor agent containing CKAP4 as target molecule | 国立大学法人大阪大学 | 2023-07-28 | — | — | CN | disclosed |
| CN-110192109-B | Combined immunoassay and magnetic immunoassay systems and devices for extended range sensitivity | 雅培医护站股份有限公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-116496249-A | Salt form and crystal form of complement factor B inhibitor, and preparation methods and applications thereof | 上海美悦生物科技发展有限公司 | 2023-07-28 | — | — | CN | disclosed |
| EP-4214507-A1 | A METHOD OF DETECTING AN ANALYTE AND RELATED SYSTEMS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-07-26 | — | — | EP | disclosed |
| EP-4214241-A2 | NOVEL ANTI-A2AP ANTIBODIES AND USES THEREOF | Bayer Aktiengesellschaft (DE) | 2023-07-26 | — | — | EP | disclosed |
| CN-110214274-B | Extended range immunoassay device using immunosensor and magnetic immunosensor | 雅培医护站股份有限公司 | 2023-07-25 | — | — | CN | disclosed |
| CN-114057692-B | Heterocyclic compound, preparation method and application thereof | 上海美悦生物科技发展有限公司 | 2023-07-21 | — | — | CN | disclosed |
| CN-116457464-A | CD19 binding molecules and uses thereof | 南京传奇生物科技有限公司 | 2023-07-18 | — | — | CN | disclosed |
| US-20230221243-A1 | METHODS AND SYSTEMS FOR INTEGRATED ON-CHIP SINGLE-MOLECULE DETECTION | NAUTILUS SUBSIDIARY, INC. | 2023-07-13 | — | — | US | disclosed |
| US-11696956-B2 | Bicyclic peptide ligands specific for EphA2 | BICYCLETX LIMITED (GB) | 2023-07-11 | — | — | US | disclosed |
| US-20230213438-A1 | METHODS AND SYSTEMS FOR INTEGRATED ON-CHIP SINGLE-MOLECULE DETECTION | NAUTILUS SUBSIDIARY, INC. | 2023-07-06 | — | — | US | disclosed |
| WO-2023125941-A1 | TIGIT SINGLE-DOMAIN ANTIBODY AND BISPECIFIC ANTIBODY BASED THEREON | 南京维立志博生物科技有限公司 | 2023-07-06 | — | — | WO | disclosed |
| EP-4204567-A1 | APTAMERS THAT TARGET CXCL9 | Rheinische Friedrich-Wilhelms-Universität Bonn (DE) | 2023-07-05 | — | — | EP | disclosed |
| CN-116390941-A | Multispecific chimeric antigen receptor and uses thereof | 南京传奇生物科技有限公司 | 2023-07-04 | — | — | CN | disclosed |
| WO-2023122682-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS TO ACCEPTOR CELLS | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2023-06-29 | — | — | WO | disclosed |
| US-20230203155-A1 | ROR1-SPECIFIC ANTIGEN BINDING MOLECULES | ALMAC DISCOVERY LIMITED (GB) | 2023-06-29 | — | — | US | disclosed |
| CN-113929776-B | Antifungal (1, 3) -beta-D glucan monoclonal antibody, encoding gene and expression and application thereof | 河北康立德生物科技有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-112462054-B | Method for quantitatively detecting escherichia coli O157: H7 | 齐鲁工业大学 | 2023-06-23 | — | — | CN | disclosed |
| CN-116323948-A | CD22 binding molecules and uses thereof | 南京传奇生物科技有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116322683-A | Compounds as C5AR inhibitors | 科越医药(苏州)有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-109863174-B | Binding molecules specific for fcγriia and uses thereof | 维埃拉生物股份有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-113683688-B | anti-HIV type I P24 antigen (HIV-1P 24) rabbit monoclonal antibody and application thereof | 无锡傲锐东源生物科技有限公司 | 2023-06-23 | — | — | CN | disclosed |
| US-20230194523-A1 | METHODS AND COMPOSITIONS FOR DETECTING FUNGI AND MYCOTOXINS | RTL PURCHASER LLC | 2023-06-22 | — | — | US | disclosed |
| US-20230192847-A1 | TIGIT ANTIBODIES, ENCODING NUCLEIC ACIDS AND METHODS OF USING SAID ANTIBODIES IN VIVO | KYMAB LTD (GB) | 2023-06-22 | — | — | US | disclosed |
| US-20230192883-A1 | CD19 BINDING MOLECULES AND USES THEREOF | LEGEND BIOTECH USA INC. | 2023-06-22 | — | — | US | disclosed |
| EP-3325010-B1 | ANTIBODIES TO COAGULATION FACTOR XIA AND USES THEREOF | UNIV CALIFORNIA (US) | 2023-06-21 | — | — | EP | disclosed |
| US-11680101-B2 | Anti-OPG antibodies | KYMAB LIMITED (GB) | 2023-06-20 | — | — | US | disclosed |
| US-11679152-B2 | Recombinant hypoallergenic Equ c 1 polypeptides for use in the immunotherapy of horse allergy | DESENTUM OY (FI) | 2023-06-20 | — | — | US | disclosed |
| US-20230182139-A1 | EVACUATED BLOOD COLLECTION TUBES CONTAINING PROTEASE INHIBITORS FOR THE ASSESSMENT OF CONTACT SYSTEM ACTIVATION | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-06-15 | — | — | US | disclosed |
| EP-4194449-A1 | HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Meiyue Biotech Development Co., Ltd. (CN) | 2023-06-14 | — | — | EP | disclosed |
| EP-4194451-A1 | COMPLEMENT FACTOR B INHIBITOR, AND PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Meiyue Biotech Development Co., Ltd. (CN) | 2023-06-14 | — | — | EP | disclosed |
| EP-4192816-A1 | COMPOUNDS AS C5AR INHIBITORS | Kira Pharmaceuticals (Suzhou) Ltd. (CN) | 2023-06-14 | — | — | EP | disclosed |
| EP-4028505-B1 | A METHOD FOR PROVIDING A CARTILAGE IMPLANT WITH CHONDROCYTES | CLINE SCIENT AB (SE) | 2023-06-14 | — | — | EP | disclosed |
| EP-3537152-B1 | IMMUNOASSAY METHOD FOR DETERMINING RENIN CONCENTRATION | FUJIREBIO KK (JP) | 2023-06-14 | — | — | EP | disclosed |
| US-11674958-B2 | Capture, purification, and release of biological substances using a surface coating | ACADEMIA SINICA (TW) | 2023-06-13 | — | — | US | disclosed |
| CN-116254225-A | Membrane protein double-positive specific extracellular vesicle subgroup separation and enrichment method, kit and application thereof | 南方医科大学南方医院 | 2023-06-13 | — | — | CN | disclosed |
| CN-116243004-A | Reagent and kit for quantitative detection of chicken protein allergen specific IgE | 江苏浩欧博生物医药股份有限公司 | 2023-06-09 | — | — | CN | disclosed |
| CN-116243004-A | Reagent and kit for quantitative detection of chicken protein allergen specific IgE | 江苏浩欧博生物医药股份有限公司 | 2023-06-09 | — | — | CN | disclosed |
| CN-114656561-B | anti-IP-10 monoclonal antibody | 南京鼓楼医院 | 2023-06-09 | — | — | CN | disclosed |
| US-11668718-B2 | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-06-06 | — | — | US | disclosed |
| CN-116217714-A | Full porcine PEDV monoclonal antibody and epitope thereof | 华中农业大学 | 2023-06-06 | — | — | CN | disclosed |
| CN-116196995-A | Vaccum blood collection tubes containing protease inhibitors for assessing contact system activation | 武田药品工业株式会社 | 2023-06-02 | — | — | CN | disclosed |
| EP-4186926-A1 | CCR8 ANTIBODY AND APPLICATION THEREOF | Harbour Biomed US, Inc. (US) | 2023-05-31 | — | — | EP | disclosed |
| WO-2023092001-A1 | TARGETED DRUG DELIVERY-RELEASE AND KILLING OF DRUG RESISTANT TUMORS AND PATHOGENS | RUBHU BIOLOGICS, INC. (US) | 2023-05-25 | — | — | WO | disclosed |
| EP-4182351-A1 | CD19 BINDING MOLECULES AND USES THEREOF | Nanjing Legend Biotech Co., Ltd. (CN) | 2023-05-24 | — | — | EP | disclosed |
| EP-4182352-A1 | CD22 BINDING MOLECULES AND USES THEREOF | Nanjing Legend Biotech Co., Ltd. (CN) | 2023-05-24 | — | — | EP | disclosed |
| EP-4182356-A1 | MULTISPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | Nanjing Legend Biotech Co., Ltd. (CN) | 2023-05-24 | — | — | EP | disclosed |
| EP-4182350-A1 | CD20 BINDING MOLECULES AND USES THEREOF | Nanjing Legend Biotech Co., Ltd. (CN) | 2023-05-24 | — | — | EP | disclosed |
| US-11655297-B2 | ILDR2 antagonists and combinations thereof | BAYER AKTIENGESELLSCHAFT (DE) | 2023-05-23 | — | — | US | disclosed |
| CN-116143865-A | Method for enriching cell surface mediated tau protein diffusion receptor | 中国科学院大连化学物理研究所 | 2023-05-23 | — | — | CN | disclosed |
| WO-2023081958-A1 | ANTIVIRAL AGENT COMPRISING A CELLULAR ENTRY RECEPTOR AND FC REGION COMPONENT | THE MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH LTD (AU) | 2023-05-19 | — | — | WO | disclosed |
| US-20230149531-A1 | Suprastructure Comprising Modified Influenza Hemagglutinin With Reduced Interaction With Sialic Acid | ARAMIS BIOTECHNOLOGIES INC. (CA) | 2023-05-18 | — | — | US | disclosed |
| US-20230151328-A1 | A Method For Providing A Cartilage Implant With Chondrocytes | CLINE SCIENTIFIC AB (SE) | 2023-05-18 | — | — | US | disclosed |
| EP-4178623-A1 | CROSSLINKED HYDROGEL FOR IMMUNE CHECKPOINT BLOCKADE DELIVERY | Georgia Tech Research Corporation (US) | 2023-05-17 | — | — | EP | disclosed |
| CN-110156892-B | anti-PD-L1 antibodies and their use as therapeutic and diagnostic agents | 百济神州有限公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-116113434-A | Heterodimeric Fc variants selective for FcgammaRIIB | 酵活生物制药有限公司 | 2023-05-12 | — | — | CN | disclosed |
| US-20230145172-A1 | A METHOD OF ADMINISTERING A NANOPARTICLE | KAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION (JP) | 2023-05-11 | — | — | US | disclosed |
| US-20230144799-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2 | BICYCLETX LIMITED (GB) | 2023-05-11 | — | — | US | disclosed |
| EP-4176079-A1 | SEPARATING POLYNUCLEOTIDE FRAGMENTS | Illumina, Inc. (US) | 2023-05-10 | — | — | EP | disclosed |
| US-11644471-B2 | Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains | ABLYNX N.V. (BE) | 2023-05-09 | — | — | US | disclosed |
| US-11642417-B2 | Compositions of protein complexes and methods of use thereof | BONUM THERAPEUTICS, INC. (US) | 2023-05-09 | — | — | US | disclosed |
| CN-114181301-B | ADE-effect-free neutralizing antibodies against SARS-CoV-2 | 复旦大学 | 2023-04-28 | — | — | CN | disclosed |
| US-20230129258-A1 | HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES | BICYCLETX LIMITED (GB) | 2023-04-27 | — | — | US | disclosed |
| CN-116004684-A | SM fusion antigen and anti-Sm antibody chemiluminescence detection kit | 广东优尼德生物科技有限公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-115997029-A | Isolation of Polynucleotide fragments | 伊鲁米纳公司 | 2023-04-21 | — | — | CN | disclosed |
| EP-3331563-B1 | ANTI-CD154 ANTIBODIES AND METHODS OF USING THEM | JANSSEN BIOTECH INC (US) | 2023-04-19 | — | — | EP | disclosed |
| EP-4165070-A1 | PRECISION RADIOIMMUNOTHERAPEUTIC TARGETING OF THE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) FOR TREATMENT OF SEVERE COVID-19 DISEASE | Monopar Therapeutics Inc. (US) | 2023-04-19 | — | — | EP | disclosed |
| EP-4165549-A1 | METHODS AND SYSTEMS FOR COMPUTATIONAL DECODING OF BIOLOGICAL, CHEMICAL, AND PHYSICAL ENTITIES | Nautilus Biotechnology, Inc. (US) | 2023-04-19 | — | — | EP | disclosed |
| CN-115947844-A | Novel anti-human IL-33 monoclonal antibody, kit containing same and detection method thereof | 江苏荃信生物医药股份有限公司 | 2023-04-11 | — | — | CN | disclosed |
| CN-111032069-B | Use of a Piezo modulator for the manufacture of a medicament | 清华大学 | 2023-04-07 | — | — | CN | disclosed |
| CN-115925927-A | anti-IL-10 monoclonal antibody, and preparation method and application thereof | 南京鼓楼医院 | 2023-04-07 | — | — | CN | disclosed |
| US-20230108636-A1 | COMPOSITIONS AND METHODS FOR ENHANCING TRANSPORT THROUGH MUCUS | UNIV JOHNS HOPKINS (US) | 2023-04-06 | — | — | US | disclosed |
| US-11618790-B2 | Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery | HOFFMANN-LA ROCHE INC. (US) | 2023-04-04 | — | — | US | disclosed |
| US-20230096410-A1 | Innate Immunity Killer Cells Targeting PSMA Positive Tumor Cells | SORRENTO THERAPEUTICS, INC. (US) | 2023-03-30 | — | — | US | disclosed |
| EP-4153621-A1 | HETERODIMERIC FC VARIANTS SELECTIVE FOR FC GAMMA RIIB | Zymeworks BC Inc. (CA) | 2023-03-29 | — | — | EP | disclosed |
| CN-115867570-A | Precisely radioimmunotherapy targeting urokinase plasminogen activator receptor (uPAR) to treat severe COVID-19 disease | 莫诺帕医疗公司 | 2023-03-28 | — | — | CN | disclosed |
| EP-4151785-A1 | FIBRONECTIN TYPE III REPEAT BASED PROTEIN SCAFFOLDS WITH ALTERNATIVE BINDING SURFACES | Janssen Biotech, Inc. (US) | 2023-03-22 | — | — | EP | disclosed |
| EP-4149554-A1 | COMPOSITIONS OF PROTEIN COMPLEXES AND METHODS OF USE THEREOF | Bonum Therapeutics, Inc. (US) | 2023-03-22 | — | — | EP | disclosed |
| US-RE49466-E1 | Solution phase homogeneous assays | BECKMAN COULTER, INC. (US) | 2023-03-21 | — | — | US | disclosed |
| CN-115785260-A | Method for preparing biotinylation antibody | 郑州伊美诺生物技术有限公司 | 2023-03-14 | — | — | CN | disclosed |
| US-11602547-B2 | FasL-engineered biomaterials with immunomodulatory function | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) | 2023-03-14 | — | — | US | disclosed |
| US-11603383-B2 | Methods of generating nanoarrays and microarrays | NAUTILUS BIOTECHNOLOGY, INC. (US) | 2023-03-14 | — | — | US | disclosed |
| US-20230071749-A1 | Fibronectin Type III Domain Based Scaffold Compositions, Methods and Uses | JANSSEN BIOTECH, INC. | 2023-03-09 | — | — | US | disclosed |
| US-20230074436-A1 | ANTI-ALPHA-SYNUCLEIN ANTIBODIES AND METHODS OF USE THEREOF | DENALI THERAPEUTICS INC. | 2023-03-09 | — | — | US | disclosed |
| US-11596692-B1 | PD-L1/STING conjugates and methods of use | INCYTE CORPORATION (US) | 2023-03-07 | — | — | US | disclosed |
| EP-4139331-A1 | SUPRASTRUCTURE COMPRISING MODIFIED INFLUENZA HEMAGGLUTININ WITH REDUCED INTERACTION WITH SIALIC ACID | Medicago Inc. (CA) | 2023-03-01 | — | — | EP | disclosed |
| US-11591375-B2 | Immunogenic compositions comprising Mycobacterium bovis surface proteins and uses thereof | OREGON STATE UNIVERSITY (US) | 2023-02-28 | — | — | US | disclosed |
| US-20230056203-A1 | METHODS AND COMPOSITIONS FOR TARGETING CANCER CELLS IN METASTASES | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-02-23 | — | — | US | disclosed |
| WO-2023012147-A1 | BISPECIFIC ANTIBODIES AND METHODS OF USE | F. HOFFMANN-LA ROCHE AG (CH) | 2023-02-09 | — | — | WO | disclosed |
| US-20230038166-A1 | METHODS OF DETECTING LIPOARABINOMANNAN AND DIAGNOSING NONTUBERCULOSIS MYCOBACTERIAL INFECTION | NATIONAL JEWISH HEALTH | 2023-02-09 | — | — | US | disclosed |
| US-20230044044-A1 | MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS | MAPP BIOPHARMACEUTICAL INC (US) | 2023-02-09 | — | — | US | disclosed |
| US-20230036181-A1 | ANTI-GAL3 ANTIBODIES AND METHODS OF USE | TRUEBINDING, INC. | 2023-02-02 | — | — | US | disclosed |
| CN-115656154-A | anti-RNP antibody chemiluminescence detection kit based on recombinant RNP multiple antigens | 广东优尼德生物科技有限公司 | 2023-01-31 | — | — | CN | disclosed |
| CN-115656153-A | Antinuclear antibody spectrum detection kit based on acridinium ester chemiluminescence | 广东优尼德生物科技有限公司 | 2023-01-31 | — | — | CN | disclosed |
| US-20230025525-A1 | NOVEL IGFR-LIKE RECEPTOR AND USES THEREOF | HELMHOLTZ ZENTRUM MUENCHEN - DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT (GMBH) (DE) | 2023-01-26 | — | — | US | disclosed |
| US-20230023615-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL DELIVERY VEHICLES | PARTICELLA, INC. | 2023-01-26 | — | — | US | disclosed |
| WO-2023003879-A2 | EARLY DETECTION OF INNATE IMMUNE DYSFUNCTION AND TREATMENT OF CONDITIONS ASSOCIATED THEREWITH | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-01-26 | — | — | WO | disclosed |
| CN-115639360-A | Preparation of precursor gastrin (PG 80) antibody and establishment of CLIA detection PG80 kit | 武汉市朗典精医生物科技有限公司 | 2023-01-24 | — | — | CN | disclosed |
| CN-115636874-A | Method for preparing neuropeptide Y (NPY) antibody and establishing NPY detection method | 武汉市朗典精医生物科技有限公司 | 2023-01-24 | — | — | CN | disclosed |
| US-20230008076-A1 | HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES | BICYCLETX LIMITED (GB) | 2023-01-12 | — | — | US | disclosed |
| WO-2023282243-A1 | METHOD FOR DETECTING HEPATITIS E VIRUS INFECTION, AND ANTIGEN POLYPEPTIDE AND KIT FOR DETECTING HEPATITIS E VIRUS INFECTION | 株式会社先端生命科学研究所 | 2023-01-12 | — | — | WO | disclosed |
| WO-2023283211-A2 | CD21 ANTIBODIES AND USES THEREOF | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2023-01-12 | — | — | WO | disclosed |
| EP-4114415-A1 | INNATE IMMUNITY KILLER CELLS TARGETING PSMA POSITIVE TUMOR CELLS | Sorrento Therapeutics, Inc. (US) | 2023-01-11 | — | — | EP | disclosed |
| EP-4115911-A1 | STABILIZED FIBRONECTIN DOMAIN COMPOSITIONS, METHODS AND USES | Janssen Biotech, Inc. (US) | 2023-01-11 | — | — | EP | disclosed |
| CN-108135547-B | Vacuum blood collection tube containing protease inhibitor for evaluating activation of contact system | 武田药品工业株式会社 | 2023-01-10 | — | — | CN | disclosed |
| CN-110208533-B | Evaluation, determination and treatment of PKAL-mediated disorders | 武田药品工业株式会社 | 2023-01-10 | — | — | CN | disclosed |
| US-11549000-B2 | Cellular glycosaminoglycan compositions and methods of making and using | TEGA THERAPEUTICS, INC. (US) | 2023-01-10 | — | — | US | disclosed |
| US-20220411508-A1 | COMPOSITIONS AND METHODS FOR MAKING AND USING MULTISPECIFIC ANTIBODIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-12-29 | — | — | US | disclosed |
| US-20220403432-A1 | METHOD FOR PREPARING CHONDROITIN SULFATE OLIGOSACCHARIDES WITH C5 PROTEIN TARGETING PROPERTY, AND APPLICATION THEREOF | SHANDONG UNIVERSITY (CN) | 2022-12-22 | — | — | US | disclosed |
| EP-4105231-A1 | AMINO ACID SEQUENCES DIRECTED AGAINST IL-17A, IL-17F AND/OR IL17-A/F AND POLYPEPTIDES COMPRISING THE SAME | Merck Patent GmbH (DE) | 2022-12-21 | — | — | EP | disclosed |
| CN-110267953-B | Tetrahydroimidazo [4,5-C ] pyridine derivatives as inducers of PD-L1 internalization | 因赛特公司 | 2022-12-20 | — | — | CN | disclosed |
| US-11529426-B2 | Methods and compositions for targeting tissue lesions | Hasty, Karen (US) | 2022-12-20 | — | — | US | disclosed |
| WO-2022260678-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL DELIVERY VEHICLES | DNALITE THERAPEUTICS, INC. (US) | 2022-12-15 | — | — | WO | disclosed |
| US-20220396632-A1 | ANTI-PSGL-1 COMPOSITIONS AND METHODS FOR MODULATING MYELOID CELL INFALMMATORY PHENOTYPES AND USES THEREOF | VERSEAU THERAPEUTICS, INC. | 2022-12-15 | — | — | US | disclosed |
| CN-115427449-A | anti-Gal 3 antibodies and methods of use | 真和制药有限公司 | 2022-12-02 | — | — | CN | disclosed |
| WO-2022251311-A1 | METHODS OF QUANTIFYING ANTI-CD40 ANTIBODIES | SEAGEN INC. (US) | 2022-12-01 | — | — | WO | disclosed |
| US-20220380454-A1 | METHODS AND COMPOSITIONS FOR TREATING ALZHEIMER'S DISEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-12-01 | — | — | US | disclosed |
| WO-2022246078-A1 | COMPOUNDS AND METHODS TARGETING EPIREGULIN | ELI LILLY AND COMPANY (US) | 2022-11-24 | — | — | WO | disclosed |
| US-20220372124-A1 | COMPOUNDS AND METHODS TARGETING EPIREGULIN | ELI LILLY AND COMPANY | 2022-11-24 | — | — | US | disclosed |
| EP-4090685-A1 | ANTI-GAL3 ANTIBODIES AND METHODS OF USE | TrueBinding, Inc. (US) | 2022-11-23 | — | — | EP | disclosed |
| CN-108653728-B | Techniques for predicting, detecting, and reducing non-specific protein interference in assays involving immunoglobulin single variable domains | 埃博灵克斯股份有限公司 | 2022-11-18 | — | — | CN | disclosed |
| US-20220363744-A1 | VEGF-BINDING MOLECULES | BOEHRINGER INGELHEIM INT (DE) | 2022-11-17 | — | — | US | disclosed |
| WO-2022233320-A1 | FC MUTANT WITH ALTERED BINDING TO FC RECEPTOR | 信达生物制药(苏州)有限公司 | 2022-11-10 | — | — | WO | disclosed |
| CN-115290883-A | Synchronous detection method for multiple exosome proteins | 郑州大学 | 2022-11-04 | — | — | CN | disclosed |
| US-11484602-B2 | Bicyclic peptide ligands specific for EphA2 | BICYCLETX LIMITED (GB) | 2022-11-01 | — | — | US | disclosed |
| CN-115279789-A | Antibodies that disrupt the interaction of GAL3 and insulin receptor or integrin and methods of use thereof | 真和制药有限公司 | 2022-11-01 | — | — | CN | disclosed |
| US-11479880-B2 | Fibronectin type III domain based scaffold compositions, methods and uses | JANSSEN BIOTECH, INC. (US) | 2022-10-25 | — | — | US | disclosed |
| EP-3334343-B1 | EVACUATED BLOOD COLLECTION TUBES CONTAINING PROTEASE INHIBITORS FOR THE ASSESSMENT OF CONTACT SYSTEM ACTIVATION | TAKEDA PHARMACEUTICALS CO (JP) | 2022-10-19 | — | — | EP | disclosed |
| CN-115184621-A | Immunity layer analysis-based copeptin detection reagent and preparation method thereof | 长春恒晓生物科技有限责任公司 | 2022-10-14 | — | — | CN | disclosed |
| CN-113238057-B | Miao-Lee's tube inhibitor receptor chemiluminescence immunoassay kit and preparation method thereof | 迪瑞医疗科技股份有限公司 | 2022-10-14 | — | — | CN | disclosed |
| CN-115184621-A | Immunity layer analysis-based copeptin detection reagent and preparation method thereof | 长春恒晓生物科技有限责任公司 | 2022-10-14 | — | — | CN | disclosed |
| US-20220324978-A1 | ANTI-PD-1 ANTIBODIES AND USES THEREOF | BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. (CN) | 2022-10-13 | — | — | US | disclosed |
| WO-2022216768-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS TO ACCEPTOR CELLS | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2022-10-13 | — | — | WO | disclosed |
| WO-2022207014-A2 | ANTIFUNGAL (1, 3)-β-D GLUCAN MONOCLONAL ANTIBODY, AND CODING GENE, EXPRESSION AND USE THEREOF | 河北康立德生物科技有限公司 | 2022-10-06 | — | — | WO | disclosed |
| US-20220315926-A1 | An Aptamer for Dengue Virus and Related Methods and Products | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2022-10-06 | — | — | US | disclosed |
| US-11458477-B2 | Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2022-10-04 | — | — | US | disclosed |
| CN-109313200-B | Bioanalytical methods for characterizing site-specific antibody-drug conjugates | 豪夫迈·罗氏有限公司 | 2022-10-04 | — | — | CN | disclosed |
| US-11453703-B2 | Heterotandem bicyclic peptide complexes | BICYCLETX LIMITED (GB) | 2022-09-27 | — | — | US | disclosed |
| US-20220296516-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL DELIVERY VEHICLES | PARTICELLA, INC. | 2022-09-22 | — | — | US | disclosed |
| US-20220298227-A9 | TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | ABLYNX N.V. (BE) | 2022-09-22 | — | — | US | disclosed |
| US-20220289792-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2 | BICYCLETX LIMITED (GB) | 2022-09-15 | — | — | US | disclosed |
| CN-115047182-A | Exosome analysis and cancer diagnosis method | 香港科技大学 | 2022-09-13 | — | — | CN | disclosed |
| US-11440960-B2 | TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in vivo | KYMAB LIMITED (GB) | 2022-09-13 | — | — | US | disclosed |
| US-11442066-B2 | Method for identifying drug-discovery target protein for development of antibody drug, and method for producing antibody against target protein | MITSUI CHEMICALS, INC (JP) | 2022-09-13 | — | — | US | disclosed |
| US-20220283171-A1 | METHODS AND SYSTEMS FOR PRODUCING NANOLIPOPROTEIN PARTICLES | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2022-09-08 | — | — | US | disclosed |
| CN-114994324-A | Composition for immunodetection, kit, detection method and application | 深圳泌码科技有限公司 | 2022-09-02 | — | — | CN | disclosed |
| WO-2022180145-A2 | INHIBITORS OF IL-11 OR IL-11RA FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING | BAYER AKTIENGESELLSCHAFT (DE) | 2022-09-01 | — | — | WO | disclosed |
| US-20220275066-A1 | SINGLE DOMAIN ANTIBODIES BINDING TO TETANUS NEUROTOXIN | SMIVET B.V. (NL) | 2022-09-01 | — | — | US | disclosed |
| WO-2022180172-A1 | INHIBITORS OF IL-11 OR IL-11RA FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING | BAYER AKTIENGESELLSCHAFT (DE) | 2022-09-01 | — | — | WO | disclosed |
| WO-2022183213-A2 | COMPOSITIONS AND METHODS FOR STABILIZATION OF ALLOSTERIC PROTEINS | UNIVERSITY OF WASHINGTON (US) | 2022-09-01 | — | — | WO | disclosed |
| EP-4049674-A1 | TRUNCATED EPIDERMAL GROWTH FACTOR RECEPTOR (EGFRT) FOR TRANSDUCED T CELL SELECTION | City of Hope (US) | 2022-08-31 | — | — | EP | disclosed |
| US-11428694-B2 | Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies | ABBOTT LABORATORIES (US) | 2022-08-30 | — | — | US | disclosed |
| CN-112485233-B | Nano sensor for detecting deacetylase and detection method and application thereof | 山东师范大学 | 2022-08-26 | — | — | CN | disclosed |
| WO-2022178040-A1 | TRUNCATED DOMAIN IV EGFR AND USES THEREOF | CITY OF HOPE (US) | 2022-08-25 | — | — | WO | disclosed |
| US-20220265806-A1 | ANTIBODIES OR ANTIBODY-FRAGMENTS THEREOF TARGETING ALPHAVIRUSES, AND COMPOSITIONS AND METHODS COMPRISING SAME | ALBERT EINSTEIN COLLEGE OF MEDICINE | 2022-08-25 | — | — | US | disclosed |
| WO-2022177677-A1 | TRUNCATED DOMAIN IV EGFR AND USES THEREOF | CITY OF HOPE (US) | 2022-08-25 | — | — | WO | disclosed |
| EP-4047368-A1 | METHOD AND KIT FOR TARGET MOLECULE DETECTION | Toppan Printing Co., Ltd. (JP) | 2022-08-24 | — | — | EP | disclosed |
| US-11421037-B2 | Nucleic acids encoding anti-CD154 antibodies | JANSSEN BIOTECH, INC. (US) | 2022-08-23 | — | — | US | disclosed |
| US-11421023-B2 | Anti-GP73 monoclonal antibodies and methods of obtaining the same | ABBOTT LABORATORIES (US) | 2022-08-23 | — | — | US | disclosed |
| WO-2021232162-A9 | HETERODIMERIC FC VARIANTS SELECTIVE FOR FC GAMMA RIIB | ZYMEWORKS INC. (CA) | 2022-08-18 | — | — | WO | disclosed |
| EP-3540100-B1 | FIBRONECTIN TYOE III REPEAT BASED PROTEIN SCAFFOLDS WITH ALTERNATIVE BINDING SURFACES | JANSSEN BIOTECH INC (US) | 2022-08-17 | — | — | EP | disclosed |
| CN-114578064-B | Application of reagent for detecting CAF22 in preparation of composition for evaluating renal tubular injury | 北京沃森赛瑟生物技术有限公司 | 2022-08-16 | — | — | CN | disclosed |
| CN-109642908-B | Compounds useful for treating metabolic disorders | 哈佛学院院长及董事 | 2022-08-16 | — | — | CN | disclosed |
| CN-114901361-A | Methods of using IL-33 antagonists | 免疫医疗有限公司 | 2022-08-12 | — | — | CN | disclosed |
| US-20220252614-A1 | Hepatitis C Virus Detection Kit | FAPON BIOTECH INC (CN) | 2022-08-11 | — | — | US | disclosed |
| US-20220252619-A1 | DETECTION OF MEDIATORS OF DOPAMINE TRANSMISSION | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2022-08-11 | — | — | US | disclosed |
| EP-4039812-A1 | REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF NEURAL INJURY CAUSED BY DISRUPTION OF BLOOD FLOW | The Penn State Research Foundation (US) | 2022-08-10 | — | — | EP | disclosed |
| EP-3558990-B1 | TETRAHYDRO IMIDAZO[4,5-C]PYRIDINE DERIVATIVES AS PD-L1 INTERNALIZATION INDUCERS | INCYTE CORP (US) | 2022-08-10 | — | — | EP | disclosed |
| US-11407816-B2 | Monoclonal antibodies and cocktails for treatment of Ebola infections | MAPP BIOPHARMACEUTICAL, INC. (US) | 2022-08-09 | — | — | US | disclosed |
| US-11407817-B2 | Monoclonal antibodies and cocktails for treatment of Ebola infections | MAPP BIOPHARMACEUTICAL, INC. (US) | 2022-08-09 | — | — | US | disclosed |
| CN-114874322-A | ILT7 binding molecules and methods of use thereof | 维埃拉生物股份有限公司 | 2022-08-09 | — | — | CN | disclosed |
| CN-114878840-A | Kit and method for measuring triiodothyronine by magnetic particle chemiluminescence | 昆明思安生物科技有限公司 | 2022-08-09 | — | — | CN | disclosed |
| CN-114805545-A | Capture antigen for detecting anti-asialoglycoprotein receptor antibody and detection method | 苏州和锐生物科技有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114814238-A | Application of CAF22 detection reagent in preparation of AKI diagnostic composition | 中元汇吉生物技术股份有限公司 | 2022-07-29 | — | — | CN | disclosed |
| US-11396530-B2 | Bicyclic peptide ligands and uses thereof | BICYCLETX LIMITED (GB) | 2022-07-26 | — | — | US | disclosed |
| CN-114773466-A | Anti-human interleukin 23, kit comprising same and detection method thereof | 江苏荃信生物医药股份有限公司 | 2022-07-22 | — | — | CN | disclosed |
| US-20220227855-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF ANGIOGENESIS RELATED DISEASES | THE UNIVERSITY OF MASSACHUSETTS | 2022-07-21 | — | — | US | disclosed |
| US-20220226378-A1 | METHOD FOR TREATING CANCER | NATIONAL TAIWAN UNIVERSITY (TW) | 2022-07-21 | — | — | US | disclosed |
| US-20220227811-A1 | HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES | BICYCLETX LIMITED (GB) | 2022-07-21 | — | — | US | disclosed |
| US-20220227857-A1 | NOVEL MODULATORS | XOMA (US) LLC | 2022-07-21 | — | — | US | disclosed |
| EP-4028058-A1 | COMPOSITIONS AND METHODS FOR MAKING AND USING MULTISPECIFIC ANTIBODIES | The Regents of the University of California (US) | 2022-07-20 | — | — | EP | disclosed |
| EP-4028505-A1 | A METHOD FOR PROVIDING A CARTILAGE IMPLANT WITH CHONDROCYTES | Cline Scientific AB (SE) | 2022-07-20 | — | — | EP | disclosed |
| CN-113583112-B | AAV specific antibodies and uses thereof | 上海勉亦生物科技有限公司 | 2022-07-19 | — | — | CN | disclosed |
| CN-113552349-B | Detection method of AAV protein coat | 上海勉亦生物科技有限公司 | 2022-07-19 | — | — | CN | disclosed |
| WO-2022143816-A1 | FULL-HUMAN BROAD-SPECTRUM CROSS-NEUTRALIZING ANTIBODY FOR SARS-COV-2 AND SARS-COV AND APPLICATION THEREOF | 中国科学院分子细胞科学卓越创新中心 | 2022-07-07 | — | — | WO | disclosed |
| WO-2022143815-A1 | NEUTRALIZING ANTIBODY AGAINST EPITOPES OF RECEPTOR BINDING DOMAIN OF NOVEL CORONAVIRUS AND USE THEREOF | 中国科学院分子细胞科学卓越创新中心 | 2022-07-07 | — | — | WO | disclosed |
| WO-2022143670-A1 | ANTIBODY CAPABLE OF BINDING TO TROP2, AND USE THEREOF | 和铂医药(苏州)有限公司 | 2022-07-07 | — | — | WO | disclosed |
| CN-114699525-A | Method for producing phthalocyanine dye conjugate and stable conjugate | 乐天医药生技股份有限公司 | 2022-07-05 | — | — | CN | disclosed |
| CN-113388029-B | Neutralizing human monoclonal antibody against novel coronavirus and application thereof | 中国科学院武汉病毒研究所 | 2022-07-05 | — | — | CN | disclosed |
| CN-114685653-A | Anti-new coronavirus receptor binding region epitope neutralizing antibody and application thereof | 中国科学院分子细胞科学卓越创新中心 | 2022-07-01 | — | — | CN | disclosed |
| CN-114685652-A | Total human broad-spectrum cross-neutralizing antibody aiming at SARS-CoV-2 and SARS-CoV and application thereof | 中国科学院分子细胞科学卓越创新中心 | 2022-07-01 | — | — | CN | disclosed |
| CN-114681623-A | Method for producing phthalocyanine dye conjugate and stable conjugate | 乐天医药生技股份有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-114685669-A | Antibodies that bind TROP2 and uses thereof | 和铂医药(苏州)有限公司 | 2022-07-01 | — | — | CN | disclosed |
| WO-2022140413-A1 | AMYLOID-SPECIFIC ANTIBODIES AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2022-06-30 | — | — | WO | disclosed |
| US-20220204549-A1 | METHODS OF GENERATING NANOARRAYS AND MICROARRAYS | NAUTILUS BIOTECHNOLOGY, INC. | 2022-06-30 | — | — | US | disclosed |
| US-20220202899-A1 | COMPOSITION FOR PREVENTION OR TREATMENT OF HAIR LOSS INCLUDING HAPLN1 | Haplnscience inc. (KR) | 2022-06-30 | — | — | US | disclosed |
| EP-4017986-A1 | A PROKARYOTIC-EUKARYOTIC HYBRID VIRAL VECTOR FOR DELIVERY OF LARGE CARGOS OF GENES AND PROTEINS INTO HUMAN CELLS | THE CATHOLIC UNIVERSITY OF AMERICA (US) | 2022-06-29 | — | — | EP | disclosed |
| CN-111606993-B | Fully human broad-spectrum neutralizing antibody 4F1 for resisting respiratory syncytial virus and application thereof | 中国科学院上海生命科学研究院 | 2022-06-28 | — | — | CN | disclosed |
| US-11370832-B2 | Anti-Tau antibodies and methods of use thereof | DENALI THERAPEUTICS INC. (US) | 2022-06-28 | — | — | US | disclosed |
| CN-109354623-B | Compositions and related uses of functional receptors for hepatitis b virus | 华辉安健（北京）生物科技有限公司 | 2022-06-24 | — | — | CN | disclosed |
| CN-114656561-A | anti-IP-10 monoclonal antibody and preparation method and application thereof | 南京鼓楼医院 | 2022-06-24 | — | — | CN | disclosed |
| WO-2022132678-A1 | BIOLOGICAL DELIVERY SYSTEMS | DNALITE THERAPEUTICS, INC. (US) | 2022-06-23 | — | — | WO | disclosed |
| US-20220195031-A1 | AMINO ACID SEQUENCES DIRECTED AGAINST IL-17A, IL-17F AND/OR IL-17A/F AND POLYPEPTIDES COMPRISING THE SAME | MERCK PATENT GMBH (DE) | 2022-06-23 | — | — | US | disclosed |
| US-11365253-B2 | Anti-ROBO2 antibodies, compositions, methods and uses thereof | PFIZER INC. (US) | 2022-06-21 | — | — | US | disclosed |
| CN-114641494-A | Anti-33 therapeutic agents FPR for the treatment of renal disorders | 免疫医疗有限公司 | 2022-06-17 | — | — | CN | disclosed |
| WO-2022123011-A1 | SUPERIOR NEUTRALIZATION OF SARS-COV-2 BY DEGLYCOSYLATED HUMAN ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) | IMBA - INSTITUT FÜR MOLEKULARE BIOTECHNOLOGIE GMBH (AT) | 2022-06-16 | — | — | WO | disclosed |
| WO-2022121151-A1 | MAGNETIC PARTICLE CHEMILUMINESCENCE-BASED NOVEL CORONAVIRUS ANTIBODY DETECTION KIT | 丹娜(天津)生物科技股份有限公司 | 2022-06-16 | — | — | WO | disclosed |
| EP-2723769-B2 | TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | ABLYNX NV (BE) | 2022-06-15 | — | — | EP | disclosed |
| EP-3569256-B1 | STABILIZED FIBRONECTIN DOMAIN COMPOSITIONS, METHODS AND USES | JANSSEN BIOTECH INC (US) | 2022-06-15 | — | — | EP | disclosed |
| EP-4011387-A1 | SUPERIOR NEUTRALIZATION OF SARS-COV-2 BY DEGLYCOSYLATED HUMAN ANGIOTENSIN CONVERTING ENZYME 2 | IMBA-Institut für Molekulare Biotechnologie GmbH (AT) | 2022-06-15 | — | — | EP | disclosed |
| CN-112180102-B | Peanut allergen specificity IgE quantitative detection reagent, kit and application thereof | 郑州安图生物工程股份有限公司 | 2022-06-14 | — | — | CN | disclosed |
| CN-112748248-B | Milk allergen specificity IgE detect reagent box | 郑州安图生物工程股份有限公司 | 2022-06-14 | — | — | CN | disclosed |
| WO-2022118975-A1 | SARS-CoV-2 SPIKE PROTEIN VARIANT AND APPLICATION THEREOF | ＨｕＬＡ ｉｍｍｕｎｅ株式会社 | 2022-06-09 | — | — | WO | disclosed |
| US-11352429-B2 | Anti-PD-1 antibodies and uses thereof | BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. (CN) | 2022-06-07 | — | — | US | disclosed |
| CN-114578064-A | Application of reagent for detecting CAF22 in preparation of composition for evaluating renal tubular injury | 北京沃森赛瑟生物技术有限公司 | 2022-06-03 | — | — | CN | disclosed |
| US-20220169736-A1 | COMBINATIONS OF ANTI-ILDR2 ANTIBODIES AND PD-1 ANTAGONISTS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-06-02 | — | — | US | disclosed |
| EP-4003530-A1 | HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES | BicycleTX Limited (GB) | 2022-06-01 | — | — | EP | disclosed |
| EP-4003529-A1 | HETEROTANDEM BICYCLIC PEPTIDE COMPLEX | BicycleTX Limited (GB) | 2022-06-01 | — | — | EP | disclosed |
| EP-4004055-A1 | ANTI-HK2 CHIMERIC ANTIGEN RECEPTOR (CAR) | Janssen Biotech, Inc. (US) | 2022-06-01 | — | — | EP | disclosed |
| CN-114555626-A | Hetero-tandem bicyclic peptide complexes | 拜斯科技术开发有限公司 | 2022-05-27 | — | — | CN | disclosed |
| US-11340219-B2 | Anti-pY1235-MET immunological binding reagent | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-05-24 | — | — | US | disclosed |
| CN-112625129-B | Anti-human interleukin 23, kit comprising same and detection method thereof | 江苏荃信生物医药股份有限公司 | 2022-05-20 | — | — | CN | disclosed |
| WO-2022102744-A1 | ANTIBODY AGAINST SPIKE PROTEIN OF SARS-COV-2 | 株式会社ハカレル | 2022-05-19 | — | — | WO | disclosed |
| CN-114502598-A | Hetero-tandem bicyclic peptide complexes | 拜斯科技术开发有限公司 | 2022-05-13 | — | — | CN | disclosed |
| US-20220143145-A1 | THERAPEUTIC CROSSLINKING OF CYTOKINE RECEPTORS | SYNERKINE PHARMA B.V. (NL) | 2022-05-12 | — | — | US | disclosed |
| US-20220145175-A1 | Near-Infrared-II Nanoparticles and Related Compositions and Methods | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2022-05-12 | — | — | US | disclosed |
| US-20220146522-A1 | METHOD FOR LATERAL FLOW IMMUNOASSAY | PURDUE RESEARCH FOUNDATION (US) | 2022-05-12 | — | — | US | disclosed |
| CN-113402607-B | anti-LAP monoclonal antibody, antigen binding fragment thereof and application thereof | 北京东方百泰生物科技股份有限公司 | 2022-05-10 | — | — | CN | disclosed |
| WO-2022093684-A1 | COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY LUNG DISEASES | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2022-05-05 | — | — | WO | disclosed |
| EP-3990018-A1 | METHODS AND COMPOSITIONS FOR TREATING ALZHEIMER'S DISEASE | The Regents of the University of California (US) | 2022-05-04 | — | — | EP | disclosed |
| CN-114423868-A | Prokaryotic-eukaryotic hybrid viral vectors for delivery of large loads of genes and proteins into human cells | 美国天主教大学 | 2022-04-29 | — | — | CN | disclosed |
| CN-108136215-B | Method for producing phthalocyanine dye conjugate and stable conjugate | 乐天医药生技股份有限公司 | 2022-04-29 | — | — | CN | disclosed |
| EP-3987035-A1 | AN APTAMER FOR DENGUE VIRUS AND RELATED METHODS AND PRODUCTS | Agency for Science, Technology and Research (SG) | 2022-04-27 | — | — | EP | disclosed |
| US-11312749-B2 | Heterotandem bicyclic peptide complex | BICYCLETX LIMITED (GB) | 2022-04-26 | — | — | US | disclosed |
| US-11312788-B2 | Pseudomonas aeruginosa PcrV binding single variable domain antibodies | ABLYNX N.V. (BE) | 2022-04-26 | — | — | US | disclosed |
| CN-114384251-A | Antibody detection kit for CD biological agent and preparation method thereof | 苏州和锐生物科技有限公司 | 2022-04-22 | — | — | CN | disclosed |
| US-20220119497-A1 | TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | ABLYNX N.V. (BE) | 2022-04-21 | — | — | US | disclosed |
| EP-3982932-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL DELIVERY VEHICLES | Dnalite Therapeutics, Inc. (US) | 2022-04-20 | — | — | EP | disclosed |
| CN-109655620-B | Biological macromolecule capable of being combined with beta amyloid protein, coding DNA (deoxyribonucleic acid), beta amyloid protein detection kit and application thereof | 浙江聚康生物工程有限公司 | 2022-04-19 | — | — | CN | disclosed |
| CN-114344297-A | Application of riluzole in treating oligospermia | 暨南大学 | 2022-04-15 | — | — | CN | disclosed |
| CN-111423507-B | Fully human antibodies that neutralize influenza viruses in a broad spectrum | 中国科学院分子细胞科学卓越创新中心 | 2022-04-15 | — | — | CN | disclosed |
| EP-3727460-B1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2 | BICYCLETX LTD (GB) | 2022-04-13 | — | — | EP | disclosed |
| EP-3980463-A1 | ANTI-PSGL-1 COMPOSITIONS AND METHODS FOR MODULATING MYELOID CELL INFLAMMATORY PHENOTYPES AND USES THEREOF | Verseau Therapeutics, Inc. (US) | 2022-04-13 | — | — | EP | disclosed |
| US-11300572-B2 | Methods and systems for producing nanolipoprotein particles | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2022-04-12 | — | — | US | disclosed |
| CN-114295841-A | Antibody detection kit for integrin biological agent and preparation method thereof | 苏州和锐生物科技有限公司 | 2022-04-08 | — | — | CN | disclosed |
| WO-2022072495-A2 | POTENT NEUTRALIZING ANTIBODIES FOR PREVENTION AND TREATMENT OF COVID-19 | ACADEMIA SINICA (TW) | 2022-04-07 | — | — | WO | disclosed |
| EP-3460474-B1 | METHOD AND KIT FOR TARGET MOLECULE DETECTION | TOPPAN PRINTING CO LTD (JP) | 2022-04-06 | — | — | EP | disclosed |
| CN-114286671-A | Compositions and methods for biological delivery vehicles | DNALite治疗学公司 | 2022-04-05 | — | — | CN | disclosed |
| CN-114276450-A | Anti-human IL-17A monoclonal antibody and application thereof | 江苏荃信生物医药股份有限公司 | 2022-04-05 | — | — | CN | disclosed |
| CN-114264827-A | Antibody detection kit for interleukin biological agent and preparation method thereof | 苏州和锐生物科技有限公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-114269379-A | Methods and compositions for treating alzheimer's disease | 加利福尼亚大学董事会 | 2022-04-01 | — | — | CN | disclosed |
| CN-114264814-A | Antibody detection kit for PD-1 biological agent and preparation method thereof | 苏州和锐生物科技有限公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-106589132-B | Composition and method for producing a composition | 布里斯托尔-迈尔斯斯奎布公司 | 2022-03-29 | — | — | CN | disclosed |
| CN-110114676-B | Method for immunologically determining renin concentration | 富士瑞必欧株式会社 | 2022-03-25 | — | — | CN | disclosed |
| CN-114236139-A | Antibody detection kit for TNF-alpha biological agent and preparation method thereof | 苏州和锐生物科技有限公司 | 2022-03-25 | — | — | CN | disclosed |
| US-20220089705-A1 | ANTI-AP2 ANTIBODIES AND ANTIGEN BINDING AGENTS TO TREAT METABOLIC DISORDERS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-03-24 | — | — | US | disclosed |
| WO-2022058944-A1 | A METHOD OF DETECTING AN ANALYTE AND RELATED SYSTEMS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2022-03-24 | — | — | WO | disclosed |
| WO-2022058261-A2 | NOVEL ANTI-A2AP ANTIBODIES AND USES THEREOF | BAYER AKTIENGESELLSCHAFT (DE) | 2022-03-24 | — | — | WO | disclosed |
| US-20220089770-A1 | NOVEL CANCER ANTIGENS AND ANTIBODIES OF SAID ANTIGENS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2022-03-24 | — | — | US | disclosed |
| EP-3971211-A1 | HIDE1 COMPOSITIONS AND METHODS | Compugen Ltd. (IL) | 2022-03-23 | — | — | EP | disclosed |
| CN-114217079-A | Capture antigen for anti-pancreatic acinar antibody detection and detection method | 苏州和锐生物科技有限公司 | 2022-03-22 | — | — | CN | disclosed |
| WO-2022052733-A1 | NEUTRALIZING ANTIBODY HAVING NO ADE EFFECT FOR SARS-COV-2 | 复旦大学 | 2022-03-17 | — | — | WO | disclosed |
| WO-2022054753-A1 | IMMUNOLOGICAL ANALYSIS KIT FOR SEPTICEMIA-CAUSING BACTERIA | 積水メディカル株式会社 | 2022-03-17 | — | — | WO | disclosed |
| WO-2022054754-A1 | METHOD FOR IMMUNOLOGICALLY ANALYZING SEPSIS-CAUSING BACTERIA, AND MONOCLONAL ANTIBODY USED IN SAID METHOD | 積水メディカル株式会社 | 2022-03-17 | — | — | WO | disclosed |
| CN-114163528-A | CD47 binding molecules and uses thereof | 东曜药业有限公司 | 2022-03-11 | — | — | CN | disclosed |
| US-20220074944-A1 | DETECTION OF BCL-2 FAMILY HETERODIMER COMPLEXES AND USE THEREOF | The United States of America, as represented by the Secretary,Department of Health and Human Service (US) | 2022-03-10 | — | — | US | disclosed |
| US-20220074929-A1 | QUANTIFICATION, ISOLATION, AND CHARACTERIZATION OF EXOSOMES USING DROPLET-BASED AND WELL-BASED MICROFLUIDIC SYSTEMS | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2022-03-10 | — | — | US | disclosed |
| US-20220072098-A1 | BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF | LAUREN SCIENCES LLC | 2022-03-10 | — | — | US | disclosed |
| EP-3963091-A1 | METHODS AND SYSTEMS FOR INTEGRATED ON-CHIP SINGLE-MOLECULE DETECTION | Nautilus Biotechnology, Inc. (US) | 2022-03-09 | — | — | EP | disclosed |
| EP-3964223-A2 | COMPOSITION FOR PREVENTION OR TREATMENT OF HAIR LOSS INCLUDING HAPLN1 | HAPLNSCIENCE INC. (KR) | 2022-03-09 | — | — | EP | disclosed |
| CN-114144433-A | Multivalent D-peptide compounds for proteins of interest | 反射制药有限公司 | 2022-03-04 | — | — | CN | disclosed |
| WO-2022042690-A1 | CCR8 ANTIBODY AND APPLICATION THEREOF | 和铂医药(上海)有限责任公司 | 2022-03-03 | — | — | WO | disclosed |
| WO-2022043578-A1 | APTAMERS THAT TARGET CXCL9 | Rheinische Friedrich-Wilhelms-Universität Bonn (DE) | 2022-03-03 | — | — | WO | disclosed |
| EP-3960861-A1 | APTAMERS THAT TARGET CXCL9 | Rheinische Friedrich-Wilhelms-Universität Bonn (DE) | 2022-03-02 | — | — | EP | disclosed |
| US-11261247-B2 | Modulators | XOMA (US) LLC (US) | 2022-03-01 | — | — | US | disclosed |
| CN-114107386-A | Method for preparing blood brain barrier defect mouse model | 中国人民解放军军事科学院军事医学研究院 | 2022-03-01 | — | — | CN | disclosed |
| EP-3955956-A1 | THERAPEUTIC CROSSLINKING OF CYTOKINE RECEPTORS | Synerkine Pharma B.V. (NL) | 2022-02-23 | — | — | EP | disclosed |
| US-11254722-B2 | Recombinant proteins and uses thereof | ACADEMIA SINICA (TW) | 2022-02-22 | — | — | US | disclosed |
| US-11254732-B2 | Monoclonal antibodies and cocktails for treatment of Ebola infections | MAPP BIOPHARMACEUTICAL, INC. (US) | 2022-02-22 | — | — | US | disclosed |
| CN-114062680-A | Sensitive multiplex immunoassay for soluble fibroblast growth factor receptors | 詹森生物科技公司 | 2022-02-18 | — | — | CN | disclosed |
| US-20220047714-A1 | COMPOSITIONS OF PROTEIN COMPLEXES AND METHODS OF USE THEREOF | GOOD THERAPEUTICS, INC. | 2022-02-17 | — | — | US | disclosed |
| US-20220050049-A1 | METHODS AND SYSTEMS FOR INTEGRATED ON-CHIP SINGLE-MOLECULE DETECTION | NAUTILUS SUBSIDIARY, INC. | 2022-02-17 | — | — | US | disclosed |
| CN-108279309-B | Detection test strip and detection method for PLA2R antibody | 深圳市伯劳特生物制品有限公司 | 2022-02-15 | — | — | CN | disclosed |
| WO-2022028586-A1 | COMPOUNDS AS C5AR INHIBITORS | KIRA PHARMACEUTICALS (SUZHOU) LTD. (CN) | 2022-02-10 | — | — | WO | disclosed |
| US-11242379-B2 | Monoclonal antibodies and cocktails for treatment of Ebola infections | MAPP BIOPHARMACEUTICAL, INC. (US) | 2022-02-08 | — | — | US | disclosed |
| US-11242378-B2 | Monoclonal antibodies and cocktails for treatment of Ebola infections | MAPP BIOPHARMACEUTICAL, INC. (US) | 2022-02-08 | — | — | US | disclosed |
| US-20210380647-A1 | BINDERS FOR INHIBITING FORMATION OF MULTIMERIC PROTEINS | AFFILOGIC (FR) | 2021-12-09 | — | — | US | disclosed |
| EP-1713514-B1 | DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS | UNIV JOHNS HOPKINS (US) | 2021-11-24 | — | — | EP | disclosed |
| EP-3861011-A1 | BINDERS FOR INHIBITING FORMATION OF MULTIMERIC PROTEINS | AFFILOGIC (FR) | 2021-08-11 | — | — | EP | disclosed |
| US-20210177982-A1 | MUCUS-PENETRATING PEPTIDES, DELIVERY VEHICLES AND METHODS OF THERAPY | DNALITE THERAPEUTICS, INC. | 2021-06-17 | — | — | US | disclosed |
| WO-2021119585-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL DELIVERY VEHICLES | DNALITE THERAPEUTICS, INC. (US) | 2021-06-17 | — | — | WO | disclosed |
| EP-3796892-A2 | MUCUS-PENETRATING PEPTIDES, DELIVERY VEHICLES AND METHODS OF THERAPY | Dnalite Therapeutics, Inc. (US) | 2021-03-31 | — | — | EP | disclosed |
| US-20210052507-A1 | DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS | UNIV JOHNS HOPKINS (US) | 2021-02-25 | — | — | US | disclosed |
| CN-112367974-A | Mucus penetrating peptides, delivery vehicles, and methods of treatment | DNALite治疗学公司 | 2021-02-12 | — | — | CN | disclosed |
| WO-2020252375-A1 | COMPOSITIONS AND METHODS FOR BIOLOGICAL DELIVERY VEHICLES | DNALITE THERAPEUTICS, INC. (US) | 2020-12-17 | — | — | WO | disclosed |
| US-20200345864-A1 | COMPOSITIONS AND METHODS FOR ENHANCING TRANSPORT THROUGH MUCUS | THE JOHNS HOPKINS UNIVERSITY | 2020-11-05 | — | — | US | disclosed |
| US-20200181601-A1 | OB-FOLD USED AS SCAFFOLD FOR ENGINEERING NEW SPECIFIC BINDERS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2020-06-11 | — | — | US | disclosed |
| US-10663469-B2 | Method for using information on complex biomarker group to diagnose lung cancer in a subject and diagnostic kit and computing system using the same | BIOINFRA LIFE SCIENCE INC. (KR) | 2020-05-26 | — | — | US | disclosed |
| CN-111108390-A | Composition for diagnosing gastric cancer and method for diagnosing gastric cancer using the same | 百奥医福股份有限公司 | 2020-05-05 | — | — | CN | disclosed |
| EP-3632924-A1 | BINDERS FOR INHIBITING FORMATION OF MULTIMERIC PROTEINS | AFFILOGIC (FR) | 2020-04-08 | — | — | EP | disclosed |
| EP-3620465-A1 | IMPROVED METHODS FOR GENERATION, LABELING AND USE OF MHC MULTIMERS | Dako Denmark A/S (DK) | 2020-03-11 | — | — | EP | disclosed |
| US-10584330-B2 | OB-fold used as scaffold for engineering new specific binders | INSTITUT PASTEUR (FR) | 2020-03-10 | — | — | US | disclosed |
| US-20190351071-A1 | STRUCTURES AND METHODS FOR GENE THERAPY | DNALITE THERAPEUTICS, INC. | 2019-11-21 | — | — | US | disclosed |
| EP-3538075-A1 | STRUCTURES AND METHODS FOR GENE THERAPY | Dnalite Therapeutics, Inc. (US) | 2019-09-18 | — | — | EP | disclosed |
| US-20190277848-A1 | METHODS AND COMPOSITIONS FOR DETECTING FUNGI AND MYCOTOXINS | ADVATECT DIAGNOSTICS LLC (US) | 2019-09-12 | — | — | US | disclosed |
| US-10314882-B2 | Methods, uses and compositions of Tie2 agonists | Sunnybrook Research Institute | 2019-06-11 | — | — | US | disclosed |
| EP-2983695-B1 | METHODS, USES AND COMPOSITIONS OF TIE2 AGONISTS | SUNNYBROOK RES INST (CA) | 2019-05-29 | — | — | EP | disclosed |
| US-10288611-B2 | Lateral flow device for diagnosing microbial infections | THE JOHNS HOPKINS UNIVERSITY (US) | 2019-05-14 | — | — | US | disclosed |
| US-10274493-B2 | Methods and compositions for detecting fungi and mycotoxins | ADVATECT DIAGNOSTICS, LLC (US) | 2019-04-30 | — | — | US | disclosed |
| US-20190101534-A1 | METHODS AND COMPOSITIONS FOR DETECTING FUNGI AND MYCOTOXINS | ADVATECT DIAGNOSTICS LLC (US) | 2019-04-04 | — | — | US | disclosed |
| US-20190101535-A1 | METHODS AND COMPOSITIONS FOR DETECTING FUNGI AND MYCOTOXINS | ADVATECT DIAGNOSTICS LLC (US) | 2019-04-04 | — | — | US | disclosed |
| US-20190085048-A1 | MHC Multimers, Methods for Their Generation, Labeling and Use | AGILENT TECHNOLOGIES, INC. | 2019-03-21 | — | — | US | disclosed |
| US-10208330-B2 | Sampling devices and methods for concentrating microorganisms | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-02-19 | — | — | US | disclosed |
| US-10208128-B2 | HER3 binding polypeptides | AFFIBODY AB (SE) | 2019-02-19 | — | — | US | disclosed |
| EP-1534324-B1 | TUMOR SPECIFIC OLIGOSACCHARIDE EPITOPES AND USE THEREOF | GLYKOS FINLAND OY (FI) | 2019-01-16 | — | — | EP | disclosed |
| US-20180344656-A1 | DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS | JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE | 2018-12-06 | — | — | US | disclosed |
| US-20180264135-A1 | COMPOSITIONS AND METHODS FOR ENHANCING TRANSPORT THROUGH MUCUS | THE JOHNS HOPKINS UNIVERSITY | 2018-09-20 | — | — | US | disclosed |
| US-10036748-B2 | Methods and compositions for detecting fungi and mycotoxins | ADVATECT DIAGNOSTICS, LLC (US) | 2018-07-31 | — | — | US | disclosed |
| US-10030065-B2 | MHC multimers, methods for their generation, labeling and use | DAKO DENMARK A/S (DK) | 2018-07-24 | — | — | US | disclosed |
| EP-3134435-B1 | BIOMOLECULE-RELEASING CELL AND SELECTION THEREOF BY MEANS OF A SURFACE PROTEIN | new/era/mabs GmbH (DE) | 2018-06-27 | — | — | EP | disclosed |
| WO-2018089799-A1 | STRUCTURES AND METHODS FOR GENE THERAPY | DNALITE THERAPEUTICS, INC. (US) | 2018-05-17 | — | — | WO | disclosed |
| US-9915657-B2 | Lateral flow device for diagnosing microbial infections | YESHIVA UNIVERSTIY (US) | 2018-03-13 | — | — | US | disclosed |
| US-20180067118-A1 | METHOD FOR USING INFORMATION ON COMPLEX BIOMARKER GROUP TO DIAGNOSE LUNG CANCER IN A SUBJECT AND DIAGNOSTIC KIT AND COMPUTING SYSTEM USING THE SAME | BIOINFRA LIFE SCIENCE INC. (KR) | 2018-03-08 | — | — | US | disclosed |
| US-20180055928-A1 | Tumor specific oligosaccharide epitopes and use thereof | GLYKOS FINLAND OY (FI) | 2018-03-01 | — | — | US | disclosed |
| US-9896503-B2 | Antigen associated with the neovasculature of tumour metastases | PHILOGEN S.P.A. (IT) | 2018-02-20 | — | — | US | disclosed |
| EP-2262480-B1 | IMMUNOMODULATOR PARTICLES | LIQUIDIA TECH INC (US) | 2018-02-14 | — | — | EP | disclosed |
| US-9874564-B2 | Detection of targets using magnetic resonance | THE GENERAL HOSPITAL CORPORATION (US) | 2018-01-23 | — | — | US | disclosed |
| US-20170370924-A1 | TARGET SUBSTANCE DETECTION CHIP, TARGET SUBSTANCE DETECTION PLATE, TARGET SUBSTANCE DETECTION DEVICE AND TARGET SUBSTANCE DETECTION METHOD | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2017-12-28 | — | — | US | disclosed |
| US-20170336410-A1 | METHODS AND COMPOSITIONS FOR DETECTING FUNGI AND MYCOTOXINS | RTL PURCHASER LLC | 2017-11-23 | — | — | US | disclosed |
| US-20170298409-A1 | SAMPLING DEVICES AND METHODS FOR CONCENTRATING MICROORGANISMS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-10-19 | — | — | US | disclosed |
| EP-2356234-B1 | DOSAGE OF OLIGONUCLEOTIDES SUITABLE FOR THE TREATMENT OF TUMORS | AUTOTELIC LLC (US) | 2017-08-16 | — | — | EP | disclosed |
| US-9719125-B2 | Sampling devices and methods for concentrating microorganisms | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-08-01 | — | — | US | disclosed |
| EP-2541248-B1 | PREPARATION METHOD OF ANTIGEN-IMMOBILIZED IMMUNOFLUORESCENCE SLIDE, AND IMMUNOFLUORESCENCE SLIDE PREPARED THEREBY | KOREA FOOD RES INST (KR) | 2017-07-12 | — | — | EP | disclosed |
| US-20170166887-A1 | OB-FOLD USED AS SCAFFOLD FOR ENGINEERING NEW SPECIFIC BINDERS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2017-06-15 | — | — | US | disclosed |
| EP-2399611-B1 | USE OF AN OLIGONUCLEOTIDE OR ITS ACTIVE DERIVATIVE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR INHIBITING THE FORMATON OF METASATASES IN CANCER TREATMENT | AUTOTELIC LLC (US) | 2017-06-14 | — | — | EP | disclosed |
| US-20170095566-A1 | Compositions and Methods for Enhancing Transport Through Mucus | THE JOHNS HOPKINS UNIVERSITY | 2017-04-06 | — | — | US | disclosed |
| EP-2062586-B1 | USE OF LOW DOSES OF OLIGONUCLEOTIDES ANTISENSE TO TGF-BETA1 GENES IN THE TREATMENT OF TUMORS | AUTOTELIC LLC (US) | 2017-03-15 | — | — | EP | disclosed |
| EP-3134435-A1 | BIOMOLECULE-RELEASING CELL AND SELECTION THEREOF BY MEANS OF A SURFACE PROTEIN | New/era/mabs GmbH (DE) | 2017-03-01 | — | — | EP | disclosed |
| US-9572864-B2 | Compositions and uses of lectins | EMORY UNIVERSITY (US) | 2017-02-21 | — | — | US | disclosed |
| US-20170044235-A1 | BIOMOLECULE-RELEASING CELL AND SELECTION THEREOF BY MEANS OF A SURFACE PROTEIN | NEW/ERA/MABS/GMBH (DE) | 2017-02-16 | — | — | US | disclosed |
| EP-2076290-B1 | MULTIMERIC TIE 2 AGONISTS AND USES THEREOF IN STIMULATING ANGIOGENESIS | SUNNYBROOK HEALTH SCIENCES CT (CA) | 2016-12-14 | — | — | EP | disclosed |
| US-20160313329-A1 | METHODS AND COMPOSITIONS FOR DETECTING FUNGI AND MYCOTOXINS | RTL PURCHASER LLC | 2016-10-27 | — | — | US | disclosed |
| EP-2653478-B1 | A novel antigen associated with the neovasculature of tumour metastases | PHILOGEN SPA (IT) | 2016-10-05 | — | — | EP | disclosed |
| EP-2570424-B1 | OB-Fold used as scaffold for engineering new specific binders | PASTEUR INSTITUT (FR) | 2016-09-28 | — | — | EP | disclosed |
| US-20160256404-A1 | Drugs and Gene Carrier Particles That Rapidly Move Through Mucous Barriers | JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE | 2016-09-08 | — | — | US | disclosed |
| US-9422548-B2 | OB-fold used as scaffold for engineering new specific binders | INSTITUT PASTEUR (FR) | 2016-08-23 | — | — | US | disclosed |
| US-20160215325-A1 | SAMPLING DEVICES AND METHODS FOR CONCENTRATING MICROORGANISMS | 3M INNOVATIVE PROPERTIES CO (US) | 2016-07-28 | — | — | US | disclosed |
| EP-2726482-B1 | HYDROXYMETHYLARYL-SUBSTITUTED PYRROLOTRIAZINES AS ALK1 INHIBITORS | BAYER IP GMBH (DE) | 2016-07-20 | — | — | EP | disclosed |
| EP-2248895-B1 | Combination therapy associating a TGF-beta antagonist with a chemotherapeutic agent | ISARNA THERAPEUTICS GMBH (DE) | 2016-07-06 | — | — | EP | disclosed |
| US-20160175394-A1 | Compositions and Uses of Lectins | EMORY UNIVERSITY (US) | 2016-06-23 | — | — | US | disclosed |
| US-20160151448-A1 | MULTIMERIC TIE 2 AGONISTS AND USES THEREOF IN STIMULATING ANGIOGENESIS | SUNNYBROOK HEALTH SCIENCES CENTRE (CA) | 2016-06-02 | — | — | US | disclosed |
| EP-3023436-A1 | IMPROVED METHODS FOR GENERATION, LABELING AND USE OF MHC MULTIMERS | Dako Denmark A/S (DK) | 2016-05-25 | — | — | EP | disclosed |
| US-9328325-B2 | Sampling devices and methods for concentrating microorganisms | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-05-03 | — | — | US | disclosed |
| CN-103328952-B | Sensing device | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2016-03-30 | — | — | CN | disclosed |
| US-20160083461-A1 | NOVEL ANTIGEN ASSOCIATED WITH THE NEOVASCULATURE OF TUMOUR METASTASES | PHILOGEN S.P.A. (IT) | 2016-03-24 | — | — | US | disclosed |
| US-20160058828-A1 | METHODS, USES AND COMPOSITIONS OF TIE2 AGONISTS | PROVIDENCE ST. JOSEPH'S AND ST. MICHAEL'S HEALTHCARE (CA) | 2016-03-03 | — | — | US | disclosed |
| EP-2983695-A1 | METHODS, USES AND COMPOSITIONS OF TIE2 AGONISTS | Sunnybrook Research Institute (CA) | 2016-02-17 | — | — | EP | disclosed |
| US-20160010083-A1 | OB-Fold Used As Scaffold For Engineering New Specific Binders | INSTITUT PASTEUR (FR) | 2016-01-14 | — | — | US | disclosed |
| EP-2533793-B1 | GAL-4 for use in the treatment of infectious diseases | UNIV EMORY (US) | 2015-12-09 | — | — | EP | disclosed |
| US-20150337396-A1 | METHOD AND COMPOSITIONS FOR DETECTING FUNGI AND MYCOTOXINS | MEDICAL SERVICE CONSULTATION INTERNATIONAL, L.L.C. | 2015-11-26 | — | — | US | disclosed |
| US-9186390-B2 | Methods and uses of TIE2 binding and/or activating agents | SUNNYBROOK HEALTH SCIENCES CENTER (CA) | 2015-11-17 | — | — | US | disclosed |
| US-9182398-B2 | Methods and compositions for detecting fungi and mycotoxins | MEDICAL SERVICE CONSULTATION INTERNATIONAL, LLC (US) | 2015-11-10 | — | — | US | disclosed |
| US-9181347-B2 | Antigen associated with the neovasculature of tumour metastases | PHILOGEN S.P.A. (IT) | 2015-11-10 | — | — | US | disclosed |
| WO-2015161835-A1 | BIOMOLECULE-RELEASING CELL AND SELECTION THEREOF BY MEANS OF A SURFACE PROTEIN | NEW / ERA / MABS GMBH (DE) | 2015-10-29 | — | — | WO | disclosed |
| US-20150273079-A1 | IMMUNOMODULATOR PARTICLES AND METHODS OF TREATING | LIQUIDIA TECHNOLOGIES, INC. (US) | 2015-10-01 | — | — | US | disclosed |
| US-9103829-B2 | Methods and compositions for detecting fungi and mycotoxins | MEDICAL SERVICE CONSULTATION INTERNATIONAL, LLC (US) | 2015-08-11 | — | — | US | disclosed |
| US-20150202251-A1 | MULTIMERIC TIE 2 AGONISTS AND USES THEREOF IN STIMULATING ANGIOGENESIS | SUNNYBROOK HEALTH SCIENCES CENTRE (CA) | 2015-07-23 | — | — | US | disclosed |
| EP-2302078-B1 | Microbubbles for affinity concentration | IRIS MOLECULAR DIAGNOSTICS INC (US) | 2015-07-15 | — | — | EP | disclosed |
| US-20150192581-A1 | Lateral Flow Device for Diagnosing Microbial Infections | YESHIVA UNIVERSITY (US) | 2015-07-09 | — | — | US | disclosed |
| US-9040691-B2 | Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-05-26 | — | — | US | disclosed |
| EP-2069790-B1 | BINDING SURFACES FOR AFFINITY ASSAYS | BECKMAN COULTER INC (US) | 2015-04-29 | — | — | EP | disclosed |
| US-8957034-B2 | Drugs and gene carrier particles that rapidly move through mucous barriers | JOHNS HOPKINS UNIVERSITY (US) | 2015-02-17 | — | — | US | disclosed |
| US-8957022-B2 | Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis | SUNNYBROOK HEALTH SCIENCES CENTRE (CA) | 2015-02-17 | — | — | US | disclosed |
| US-20150044666-A1 | NON-EQUILIBRIUM TWO-SITE ASSAYS FOR LINEAR, ULTRASENSITIVE ANALYTE DETECTION | IRIS INTERNATIONAL, INC. | 2015-02-12 | — | — | US | disclosed |
| EP-2099817-B1 | OB-FOLD USED AS SCAFFOLD FOR ENGINEERING NEW SPECIFIC BINDERS | PASTEUR INSTITUT (FR) | 2015-02-11 | — | — | EP | disclosed |
| US-8937721-B2 | Sensing device | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2015-01-20 | — | — | US | disclosed |
| EP-2340308-B1 | Combination of dacarbazine and an inhibitor of the TGF-beta system | ISARNA THERAPEUTICS GMBH (DE) | 2014-12-24 | — | — | EP | disclosed |
| US-20140342927-A1 | METHODS AND COMPOSITIONS FOR DETECTING FUNGI AND MYCOTOXINS | MEDICAL SERVICE CONSULTATION INTERNATIONAL LLC (US) | 2014-11-20 | — | — | US | disclosed |
| WO-2014165963-A1 | METHODS, USES AND COMPOSITIONS OF TIE2 AGONISTS | Sunnybrook Research Institute (CA) | 2014-10-16 | — | — | WO | disclosed |
| US-8835186-B2 | Microbubbles for affinity separation | IRIS INTERNATIONAL, INC. (US) | 2014-09-16 | — | — | US | disclosed |
| US-20140256718-A1 | HYDROXYMETHYLARYL-SUBSTITUTED PYRROLOTRIAZINES AS ALK1 INHIBITORS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-09-11 | — | — | US | disclosed |
| US-8822425-B2 | Dosage of oligonucleotides suitable for the treatment of tumors | ANTISENSE PHARMA GMBH (DE) | 2014-09-02 | — | — | US | disclosed |
| US-20140234318-A1 | TUMOR SPECIFIC OLIGOSACCHARIDE EPITOPES AND USE THEREOF | GLYKOS FINLAND OY (FI) | 2014-08-21 | — | — | US | disclosed |
| EP-1419393-B1 | TUMOR SPECIFIC OLIGOSACCHARIDE SEQUENCES AND USE THEREOF | GLYKOS FINLAND OY (FI) | 2014-08-13 | — | — | EP | disclosed |
| US-20140187431-A1 | Method Using A Nonlinear Optical Technique for Detection of Interactions Involving A Conformational Change | BIODESY, LLC (US) | 2014-07-03 | — | — | US | disclosed |
| US-20140187432-A1 | METHODS USING A NONLINEAR OPTICAL TECHNIQUE FOR DETECTION OF INTERACTIONS INVOLVING A CONFORMATIONAL CHANGE | BIODESY, LLC (US) | 2014-07-03 | — | — | US | disclosed |
| US-20140186854-A1 | Method Using A Nonlinear Optical Technique for Detection of Interactions Involving A Conformational Change | BIODESY, LLC (US) | 2014-07-03 | — | — | US | disclosed |
| US-20140187433-A1 | METHODS USING A NONLINEAR OPTICAL TECHNIQUE FOR DETECTION OF INTERACTIONS INVOLVING A CONFORMATIONAL CHANGE | BIODESY, LLC (US) | 2014-07-03 | — | — | US | disclosed |
| US-20140178896-A1 | Method Using A Nonlinear Optical Technique for Detection of Interactions Involving A Conformational Change | BLUELIGHT THERAPEUTICS, INC. | 2014-06-26 | — | — | US | disclosed |
| US-20140178897-A1 | METHODS USING A NONLINEAR OPTICAL TECHNIQUE FOR DETECTION OF INTERACTIONS INVOLVING A CONFORMATIONAL CHANGE | BIODESY, LLC (US) | 2014-06-26 | — | — | US | disclosed |
| US-8759482-B2 | Kinetically efficient substrate for lipoic acid ligase | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2014-06-24 | — | — | US | disclosed |
| US-20140170024-A1 | TARGET SUBSTANCE DETECTION CHIP, TARGET SUBSTANCE DETECTION PLATE, TARGET SUBSTANCE DETECTION DEVICE AND TARGET SUBSTANCE DETECTION METHOD | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2014-06-19 | — | — | US | disclosed |
| EP-2726482-A1 | HYDROXYMETHYLARYL-SUBSTITUTED PYRROLOTRIAZINES AS ALK1 INHIBITORS | Bayer Intellectual Property GmbH (DE) | 2014-05-07 | — | — | EP | disclosed |
| EP-2725344-A1 | TARGET SUBSTANCE DETECTION CHIP, TARGET SUBSTANCE DETECTION PLATE, TARGET SUBSTANCE DETECTION DEVICE AND TARGET SUBSTANCE DETECTION METHOD | National Institute of Advanced Industrial Science And Technology (JP) | 2014-04-30 | — | — | EP | disclosed |
| US-8697061-B2 | Tumor specific oligosaccharide epitopes and use thereof | GLYKOS FINLAND OY (FI) | 2014-04-15 | — | — | US | disclosed |
| US-8673653-B2 | Signal amplification technique for mass analysis | DIATECH KOREA CO., LTD. (KR) | 2014-03-18 | — | — | US | disclosed |
| WO-2013184851-A1 | METHOD FOR DETERMINING RECURRENCE OR STABLE DISEASE AFTER TREATMENT FOR PROSTATE CANCER | IRIS INTERNATIONAL, INC. (US) | 2013-12-12 | — | — | WO | disclosed |
| US-20130323739-A1 | METHOD FOR DETERMINING RECURRENCE OR STABLE DISEASE AFTER TREATMENT FOR PROSTATE CANCER | IRIS INTERNATIONAL, INC. (US) | 2013-12-05 | — | — | US | disclosed |
| US-8597959-B2 | Methods of use of solid support material for binding biomolecules | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-12-03 | — | — | US | disclosed |
| EP-2667181-A1 | SENSING DEVICE | National Institute of Advanced Industrial Science And Technology (JP) | 2013-11-27 | — | — | EP | disclosed |
| US-8580578-B2 | Optical detection of label-free biomolecular interactions using microreplicated plastic | X-BODY, INC. (US) | 2013-11-12 | — | — | US | disclosed |
| US-20130293896-A1 | Sensing Device | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2013-11-07 | — | — | US | disclosed |
| US-20130280759-A1 | NOVEL ANTIGEN ASSOCIATED WITH THE NEOVASCULATURE OF TUMOUR METASTASES | ETH ZURICH (CH) | 2013-10-24 | — | — | US | disclosed |
| EP-2252893-B1 | METHOD FOR EARLY DETERMINATION OF RECURRENCE AFTER THERAPY FOR PROSTATE CANCER | IRIS INT INC (US) | 2013-10-23 | — | — | EP | disclosed |
| EP-1797126-B1 | COMPOSITIONS MONOVALENT FOR CD40L BINDING AND METHODS OF USE | DOMANTIS LTD (GB) | 2013-10-23 | — | — | EP | disclosed |
| EP-2653478-A1 | A novel antigen associated with the neovasculature of tumour metastases | Philogen S.p.A. (IT) | 2013-10-23 | — | — | EP | disclosed |
| US-20130266511-A1 | NOVEL ANTIGEN ASSOCIATED WITH THE NEOVASCULATURE OF TUMOUR METASTASES | PHILOGEN S.P.A. | 2013-10-10 | — | — | US | disclosed |
| CN-103328952-A | Sensing device | NAT INST OF ADVANCED IND SCIEN | 2013-09-25 | — | — | CN | disclosed |
| US-8524236-B2 | Methods of antagonizing the binding of CD40 to CD40L with CD40L-specific monovalent polypeptides in autoimmune individuals | DOMANTIS LIMITED (GB) | 2013-09-03 | — | — | US | disclosed |
| US-20130224752-A1 | METHOD FOR EARLY DETERMINATION OF RECURRENCE AFTER THERAPY FOR PROSTATE CANCER | IRIS INTERNATIONAL INC. (US) | 2013-08-29 | — | — | US | disclosed |
| US-8518714-B2 | Binding surfaces for affinity assays | BECKMAN COULTER, INC. (US) | 2013-08-27 | — | — | US | disclosed |
| US-8513032-B2 | Microbubbles for affinity separation | IRIS INTERNATIONAL, INC. (US) | 2013-08-20 | — | — | US | disclosed |
| EP-2623985-A1 | Method for early determination of recurrence after therapy for prostate cancer | Iris International, Inc. (US) | 2013-08-07 | — | — | EP | disclosed |
| US-8497073-B2 | Method using a nonlinear optical technique for detection of interactions involving a conformational change | BIODESY, LLC (US) | 2013-07-30 | — | — | US | disclosed |
| EP-2349359-B1 | MEDICAL IMPLANT HAVING BIO-FUNCTIONALIZED SURFACE | FACHHOCHSCHULE GELSENKIRCHEN (DE) | 2013-07-24 | — | — | EP | disclosed |
| WO-2013106778-A2 | NON-EQUILIBRIUM TWO-SITE ASSAYS FOR LINEAR, ULTRASENSITIVE ANALYTE DETECTION | IRIS INTERNATIONAL, INC. (US) | 2013-07-18 | — | — | WO | disclosed |
| US-20130183697-A1 | Methods And Compositions For Detecting Fungi And Mycotoxins | MEDICAL SERVICE CONSULTATION INTERNATIONAL LLC (US) | 2013-07-18 | — | — | US | disclosed |
| US-8481684-B2 | Antigen associated with the neovasculature of tumour metastases | PHILOGEN S.P.A. (IT) | 2013-07-09 | — | — | US | disclosed |
| US-20130172234-A1 | MULTIMERIC TIE 2 AGONISTS AND USES THEREOF IN STIMULATING ANGIOGENESIS | SUNNYBROOK HEALTH SCIENCES CENTER (CA) | 2013-07-04 | — | — | US | disclosed |
| US-8476246-B2 | Combination of a chemotherapeutic agent and an inhibitor of the TGF-beta system | ANTISENSE PHARMA GMBH (DE) | 2013-07-02 | — | — | US | disclosed |
| US-20130164343-A1 | COMPOSITIONS AND METHODS FOR ENHANCING TRANSPORT THROUGH MUCUS | THE JOHNS HOPKINS UNIVERSITY (US) | 2013-06-27 | — | — | US | disclosed |
| EP-2278333-B1 | NEW SIGNAL AMPLIFICATION TECHNIQUE FOR MASS ANALYSIS | PROBIOND CO LTD (KR) | 2013-06-12 | — | — | EP | disclosed |
| CN-103145812-A | OB-FOLD used as scaffold for engineering new specific binders | PASTEUR INSTITUT | 2013-06-12 | — | — | CN | disclosed |
| US-8450068-B2 | IgE antibodies to chimeric or humanized IgG therapeutic monoclonal antibodies as a screening test for anaphylaxis | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2013-05-28 | — | — | US | disclosed |
| US-20130115226-A1 | METHODS AND USES OF TIE2 BINDING AND/OR ACTIVATING AGENTS | SUNNYBROOK HEALTH SCIENCES CENTRE (CA) | 2013-05-09 | — | — | US | disclosed |
| EP-2570424-A1 | OB-Fold used as scaffold for engineering new specific binders | INSTITUT PASTEUR (FR) | 2013-03-20 | — | — | EP | disclosed |
| CN-101652386-B | OB-FOLD as scaffold for engineering novel specific binders | PASTEUR INSTITUT | 2013-03-20 | — | — | CN | disclosed |
| US-8399207-B2 | Monoclonal antibodies against osteopontin | MAINE MEDICAL CENTER (US) | 2013-03-19 | — | — | US | disclosed |
| US-8394590-B2 | Capture agents and related methods and systems for detecting and/or sorting targets | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2013-03-12 | — | — | US | disclosed |
| US-20130059307-A1 | Methods And Compositions For Detecting Fungi And Mycotoxins | MEDICAL SERVICE CONSULTATION INTERNATIONAL, LLC (US) | 2013-03-07 | — | — | US | disclosed |
| US-20130040361-A1 | NOVEL ANTIGEN ASSOCIATED WITH THE NEOVASCULATURE OF TUMOUR METASTASES | PHILOGEN S.P.A. | 2013-02-14 | — | — | US | disclosed |
| US-20130029428-A1 | PREPARATION METHOD OF ANTIGEN-IMMOBILIZED IMMUNO- FLUORESCENCE SLIDE AND IMMUNO-FLUOROSCENCE SLIDE PREPARED THEREBY | KOREA FOOD RESEARCH INSTITUTE (KR) | 2013-01-31 | — | — | US | disclosed |
| US-8365311-B2 | Quantitative analysis of MRNA and protein expression | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-01-29 | — | — | US | disclosed |
| US-20130022612-A1 | METHODS AND COMPOSITIONS FOR MALARIA PROPHYLAXIS | NEW YORK UNIVERSITY (US) | 2013-01-24 | — | — | US | disclosed |
| US-20130017561-A1 | Lateral Flow Device for Diagnosing Microbial Infections | YESHIVA UNIVERSITY (US) | 2013-01-17 | — | — | US | disclosed |
| EP-2142567-B1 | THE ED-A ANTIGEN OF FIBRINOGEN IS ASSOCIATED WITH THE NEOVASCULATURE OF TUMOUR METASTASES | PHILOGEN SPA (IT) | 2013-01-16 | — | — | EP | disclosed |
| WO-2013004551-A1 | HYDROXYMETHYLARYL-SUBSTITUTED PYRROLOTRIAZINES AS ALK1 INHIBITORS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-01-10 | — | — | WO | disclosed |
| EP-2541248-A2 | PREPARATION METHOD OF ANTIGEN-IMMOBILIZED IMMUNOFLUORESCENCE SLIDE, AND IMMUNOFLUORESCENCE SLIDE PREPARED THEREBY | Korea Food Research Institute (KR) | 2013-01-02 | — | — | EP | disclosed |
| US-20120328568-A1 | COMPOSITIONS AND USES OF LECTINS | EMORY UNIVERSITY (US) | 2012-12-27 | — | — | US | disclosed |
| US-20120329713-A1 | METHOD FOR DETERMINING LIKELIHOOD OF CLINICAL RECURRENCE OR CLINICALLY STABLE DISEASE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY | IRIS INTERNATIONAL, INC. | 2012-12-27 | — | — | US | disclosed |
| EP-2453017-A9 | Oligonucleotides for use in prophylaxis and/or treatment of TGF-beta1 and TGF-beta2, TGF-beta2 and TGF-beta3, TGF-beta1 and TGF-beta3, or TGF-beta1, TGF-beta2, and TGF-beta3 mRNA overexpressing diseases | Antisense Pharma GmbH (DE) | 2012-12-26 | — | — | EP | disclosed |
| EP-2533793-A2 | COMPOSITIONS AND USES OF LECTINS | Emory University (US) | 2012-12-19 | — | — | EP | disclosed |
| WO-2012150314-A1 | METHOD FOR GENERATING PROTEINS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2012-11-08 | — | — | WO | disclosed |
| WO-2012129281-A2 | DETECTION OF TARGETS USING MAGNETIC RESONANCE | THE GENERAL HOSPITAL CORPORATION (US) | 2012-09-27 | — | — | WO | disclosed |
| US-8263041-B2 | Antigen associated with the neovasculature of tumour metastases | PHILOGEN, S.P.A. (IT) | 2012-09-11 | — | — | US | disclosed |
| US-8236487-B2 | Tumor specific oligosaccharide sequences and use thereof | GLYKOS FINLAND OY (FI) | 2012-08-07 | — | — | US | disclosed |
| EP-2457509-A1 | Implantable sensor unit | BIOTRONIK SE & Co. KG (DE) | 2012-05-30 | — | — | EP | disclosed |
| US-20120130209-A1 | Implantable Sensor Unit | BIOTRONIK SE & CO. KG (DE) | 2012-05-24 | — | — | US | disclosed |
| US-20120131703-A1 | QUANTITATIVE ANALYSIS OF MRNA AND PROTEIN EXPRESSION | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2012-05-24 | — | — | US | disclosed |
| EP-2453017-A1 | Oligonucleotides for use in prophylaxis and/or treatment of TGF-beta1 and TGF-beta2, TGF-beta2 and TGF-beta3, TGF-beta1 and TGF-beta3, or TGF-beta1, TGF-beta2, and TGF-beta3 mRNA overexpressing diseases | Antisense Pharma GmbH (DE) | 2012-05-16 | — | — | EP | disclosed |
| WO-2012034613-A3 | REFRIGERATOR | RED BULL GMBH (AT) | 2012-05-10 | — | — | WO | disclosed |
| US-8168447-B2 | Multiple component nanoparticles for multiplexed signaling and optical encoding | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2012-05-01 | — | — | US | disclosed |
| US-20120101230-A1 | HIGH-DENSITY POLYMER SURFACE COATING TO IMMOBILIZE CHEMICAL OR BIOLOGICAL MOLECULES | X-BODY, INC. | 2012-04-26 | — | — | US | disclosed |
| US-20120077284-A1 | Binding Surfaces for Affinity Assays | BECKMAN COULTER, INC. | 2012-03-29 | — | — | US | disclosed |
| US-20120027873-A1 | COMBINATION OF A CHEMOTHERAPEUTIC AGENT AND AN INHIBITOR OF THE TGF-BETA SYSTEM | ANTISENSE PHARMA GMBH (DE) | 2012-02-02 | — | — | US | disclosed |
| EP-1930342-B1 | OB-fold used as scaffold for engineering new specific binders | PASTEUR INSTITUT (FR) | 2012-01-25 | — | — | EP | disclosed |
| US-8101423-B2 | Label-free high-throughput optical technique for detecting biomolecular interactions | SRU BIOSYSTEMS, INC. (US) | 2012-01-24 | — | — | US | disclosed |
| US-8097597-B2 | Use of low doses of oligonucleotides antisense to TGF-β genes in the treatment of brain tumors | ANTISENSE PHARMA GMBH (DE) | 2012-01-17 | — | — | US | disclosed |
| US-20120011597-A1 | CERTAIN HUMAN GENOMIC DNA ASSOCIATED WITH TOTAL RED-GREEN COLORBLINDNESS | ZELENY CHARLES TIMBERLAKE (US) | 2012-01-12 | — | — | US | disclosed |
| US-20120003626-A1 | SAMPLING DEVICES AND METHODS FOR CONCENTRATING MICROORGANISMS | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2012-01-05 | — | — | US | disclosed |
| EP-2402739-A1 | HIGH-THROUGHPUT OPTICAL TECHNIQUE FOR DETECTING BIOMOLECULAR INTERACTIONS | SRU Biosystems, Inc. (US) | 2012-01-04 | — | — | EP | disclosed |
| US-20110319985-A1 | METHODS AND APPARATUS FOR LOCALIZED ADMINISTRATION OF INHIBITORY MOIETIES TO A PATIENT | ABBOTT LABORATORIES VASCULAR ENTERPRISES LIMITED (IE) | 2011-12-29 | — | — | US | disclosed |
| EP-2399611-A2 | Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formation of metasatases in cancer treatment | Antisense Pharma GmbH (DE) | 2011-12-28 | — | — | EP | disclosed |
| US-8084218-B2 | Method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis and kit for diagnosis of cancers using the same | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2011-12-27 | — | — | US | disclosed |
| EP-1329513-B1 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIV WASHINGTON (US) | 2011-12-07 | — | — | EP | disclosed |
| US-8053553-B2 | Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens | SOCPRA SCIENCES SANTE ET HUMAINES (CA) | 2011-11-08 | — | — | US | disclosed |
| WO-2011134056-A1 | METHODS AND USES OF TIE2 BINDING AND/OR ACTIVATING AGENTS | SUNNYBROOK HEALTH SCIENCES CENTRE (CA) | 2011-11-03 | — | — | WO | disclosed |
| US-20110262895-A1 | METHODS FOR THE DIAGNOSIS OF VARICELLA ZOSTER VIRUS INFECTION | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2011-10-27 | — | — | US | disclosed |
| EP-2379697-A2 | SAMPLING DEVICES AND METHODS FOR CONCENTRATING MICROORGANISMS | 3M Innovative Properties Company (US) | 2011-10-26 | — | — | EP | disclosed |
| EP-1815028-B1 | MICROBUBBLES FOR AFFINITY SEPARATION | IRIS MOLECULAR DIAGNOSTICS INC (US) | 2011-10-26 | — | — | EP | disclosed |
| EP-2371862-A2 | Compositions monovalent for CD40L binding and methods of use | Domantis Limited (GB) | 2011-10-05 | — | — | EP | disclosed |
| US-20110236884-A1 | MICROBUBBLES FOR AFFINITY SEPARATION | IRIS MOLECULAR DIAGNOSTICS, INC. | 2011-09-29 | — | — | US | disclosed |
| US-20110237464-A1 | Guided Mode Resonant Filter Biosensor Using a Linear Grating Surface Structure | SRU BIOSYSTEMS, INC. | 2011-09-29 | — | — | US | disclosed |
| US-20110230644-A1 | MICROBUBBLES FOR AFFINITY SEPARATION | IRIS MOLECULAR DIAGNOSTICS, INC. | 2011-09-22 | — | — | US | disclosed |
| US-20110223179-A1 | METHODS AND COMPOSITIONS FOR MALARIA PROPHYLAXIS | NEW YORK UNIVERSITY (US) | 2011-09-15 | — | — | US | disclosed |
| WO-2011100528-A2 | COMPOSITIONS AND USES OF LECTINS | EMORY UNIVERSITY (US) | 2011-08-18 | — | — | WO | disclosed |
| US-20110201132-A1 | Optical Detection of Label-Free Biomolecular Interactions using Microreplicated Plastic | SRU BIOSYSTEMS, INC. | 2011-08-18 | — | — | US | disclosed |
| EP-2356234-A2 | DOSAGE OF OLIGONUCLEOTIDES SUITABLE FOR THE TREATMENT OF TUMORS | Antisense Pharma GmbH (DE) | 2011-08-17 | — | — | EP | disclosed |
| EP-2349359-A2 | MEDICAL IMPLANT HAVING BIO-FUNCTIONALIZED SURFACE | Fachhochschule Gelsenkirchen (DE) | 2011-08-03 | — | — | EP | disclosed |
| US-20110172400-A1 | COMPOSITIONS MONOVALENT FOR CD40L BINDING AND METHODS OF USE | DOMANTIS LIMITED (GB) | 2011-07-14 | — | — | US | disclosed |
| US-20110165697-A1 | MONOCLONAL ANTIBODIES AGAINST OSTEOPONTIN | UNIVERSITY OF MAINE SYSTEM BOARD OF TRUSTEES (US) | 2011-07-07 | — | — | US | disclosed |
| US-20110166034-A1 | CAPTURE AGENTS AND RELATED METHODS AND SYSTEMS FOR DETECTING AND/OR SORTING TARGETS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-07-07 | — | — | US | disclosed |
| EP-2341079-A1 | Immunoglobulin-binding proteins derived from Sac7d and uses thereof | Institut Pasteur (FR) | 2011-07-06 | — | — | EP | disclosed |
| EP-2340308-A1 | COMBINATION OF A CHEMOTHERAPEUTIC AGENT AND AN INHIBITOR OF THE TGF-BETA SYSTEM | Antisense Pharma GmbH (DE) | 2011-07-06 | — | — | EP | disclosed |
| WO-2011077395-A1 | IMMUNOGLOBULIN-BINDING PROTEINS DERIVED FROM Sac7d AND USES THEREOF | INSTITUT PASTEUR (FR) | 2011-06-30 | — | — | WO | disclosed |
| US-20110151015-A1 | IMMUNOMODULATOR PARTICLES AND METHODS OF TREATING | LIQUIKIA TECHNOLOGIES, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| US-7964340-B2 | One-step enzymatic and amine detection technique | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2011-06-21 | — | — | US | disclosed |
| US-20110130348-A1 | KINETICALLY EFFICIENT SUBSTRATE FOR LIPOIC ACID LIGASE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2011-06-02 | — | — | US | disclosed |
| EP-2322209-A2 | Tumor specific oligosaccharide epitopes and use thereof | Glykos Finland Oy (FI) | 2011-05-18 | — | — | EP | disclosed |
| US-7935520-B2 | Optical detection of label-free biomolecular interactions using microreplicated plastic sensor elements | SRU BIOSYSTEMS, INC. (US) | 2011-05-03 | — | — | US | disclosed |
| US-20110097300-A1 | MULTIMERIC TIE 2 AGONISTS AND USES THEREOF IN STIMULATING ANGIOGENESIS | SUNNYBROOK HEALTH SCIENCES CENTRE (CA) | 2011-04-28 | — | — | US | disclosed |
| US-7927596-B2 | Methods of antagonizing binding of CD40 to CD40L with CD40L-specific monovalent polypeptides | DOMANTIS LIMITED (GB) | 2011-04-19 | — | — | US | disclosed |
| US-7923239-B2 | One-dimensional grating surface of low refractive index material covered with high refractive index material having one or more specific binding substances immobilized on it; no detection labels; when illuminated a resonant grating effect is produced on a reflected radiation spectrum; high throughput | SRU BIOSYSTEMS, INC. (US) | 2011-04-12 | — | — | US | disclosed |
| EP-2302078-A1 | Microbubbles for affinity separation | Iris Molecular Diagnostics, Inc. (US) | 2011-03-30 | — | — | EP | disclosed |
| US-7910563-B2 | Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA | ANTISENSE PHARMA GMBH (DE) | 2011-03-22 | — | — | US | disclosed |
| EP-2295988-A2 | Multiplexed molecular analysis apparatus and its fabrication method | High Throughput Genomics, Inc. (US) | 2011-03-16 | — | — | EP | disclosed |
| US-7906276-B2 | Enzymatic detection techniques | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2011-03-15 | — | — | US | disclosed |
| US-20110059018-A1 | COVALENTLY BINDING IMAGING PROBES | SANOFI-AVENTIS (FR) | 2011-03-10 | — | — | US | disclosed |
| US-20110053292-A1 | SIGNAL AMPLIFICATION TECHNIQUE FOR MASS ANALYSIS | PROBIOND CO., LTD. (KR) | 2011-03-03 | — | — | US | disclosed |
| US-20110045095-A1 | POLYMER-PHOSPHOLIPID SHELLED MICROBUBBLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-02-24 | — | — | US | disclosed |
| EP-2284537-A1 | Guided mode resonant filter biosensor using linear grating surface structure | SRU Biosystems, Inc. (US) | 2011-02-16 | — | — | EP | disclosed |
| EP-2061433-B1 | COMPOSITIONS FOR ENHANCING TRANSPORT THROUGH MUCUS | UNIV JOHNS HOPKINS (US) | 2011-02-16 | — | — | EP | disclosed |
| WO-2011012713-A1 | COMBINATION OF A CHEMOTHERAPEUTIC AGENT AND AN INHIBITOR OF THE TGF-BETA SYSTEM | ANTISENSE PHARMA GMBH (DE) | 2011-02-03 | — | — | WO | disclosed |
| EP-2278333-A2 | NEW SIGNAL AMPLIFICATION TECHNIQUE FOR MASS ANALYSIS | Probiond Co., Ltd. (KR) | 2011-01-26 | — | — | EP | disclosed |
| EP-1972939-B1 | Method for the diagnosis of cancers by measuring the changes of glycosylation of TIMP-1 related to tumorigenesis and metastasis | KOREA RES INST OF BIOSCIENCE (KR) | 2011-01-26 | — | — | EP | disclosed |
| US-7875434-B2 | Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor | SRU BIOSYSTEMS, INC. (US) | 2011-01-25 | — | — | US | disclosed |
| US-20110014297-A1 | MULTIMODAL THERAPEUTIC HYBRID PARTICLE COMPLEX AND SYSTEM | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-01-20 | — | — | US | disclosed |
| EP-2274443-A2 | CAPTURE AGENTS AND RELATED METHODS AND SYSTEMS FOR DETECTING AND/OR SORTING TARGETS | California Institute of Technology (US) | 2011-01-19 | — | — | EP | disclosed |
| US-7867725-B2 | Monoclonal antibodies against osteopontin | MAINE MEDICAL CENTER (US) | 2011-01-11 | — | — | US | disclosed |
| US-7867781-B2 | Detection methods | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH (DE) | 2011-01-11 | — | — | US | disclosed |
| EP-2262783-A2 | COVALENTLY BINDING IMAGING PROBES | Sanofi-Aventis (FR) | 2010-12-22 | — | — | EP | disclosed |
| EP-2262480-A1 | IMMUNOMODULATOR PARTICLES AND METHODS OF TREATING | Liquidia Technologies, Inc. (US) | 2010-12-22 | — | — | EP | disclosed |
| US-20100311185-A1 | DETECTION METHODS | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH (DE) | 2010-12-09 | — | — | US | disclosed |
| US-20100300530-A1 | Flagella as a Biological Material for Nanostructured Devices | DREXEL UNIVERSITY | 2010-12-02 | — | — | US | disclosed |
| EP-2252893-A1 | METHOD FOR EARLY DETERMINATION OF RECURRENCE AFTER THERAPY FOR PROSTATE CANCER | Iris International, Inc. (US) | 2010-11-24 | — | — | EP | disclosed |
| US-20100286236-A1 | Dosage of oligonucleotides suitable for the treatment of tumors | ANTISENSE PHARMA GMBH (DE) | 2010-11-11 | — | — | US | disclosed |
| EP-2248895-A2 | Combination therapy associating a TGF-beta antagonist with a chemotherapeutic agent | Antisense Pharma GmbH (DE) | 2010-11-10 | — | — | EP | disclosed |
| US-7829096-B2 | CD40L-specific monovalent polypeptides | DOMANTIS LTD. (GB) | 2010-11-09 | — | — | US | disclosed |
| EP-1412471-B1 | APPARATUS AND METHOD FOR DETERMINING THE ONSET AND PRESENCE OF SEPSIS CONDITIONS | WEBBER ROBERT (US) | 2010-10-06 | — | — | EP | disclosed |
| US-20100247541-A1 | NOVEL ANTIGEN ASSOCIATED WITH THE NEOVASCULATURE OF TUMOUR METASTASES | PHILOGEN S.P.A. | 2010-09-30 | — | — | US | disclosed |
| US-7803361-B2 | Therapeutic use of interleukin-2 mutants | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2010-09-28 | — | — | US | disclosed |
| US-7799526-B2 | Phosphoprotein detection reagent and methods of making and using the same | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2010-09-21 | — | — | US | disclosed |
| US-20100216256-A1 | NANOBELT-BASED SENSORS AND DETECTION METHODS | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2010-08-26 | — | — | US | disclosed |
| US-20100215580-A1 | Compositions and methods for enhancing transport through mucus | THE JOHNS HOPKINS UNIVERSITY (US) | 2010-08-26 | — | — | US | disclosed |
| US-20100209946-A1 | USES OF WATER-DISPERSIBLE SILICA NANOPARTICLES FOR ATTACHING BIOMOLECULES | 3M INNOVATIVE PROPERTIES COMPANY | 2010-08-19 | — | — | US | disclosed |
| EP-1112085-B1 | HUMANIZED ANTI-VON WILLEBRAND FACTOR MONOCLONAL ANTIBODY | AJINOMOTO KK (JP) | 2010-08-11 | — | — | EP | disclosed |
| US-20100184103-A1 | METHODS OF USE OF SOLID SUPPORT MATERIAL FOR BINDING BIOMOLECULES | 3M INNOVATIVE PROPERTIES COMPANY | 2010-07-22 | — | — | US | disclosed |
| WO-2010078399-A2 | SAMPLING DEVICES AND METHODS FOR CONCENTRATING MICROORGANISMS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-07-08 | — | — | WO | disclosed |
| EP-2204652-A1 | A guided mode resonant filter biosensor using a linear grating surface structure | SRU Biosystems Inc. (US) | 2010-07-07 | — | — | EP | disclosed |
| US-20100168390-A1 | MHC MULTIMERS, METHODS FOR THEIR GENERATION, LABELING AND USE | DAKO DENMARK A/S (DK) | 2010-07-01 | — | — | US | disclosed |
| US-20100160208-A1 | Pharmaceutical composition | ANTISENSE PHARMA GMBH | 2010-06-24 | — | — | US | disclosed |
| US-7736866-B2 | Enzyme-based time temperature indicator | CIBA CORPORATION (US) | 2010-06-15 | — | — | US | disclosed |
| US-20100145008-A1 | OB-FOLD USED AS SCAFFOLD FOR ENGINEERING NEW SPECIFIC BINDERS | INSTITUT PASTEUR (FR) | 2010-06-10 | — | — | US | disclosed |
| WO-2010055148-A2 | DOSAGE OF OLIGONUCLEOTIDES SUITABLE FOR THE TREATMENT OF TUMORS | ANTISENSE PHARMA GMBH (DE) | 2010-05-20 | — | — | WO | disclosed |
| US-20100122363-A1 | Certain human genomic DNA associated with total red-green colorblindness | ZELENY CHARLES TIMBERLAKE | 2010-05-13 | — | — | US | disclosed |
| US-20100120164-A1 | METHOD USING A NONLINEAR OPTICAL TECHNIQUE FOR DETECTION OF INTERACTIONS INVOLVING A CONFORMATIONAL CHANGE | BIODESY, LLC (US) | 2010-05-13 | — | — | US | disclosed |
| US-20100120058-A1 | IgE Antibodies to Chimeric or Humanized IgG Therapeutic Monoclonal Antibodies as a Screening Test for Anaphylaxis | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2010-05-13 | — | — | US | disclosed |
| WO-2010049171-A2 | MEDICAL IMPLANT HAVING BIO-FUNCTIONALIZED SURFACE | FACHHOCHSCHULE GELSENKIRCHEN (DE) | 2010-05-06 | — | — | WO | disclosed |
| US-20100113609-A1 | METHODS AND COMPOSITIONS FOR MALARIA PROPHYLAXIS | NEW YORK UNIVERSITY | 2010-05-06 | — | — | US | disclosed |
| US-20100099202-A1 | DETECTION OF VON-WILLEBRAND FACTOR (vWF) ACTIVITY | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 2010-04-22 | — | — | US | disclosed |
| US-20100099121-A1 | METHOD FOR THE DIAGNOSIS OF CANCERS BY MEASURING THE CHANGES OF GLYCOSYLATION OF PROTEINS RELATED TO TUMORIGENESIS AND METASTASIS AND KIT FOR DIAGNOSIS OF CANCERS USING THE SAME | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY | 2010-04-22 | — | — | US | disclosed |
| US-20100092483-A1 | Compositions monovalent for CD40L binding and methods of use | DOMANTIS LIMITED | 2010-04-15 | — | — | US | disclosed |
| US-20100092482-A1 | Compositions monovalent for CD40L binding and methods of use | DOMANTIS LIMITED (GB) | 2010-04-15 | — | — | US | disclosed |
| EP-2167536-A1 | MHC MULTIMERS, METHODS FOR THEIR GENERATION, LABELING AND USE | Dako Denmark A/S (DK) | 2010-03-31 | — | — | EP | disclosed |
| US-20100075322-A1 | Methods and Compositions for Identifying Mycotoxins and Fungal Species | MEDICAL SERVICE CONSULTATION INTERNATIONAL, L.L.C. | 2010-03-25 | — | — | US | disclosed |
| EP-2155894-A2 | TARGETING HOST PROTEINASES AS A THERAPEUTIC STRATEGY AGAINST VIRAL AND BACTERIAL PATHOGENS | Burnham Institute for Medical Research (US) | 2010-02-24 | — | — | EP | disclosed |
| CN-101652386-A | OB-FOLD as scaffold for engineering novel specific binders | PASTEUR INST FR | 2010-02-17 | — | — | CN | disclosed |
| WO-2010017381-A2 | METHODS FOR THE DIAGNOSIS OF VARICELLA ZOSTER VIRUS INFECTION | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2010-02-11 | — | — | WO | disclosed |
| US-7651842-B2 | Ribosomal complex of the large and small subunits of ribosomes which are particulate; an adhesin of a microbe or antigen of a virus | BT PHARMA (FR) | 2010-01-26 | — | — | US | disclosed |
| EP-1468290-B1 | A GUIDED MODE RESONANT FILTER BIOSENSOR USING A LINEAR GRATING SURFACE STRUCTURE | SRU BIOSYSTEMS INC (US) | 2010-01-13 | — | — | EP | disclosed |
| EP-2140264-A1 | METHODS OF USE OF SOLID SUPPORT MATERIAL FOR BINDING BIOMOLECULES | 3M Innovative Properties Company (US) | 2010-01-06 | — | — | EP | disclosed |
| US-20090325315-A1 | DETECTION METHOD OF TARGET SUBSTANCE, DETECTION REAGENT USED FOR THE SAME, AND THE USES THEREOF | ARKRAY, INC. (JP) | 2009-12-31 | — | — | US | disclosed |
| EP-2137533-A2 | USES OF WATER-DISPERSIBLE SILICA NANOPARTICLES FOR ATTACHING BIOMOLECULES | 3M Innovative Properties Company (US) | 2009-12-30 | — | — | EP | disclosed |
| US-20090306176-A1 | Use Of Low Doses Of Oligonucleotides Antisense To TGF-Beta, VEGF, Interleukin-10, C-Jun, C-Fos Or Prostaglandin E2 Genes In The Treatment Of Tumors | ANTISENSE PHARMA GMBH (DE) | 2009-12-10 | — | — | US | disclosed |
| EP-1781805-B1 | ENZYME-BASED TIME TEMPERATURE INDICATOR | BASF SE (DE) | 2009-12-09 | — | — | EP | disclosed |
| US-20090297524-A1 | Compositions monovalent for CD40L binding and methods of use | DOMANTIS LIMITED (GB) | 2009-12-03 | — | — | US | disclosed |
| US-7622259-B1 | Discriminating between types of von-Willebrand disease using a von-Willebrand factor (vWF) binding activity; assaying a sample in the presence of a soluble form or portion of glycoprotein Ib( alpha ) (GPIb( alpha ) and ristocetin | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 2009-11-24 | — | — | US | disclosed |
| US-7622261-B2 | Method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis and kit for diagnosis of cancers using the same | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2009-11-24 | — | — | US | disclosed |
| US-20090274653-A1 | Decreasing solid tumor size in a cancer patient by administering an interleukin-2 mutant with reduced vasopermeability activity compared to a wildtype form, and being Arg38Trp, wherein said wildtype form is human IL-2 mutant and the IL-2 mutant is not linked to an antibody. | UNIVERSITY OF SOUTHERN CALIFORNIA | 2009-11-05 | — | — | US | disclosed |
| US-20090264314-A1 | Optical Detection of Label-Free Biomolecular Interactions Using Microreplicated Plastic Sensor Elements | SRU BIOSYSTEMS, INC. | 2009-10-22 | — | — | US | disclosed |
| WO-2009126828-A2 | CAPTURE AGENTS AND RELATED METHODS AND SYSTEMS FOR DETECTING AND/OR SORTING TARGETS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2009-10-15 | — | — | WO | disclosed |
| US-20090246781-A1 | Method for early determination of recurrence after therapy for prostate cancer | IRIS INTERNATIONAL, INC. | 2009-10-01 | — | — | US | disclosed |
| EP-1105517-B2 | RAPID QUANTITATIVE ANALYSIS OF PROTEINS OR PROTEIN FUNCTION IN COMPLEX MIXTURES | UNIV WASHINGTON (US) | 2009-09-30 | — | — | EP | disclosed |
| US-7595198-B2 | Photocleavable isotope-coded affinity tags | AMBERGEN, INC. (US) | 2009-09-29 | — | — | US | disclosed |
| US-20090239759-A1 | MULTIPLEXED MOLECULAR ANALYSIS SYSTEMS | BALCH WILLIAM J | 2009-09-24 | — | — | US | disclosed |
| EP-2099817-A2 | OB-FOLD USED AS SCAFFOLD FOR ENGINEERING NEW SPECIFIC BINDERS | Institut Pasteur (FR) | 2009-09-16 | — | — | EP | disclosed |
| WO-2009111588-A1 | IMMUNOMODULATOR PARTICLES AND METHODS OF TREATING | LIQUIDIA TECHNOLOGIES, INC. (US) | 2009-09-11 | — | — | WO | disclosed |
| US-20090226948-A1 | Enzyme-based time temperature indicator | CIBA CORP. | 2009-09-10 | — | — | US | disclosed |
| US-20090226938-A1 | One-Step Enzymatic and Amine Detection Technique | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2009-09-10 | — | — | US | disclosed |
| WO-2009105264-A1 | METHOD FOR EARLY DETERMINATION OF RECURRENCE AFTER THERAPY FOR PROSTATE CANCER | IRIS INTERNATIONAL INC. (US) | 2009-08-27 | — | — | WO | disclosed |
| WO-2009103432-A2 | COVALENTLY BINDING IMAGING PROBES | SANOFI-AVENTIS (FR) | 2009-08-27 | — | — | WO | disclosed |
| US-7575939-B2 | Optical detection of label-free biomolecular interactions using microreplicated plastic sensor elements | SRU BIOSYSTEMS, INC. (US) | 2009-08-18 | — | — | US | disclosed |
| EP-2087353-A2 | METHOD FOR BLOCKING NON-SPECIFIC PROTEIN BINDING ON A FUNCTIONALIZED SURFACE | SRU Biosystems, Inc. (US) | 2009-08-12 | — | — | EP | disclosed |
| US-7563443-B2 | Monovalent anti-CD40L antibody polypeptides and compositions thereof | DOMANTIS LIMITED (GB) | 2009-07-21 | — | — | US | disclosed |
| US-20090176201-A1 | MICROBUBBLES FOR AFFINITY SEPARATION | IRIS MOLECULAR DIAGNOSTICS, INC (US) | 2009-07-09 | — | — | US | disclosed |
| EP-2076290-A1 | MULTIMERIC TIE 2 AGONISTS AND USES THEREOF IN STIMULATING ANGIOGENESIS | Sunnybrook Health Sciences Center (US) | 2009-07-08 | — | — | EP | disclosed |
| EP-2069790-A2 | BINDING SURFACES FOR AFFINITY ASSAYS | Beckman Coulter, Inc. (US) | 2009-06-17 | — | — | EP | disclosed |
| US-20090148955-A1 | Label-Free High-Throughput Optical Technique for Detecting Biomolecular Interactions | SRU BIOSYSTEMS, INC. | 2009-06-11 | — | — | US | disclosed |
| US-7544518-B2 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON (US) | 2009-06-09 | — | — | US | disclosed |
| EP-2061433-A2 | COMPOSITIONS AND METHODS FOR ENHANCING TRANSPORT THROUGH MUCUS | Johns Hopkins University (US) | 2009-05-27 | — | — | EP | disclosed |
| EP-2062586-A2 | USE OF LOW DOSES OF OLIGONUCLEOTIDES ANTISENSE TO TGF-BETA, VEGF, INTERLEUKIN-10, C-JUN, C-FOS OR PROSTAGLANDIN E2 GENES IN THE TREATMENT OF TUMORS | Antisense Pharma GmbH (DE) | 2009-05-27 | — | — | EP | disclosed |
| US-7521226-B2 | One-step enzymatic and amine detection technique | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2009-04-21 | — | — | US | disclosed |
| US-20090092619-A1 | METHODS AND COMPOSITIONS FOR MALARIA PROPHYLAXIS | NEW YORK UNIVERSITY | 2009-04-09 | — | — | US | disclosed |
| US-7514073-B2 | Therapeutic use of interleukin-2 mutants | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2009-04-07 | — | — | US | disclosed |
| WO-2009023306-A2 | TARGETING HOST PROTEINASES AS A THERAPEUTIC STRATEGY AGAINST VIRAL AND BACTERIAL PATHOGENS | BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2009-02-19 | — | — | WO | disclosed |
| US-20090029924-A1 | Targeting Host Proteinases as a Therapeutic Strategy Against Viral and Bacterial Pathogens | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2009-01-29 | — | — | US | disclosed |
| WO-2009009188-A2 | USES OF WATER-DISPERSIBLE SILICA NANOPARTICLES FOR ATTACHING BIOMOLECULES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-01-15 | — | — | WO | disclosed |
| US-20090017476-A1 | Multiple Component Nanoparticles for Multiplexed Signaling and Optical Encoding | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2009-01-15 | — | — | US | disclosed |
| WO-2009003492-A1 | MHC MULTIMERS, METHODS FOR THEIR GENERATION, LABELING AND USE | DAKO DENMARK A/S (DK) | 2009-01-08 | — | — | WO | disclosed |
| EP-1448978-B1 | INTEGRATED OPTOELECTRONIC SILICON BIOSENSOR FOR THE DETECTION OF BIOMOLECULES LABELED WITH CHROMOPHORE GROUPS OR NANOPARTICLES | NAT CT SCIENT RES DEMOKRITOS (GR) | 2009-01-07 | — | — | EP | disclosed |
| EP-1877070-B1 | THERAPEUTIC USE OF TGF-BETA2 ANTISENSE OLIGONUCLEOTIDES | ANTISENSE PHARMA GMBH (DE) | 2008-12-31 | — | — | EP | disclosed |
| US-7465747-B2 | Fluorescent label compounds | Matsumoto, Kazuko (JP) | 2008-12-16 | — | — | US | disclosed |
| CN-101321686-A | Multiple component nanoparticles for multiplexed signaling and optical encoding | UNIV FLORIDA (US) | 2008-12-10 | — | — | CN | disclosed |
| WO-2008131063-A1 | METHODS OF USE OF SOLID SUPPORT MATERIAL FOR BINDING BIOMOLECULES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-10-30 | — | — | WO | disclosed |
| US-7435385-B2 | Label-free high-throughput optical technique for detecting biomolecular interactions | SRU BIOSYSTEMS, INC. (US) | 2008-10-14 | — | — | US | disclosed |
| EP-1466179-B1 | METHOD FOR THE DIAGNOSIS OF CANCERS BY MEASURING THE CHANGES OF GLYCOSYLATION OF PROSTATE-DERIVED FACTOR (PDF) RELATED TO TUMORIGENESIS AND METASTASIS. | KOREA RES INST OF BIOSCIENCE (KR) | 2008-10-08 | — | — | EP | disclosed |
| EP-1972939-A1 | Method for the diagnosis of cancers by measuring the changes of glycosylation of TIMP-1 related to tumorigenesis and metastasis, and kit for diagnosis of cancers using the same | Korea Research Institute of Bioscience and Biotechnology (KR) | 2008-09-24 | — | — | EP | disclosed |
| US-20080219892-A1 | Guided Mode Resonant Filter Biosensor Using a Linear Grating Surface Structure | SRU BIOSYSTEMS INC. | 2008-09-11 | — | — | US | disclosed |
| EP-1815028-A4 | MICROBUBBLES FOR AFFINITY SEPARATION | IRIS MOLECULAR DIAGNOSTICS INC (US) | 2008-09-10 | — | — | EP | disclosed |
| US-7422891-B2 | Label-free high-throughput optical technique for detecting biomolecular interactions | SRU BIOSYSTEMS, INC. (US) | 2008-09-09 | — | — | US | disclosed |
| US-20080213910-A1 | METHOD FOR BLOCKING NON-SPECIFIC PROTEIN BINDING ON A FUNCTIONALIZED SURFACE | X-BODY, INC. | 2008-09-04 | — | — | US | disclosed |
| WO-2008101177-A2 | IGE ANTIBODIES TO CHIMERIC OR HUMANIZED IGG THERAPEUTIC MONOCLONAL ANTIBODIES AS A SCREENING TEST FOR ANAPHYLAXIS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2008-08-21 | — | — | WO | disclosed |
| US-7413852-B2 | Multiplexed diagnostic and therapeutics | HIGH THROUGHPUT GENOMICS (US) | 2008-08-19 | — | — | US | disclosed |
| US-20080176340-A1 | Binding surfaces for affinity assays | BECKMAN COULTER, INC. (US) | 2008-07-24 | — | — | US | disclosed |
| US-20080176337-A1 | Monoclonal antibodies against osteopontin | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-07-24 | — | — | US | disclosed |
| US-20080166414-A1 | Drugs And Gene Carrier Particles That Rapidly Move Through Mucous Barriers | JOHNS HOPKINS UNIVERSITY (US) | 2008-07-10 | — | — | US | disclosed |
| WO-2008030557-A9 | COMPOSITIONS AND METHODS FOR ENHANCING TRANSPORT THROUGH MUCUS | UNIV JOHNS HOPKINS (US) | 2008-06-26 | — | — | WO | disclosed |
| EP-1931593-A1 | MULTIPLE COMPONENT NANOPARTICLES FOR MULTIPLEXED SIGNALING AND OPTICAL ENCODING | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2008-06-18 | — | — | EP | disclosed |
| WO-2008068637-A2 | OB-FOLD USED AS SCAFFOLD FOR ENGINEERING NEW SPECIFIC BINDERS | INSTITUT PASTEUR (FR) | 2008-06-12 | — | — | WO | disclosed |
| EP-1930342-A1 | OB-fold used as scaffold for engineering new specific binders | INSTITUT PASTEUR (FR) | 2008-06-11 | — | — | EP | disclosed |
| WO-2008057366-A2 | BINDING SURFACES FOR AFFINITY ASSAYS | BECKMAN COULTER, INC. (US) | 2008-05-15 | — | — | WO | disclosed |
| US-7371371-B2 | Interleukin-2 mutants with reduced toxicity | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2008-05-13 | — | — | US | disclosed |
| US-7371755-B1 | Antiviral agents | BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) | 2008-05-13 | — | — | US | disclosed |
| US-7371562-B2 | Guided mode resonant filter biosensor using a linear grating surface structure | SRU BIOSYSTEMS, INC. (US) | 2008-05-13 | — | — | US | disclosed |
| WO-2008055080-A2 | METHOD FOR BLOCKING NON-SPECIFIC PROTEIN BINDING ON A FUNCTIONALIZED SURFACE | SRU BIOSYSTEMS, INC. (US) | 2008-05-08 | — | — | WO | disclosed |
| WO-2008051285-A2 | METHODS AND COMPOSITIONS FOR DETECTING FUNGI AND MYCOTOXINS | MEDICAL SERVICE CONSULTATION INTERNATIONAL, LLC (US) | 2008-05-02 | — | — | WO | disclosed |
| WO-2008049227-A1 | MULTIMERIC TIE 2 AGONISTS AND USES THEREOF IN STIMULATING ANGIOGENESIS | SUNNYBROOK HEALTH SCIENCES CENTER (CA) | 2008-05-02 | — | — | WO | disclosed |
| US-20080103056-A1 | Label-Free Methods for Performing Assays Using a Colorimetric Resonant Reflectance Optical Biosensor | SRU BIOSYSTEMS, INC. | 2008-05-01 | — | — | US | disclosed |
| US-20080090255-A1 | Phosphoprotein detection reagent and method of making and using the same | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2008-04-17 | — | — | US | disclosed |
| US-7358063-B2 | Method of detecting PS2V | SYSMEX CORPORATION (JP) | 2008-04-15 | — | — | US | disclosed |
| WO-2008030557-A2 | COMPOSITIONS AND METHODS FOR ENHANCING TRANSPORT THROUGH MUCUS | JOHNS HOPKINS UNIVERSITY (US) | 2008-03-13 | — | — | WO | disclosed |
| EP-1892518-A2 | A label-free high throughput optical technique for detecting bio-molecular interactions | SRU Biosystems, Inc. (US) | 2008-02-27 | — | — | EP | disclosed |
| US-7332352-B2 | Separation particles | GE HEALTHCARE LIMITED (GB) | 2008-02-19 | — | — | US | disclosed |
| US-20080032417-A1 | Photocleavable isotope-coded affinity tags | AMBERGEN, INC | 2008-02-07 | — | — | US | disclosed |
| US-20080014582-A1 | Methods and compositions for detecting fungi and mycotoxins | RTL PURCHASER LLC | 2008-01-17 | — | — | US | disclosed |
| EP-1877070-A2 | DOSAGE OF OLIGONUCLEOTIDES | Antisense Pharma GmbH (DE) | 2008-01-16 | — | — | EP | disclosed |
| US-7319046-B2 | Integrated optoelectronic silicon biosensor for the detection of biomolecules labeled with chromophore groups or nanoparticles | Misiakos, Konstantinos (GR) | 2008-01-15 | — | — | US | disclosed |
| US-20070299022-A1 | Antisense Oligonucleotide to Inhibit Melanoma Inhibitory Activity Mia | ANTISENSE PHARMA GMBH (DE) | 2007-12-27 | — | — | US | disclosed |
| US-7312090-B2 | Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor | SRU BIOSYSTEMS, INC. (US) | 2007-12-25 | — | — | US | disclosed |
| US-7311913-B2 | Methods of treating thrombotic diseases with von Willebrand factor specific antibodies | AJINOMOTO CO., INC. (JP) | 2007-12-25 | — | — | US | disclosed |
| US-20070275410-A1 | Methods and Compositions Relating to Modulation of Gpcr Signaling | ARENA PHARMACEUTICALS, INC. (US) | 2007-11-29 | — | — | US | disclosed |
| US-7300803-B2 | Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor | SRU BIOSYSTEMS, INC. (US) | 2007-11-27 | — | — | US | disclosed |
| US-20070244071-A1 | Treatment of proliferative diseases | MOUNT SINAI HOSPITAL (CA) | 2007-10-18 | — | — | US | disclosed |
| US-7264973-B2 | Label-free methods for performing assays using a colorimetric resonant optical biosensor | SRU BIOSYSTEMS, INC. (US) | 2007-09-04 | — | — | US | disclosed |
| US-20070196269-A1 | Pharmaceutical composition | ANTISENSE PHARMA GMBH (DE) | 2007-08-23 | — | — | US | disclosed |
| EP-1660656-B1 | AN ANTISENSE OLIGONUCLEOTIDE TO INHIBIT MELANOMA INHIBITORY ACTIVITY, MIA | ANTISENSE PHARMA GMBH (DE) | 2007-08-08 | — | — | EP | disclosed |
| EP-1815028-A2 | MICROBUBBLES FOR AFFINITY SEPARATION | Leucadia Technologies, Inc. (US) | 2007-08-08 | — | — | EP | disclosed |
| EP-1412471-A4 | APPARATUS AND METHOD FOR DETERMINING THE ONSET AND PRESENCE OF SEPSIS CONDITIONS | WEBBER ROBERT (US) | 2007-07-11 | — | — | EP | disclosed |
| US-20070155685-A1 | Pharmaceutical composition | ANTISENSE PHARMA GMBH (DE) | 2007-07-05 | — | — | US | disclosed |
| EP-1047929-B1 | METHOD FOR QUALITATIVE AND QUANTITATIVE MEASUREMENTS | REICHERT INC (US) | 2007-07-04 | — | — | EP | disclosed |
| US-20070141052-A1 | Fc region variants | WATKINS JEFFRY D | 2007-06-21 | — | — | US | disclosed |
| EP-1797126-A1 | COMPOSITIONS MONOVALENT FOR CD40L BINDING AND METHODS OF USE | Domantis Limited (GB) | 2007-06-20 | — | — | EP | disclosed |
| EP-1264181-B1 | CARRIERS COATED WITH POLYSACCHARIDES, THEIR PREPARATION AND USE | DADE BEHRING MARBURG GMBH (DE) | 2007-06-06 | — | — | EP | disclosed |
| US-20070104731-A1 | Helicobacter proteins and vaccines | RICAN LIMITED (IE) | 2007-05-10 | — | — | US | disclosed |
| EP-1781805-A2 | ENZYME-BASED TIME TEMPERATURE INDICATOR | Ciba Specialty Chemicals Holding Inc. (CH) | 2007-05-09 | — | — | EP | disclosed |
| EP-1782069-A1 | ENZYMATIC DETECTION TECHNIQUES | Kimberly Clark Worldwide, Inc. (US) | 2007-05-09 | — | — | EP | disclosed |
| US-20070092558-A1 | Methods of Preparing Targeted Immunoliposomes | HEAVNER GEORGE | 2007-04-26 | — | — | US | disclosed |
| WO-2007044711-A1 | MULTIPLE COMPONENT NANOPARTICLES FOR MULTIPLEXED SIGNALING AND OPTICAL ENCODING | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2007-04-19 | — | — | WO | disclosed |
| US-7202076-B2 | Label-free high-throughput optical technique for detecting biomolecular interactions | SRU BIOSYSTEMS, INC. (US) | 2007-04-10 | — | — | US | disclosed |
| US-20070054339-A1 | Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor | SRU BIOSYSTEMS, INC. | 2007-03-08 | — | — | US | disclosed |
| US-7179660-B1 | Carriers coated with polysaccharides, their preparation and use | DADE BEHRING MARBURG GMBH (DE) | 2007-02-20 | — | — | US | disclosed |
| WO-2007010240-A2 | METHOD FOR HIGH-THROUGHPUT SCREENING | EUROPEAN CARDIOVASCULAR GENETICS FOUNDATION (GB) | 2007-01-25 | — | — | WO | disclosed |
| EP-1206288-B1 | TARGETED FIBERLESS RADIATIVE EFFECTORS | UNIV MICHIGAN (US) | 2007-01-10 | — | — | EP | disclosed |
| EP-0984281-B1 | A homogeneous assay for determining analyte | DADE BEHRING MARBURG GMBH (DE) | 2007-01-03 | — | — | EP | disclosed |
| WO-2006137933-A2 | MICROBUBBLES FOR AFFINITY SEPARATION | LEUCADIA TECHNOLOGIES, INC. (US) | 2006-12-28 | — | — | WO | disclosed |
| US-20060292116-A1 | Interleukin-2 mutants with reduced toxicity | UNIVERSITY OF SOUTHERN CALIFORNIA | 2006-12-28 | — | — | US | disclosed |
| US-7153702-B2 | Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor | SRU BIOSYSTEMS, INC. (US) | 2006-12-26 | — | — | US | disclosed |
| EP-1594979-A4 | NANOCYLINDER-MODIFIED SURFACES | WISCONSIN ALUMNI RES FOUND (US) | 2006-12-20 | — | — | EP | disclosed |
| US-20060281077-A1 | Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor | SRU BIOSYSTEMS, INC. | 2006-12-14 | — | — | US | disclosed |
| US-7145019-B2 | Photocleavable isotope-coded affinity tags | AMBERGEN, INC. (US) | 2006-12-05 | — | — | US | disclosed |
| EP-1722823-A2 | PHARMACEUTICAL COMPOSITION | Antisense Pharma GmbH (DE) | 2006-11-22 | — | — | EP | disclosed |
| US-7138116-B2 | Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody | AJINOMOTO CO., INC. (JP) | 2006-11-21 | — | — | US | disclosed |
| EP-1278768-B1 | METHOD FOR IDENTIFYING HELICOBACTER ANTIGENS | MAX PLANCK GESELLSCHAFT (DE) | 2006-11-15 | — | — | EP | disclosed |
| WO-2006117400-A2 | USE OF LOW DOSES OF OLIGONUCLEOTIDES ANTISENSE TO TGF-BETA, VEGF, INTERLEUKIN-10, C-JUN, C-FOS OR PROSTAGLANDIN E2 GENES IN THE TREATMENT OF TUMORS | ANTISENSE PHARMA GMBH (DE) | 2006-11-09 | — | — | WO | disclosed |
| EP-1713514-A2 | DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS | The Johns Hopkins University (US) | 2006-10-25 | — | — | EP | disclosed |
| WO-2006030220-A9 | COMPOSITIONS MONOVALENT FOR CD40L BINDING AND METHODS OF USE | DOMANTIS LTD (GB) | 2006-10-19 | — | — | WO | disclosed |
| US-20060228725-A1 | Method using a nonlinear optical technique for detection of interactions involving a conformational change | BIODESY LLC (US) | 2006-10-12 | — | — | US | disclosed |
| US-7118710-B2 | Label-free high-throughput optical technique for detecting biomolecular interactions | SRU BIOSYSTEMS, INC. (US) | 2006-10-10 | — | — | US | disclosed |
| EP-1466179-A4 | METHOD FOR THE DIAGNOSIS OF CANCERS BY MEASURING THE CHANGES OF GLYCOSYLATION OF PROTEINS RELATED TO TUMORIGENESIS AND METASTASIS AND KIT FOR DIAGNOSIS OF CANCERS USING THE SAME | KOREA RES INST OF BIOSCIENCE (KR) | 2006-09-20 | — | — | EP | disclosed |
| EP-1694840-A2 | COMBINATION THERAPY ASSOCIATING A TGF-BETA ANTAGONIST WITH A CHEMOTHERAPEUTIC AGENT | Antisense Pharma GmbH (DE) | 2006-08-30 | — | — | EP | disclosed |
| US-7094595-B2 | Label-free high-throughput optical technique for detecting biomolecular interactions | SRU BIOSYSTEMS, INC. (US) | 2006-08-22 | — | — | US | disclosed |
| US-7094528-B2 | Magnetic enzyme detection techniques | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2006-08-22 | — | — | US | disclosed |
| US-20060153838-A1 | Fc region variants | WATKINS JEFFRY D | 2006-07-13 | — | — | US | disclosed |
| EP-1606314-A4 | Fc REGION VARIANTS | APPLIED MOLECULAR EVOLUTION (US) | 2006-07-05 | — | — | EP | disclosed |
| US-7070987-B2 | Guided mode resonant filter biosensor using a linear grating surface structure | SRU BIOSYSTEMS, INC. (US) | 2006-07-04 | — | — | US | disclosed |
| US-20060122266-A1 | Methods and compositions for malaria prophylaxis | SINNIS PHOTINI | 2006-06-08 | — | — | US | disclosed |
| EP-1660656-A2 | AN ANTISENSE OLIGONUCLEOTIDE TO INHIBIT MELANOMA INHIBITORY ACTIVITY, MIA | Antisense Pharma GmbH (DE) | 2006-05-31 | — | — | EP | disclosed |
| US-20060078493-A1 | Methods and apparatus for localized administration of inhibitory moieties to a patient | ABBOTT LABORATORIES VASCULAR ENTERPRISES LIMITED (IE) | 2006-04-13 | — | — | US | disclosed |
| EP-1219964-B1 | Assay method, in which the High-Dose-Hook-Effect is avoided, reduced or detected | DADE BEHRING MARBURG GMBH (DE) | 2006-04-05 | — | — | EP | disclosed |
| US-20060062784-A1 | Compositions monovalent for CD40L binding and methods of use | DOMANTIS LIMITED | 2006-03-23 | — | — | US | disclosed |
| WO-2006030220-A1 | COMPOSITIONS MONOVALENT FOR CD40L BINDING AND METHODS OF USE | DOMANTIS LIMITED (GB) | 2006-03-23 | — | — | WO | disclosed |
| US-20060057661-A1 | Magnetic enzyme detection techniques | KIMBERLY-CLARK WORLDWIDE, INC. | 2006-03-16 | — | — | US | disclosed |
| US-20060057707-A1 | High-throughput instrument for high sensitivity assays without any type of label in a format that is readily compatible with the microtiter plate-based or microarray-based infrastructureoften used for biomolecular interaction analysis; optical grating having a high refractive index; immobilization | SRU BIOSYSTMES, INC. (US) | 2006-03-16 | — | — | US | disclosed |
| US-20060040376-A1 | Guided mode resonant filter biosensor using a linear grating surface structure | SRU BIOSYSTEMS, INC. (US) | 2006-02-23 | — | — | US | disclosed |
| WO-2006015961-A2 | ENZYME-BASED TIME TEMPERATURE INDICATOR | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-02-16 | — | — | WO | disclosed |
| US-20060030033-A1 | Label-free high-throughput optical technique for detecting biomolecular interactions | SRU BIOSYSTEMS, INC. | 2006-02-09 | — | — | US | disclosed |
| WO-2006006961-A1 | ENZYMATIC DETECTION TECHNIQUES | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2006-01-19 | — | — | WO | disclosed |
| US-20060014672-A1 | Tumor specific oligosaccharide epitopes and use thereof | GLYKOS FINLAND OY (FI) | 2006-01-19 | — | — | US | disclosed |
| US-20060003336-A1 | One-step enzymatic and amine detection technique | KIMBERLY-CLARK WORLDWIDE, INC. | 2006-01-05 | — | — | US | disclosed |
| US-20060003394-A1 | Enzymatic detection techniques | KIMBERLY-CLARK WORLDWIDE, INC. | 2006-01-05 | — | — | US | disclosed |
| EP-1606314-A2 | Fc REGION VARIANTS | Applied Molecular Evolution, Inc. (US) | 2005-12-21 | — | — | EP | disclosed |
| US-20050272100-A1 | Separation and quantification of biotinylated macromolecules | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-12-08 | — | — | US | disclosed |
| EP-1224467-B1 | PROTECTING ALKYLATING REAGENTS USED FOR QUANTIFYING HOMOCYSTEINE | DADE BEHRING MARBURG GMBH (DE) | 2005-11-30 | — | — | EP | disclosed |
| US-20050255465-A1 | Novel fluorescent label compounds | KAZUKO MATSUMOTO (JP) | 2005-11-17 | — | — | US | disclosed |
| EP-1594979-A2 | NANOCYLINDER-MODIFIED SURFACES | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2005-11-16 | — | — | EP | disclosed |
| US-20050244898-A1 | Large-area two-dimensional non-adhesive cell arrays for sensing and cell-sorting applications | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2005-11-03 | — | — | US | disclosed |
| US-20050233399-A1 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON | 2005-10-20 | — | — | US | disclosed |
| US-6951715-B2 | Optical detection of label-free biomolecular interactions using microreplicated plastic sensor elements | SRU BIOSYSTEMS, INC. (US) | 2005-10-04 | — | — | US | disclosed |
| US-20050214878-A1 | Method for the diagnosis of cancer by measuring the changes of glycosylation of proteins related to tumorgenesis and metastasis and kit for diagnosis of cancers using the same | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2005-09-29 | — | — | US | disclosed |
| WO-2005084712-A2 | USE OF AN OLIGONUCLEOTIDE OR ITS ACTIVE DERIVATIVE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR INHIBITING THE FORMATION OF METASTASES IN CANCER TREATMENT | ANTISENSE PHARMA GMBH (DE) | 2005-09-15 | — | — | WO | disclosed |
| US-20050201979-A1 | Interleukin-2 mutants with reduced toxicity | UNIVERSITY OF SOUTHERN CALIFORNIA | 2005-09-15 | — | — | US | disclosed |
| EP-1070255-B1 | METHOD TO DETECT THE COMPLEX OF IGFBP-3 WITH IGF AND/OR ALS | DIAGNOSTIC SYSTEMS LAB INC (US) | 2005-09-14 | — | — | EP | disclosed |
| US-20050197494-A1 | Methods of treating thrombotic diseases with von willebrand factor specific antibodies | AJINOMOTO CO., INC. (JP) | 2005-09-08 | — | — | US | disclosed |
| EP-1568383-A2 | Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formation of metastases in cancer treatment | Antisense Pharma GmbH (DE) | 2005-08-31 | — | — | EP | disclosed |
| WO-2005072710-A2 | DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS | JOHNS HOPKINS UNIVERSITY (US) | 2005-08-11 | — | — | WO | disclosed |
| WO-2005059133-A2 | COMBINATION THERAPY ASSOCIATING A TGF-BRETA ANTAGONIST WITH A CHEMIOTHERAPEUTIC AGENT | ANTISENSE PHARMA GMBH (DE) | 2005-06-30 | — | — | WO | disclosed |
| WO-2005051905-A2 | LARGE-AREA TWO-DIMENSIONAL NON-ADHESIVE CELL ARRAYS FOR SENSING AND CELL-SORTING APPLICATIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2005-06-09 | — | — | WO | disclosed |
| EP-1534324-A2 | TUMOR SPECIFIC OLIGOSACCHARIDE EPITOPES AND USE THEREOF | BioTie Therapies Ltd. (FI) | 2005-06-01 | — | — | EP | disclosed |
| US-6892140-B1 | Immunogenic cancer peptides and uses thereof | ENTERON, INC. (US) | 2005-05-10 | — | — | US | disclosed |
| WO-2005037210-A2 | PHOTOCLEAVABLE ISOTOPE-CODED AFFINITY TAGS | AMBERGEN, INC. (US) | 2005-04-28 | — | — | WO | disclosed |
| US-20050085630-A1 | Photocleavable isotope-coded affinity tags | AMBERGEN INC. | 2005-04-21 | — | — | US | disclosed |
| EP-1476180-A4 | INTERLEUKIN-2 MUTANTS WITH REDUCED TOXICITY | UNIV SOUTHERN CALIFORNIA (US) | 2005-04-20 | — | — | EP | disclosed |
| EP-0726905-B1 | SINGLE NUCLEOTIDE POLYMORPHISMS AND THEIR USE IN GENETIC ANALYSIS | ORCHID BIOSCIENCES INC (US) | 2005-03-23 | — | — | EP | disclosed |
| WO-2005019834-A1 | METHODS AND C0MPOSITIONS RELATING TO MODULATION OF GPCR SIGNALING | ARENA PHARMACEUTICALS, INC. (US) | 2005-03-03 | — | — | WO | disclosed |
| WO-2005014812-A2 | AN ANTISENSE OLIGONUCLEOTIDE TO INHIBIT MELANOMA INHIBITORY ACTIVITY, MIA | ANTISENSE PHARMA GMBH (DE) | 2005-02-17 | — | — | WO | disclosed |
| US-6852544-B2 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON (US) | 2005-02-08 | — | — | US | disclosed |
| US-20050014718-A1 | Cancer indicator; vaccine | GLYKOS FINLAND OY (FI) | 2005-01-20 | — | — | US | disclosed |
| US-20050003520-A1 | Integrated optoelectronic silicon biosensor for the detection of biomolecules labeled with chromophore groups or nanoparticles | KAKABAKOS, SOTIRIOS (GR) | 2005-01-06 | — | — | US | disclosed |
| EP-1489418-A1 | NOVEL FLUORESCENT LABEL COMPOUNDS | Matsumoto, Kazuko (JP) | 2004-12-22 | — | — | EP | disclosed |
| EP-1047929-A4 | REFRACTOMETER AND METHOD FOR QUALITATIVE AND QUANTITATIVE MEASUREMENTS | REICHERT INC (US) | 2004-12-15 | — | — | EP | disclosed |
| WO-2004101612-A2 | THIOREDOXIN-PEROXIDASE OF C. ALBICANS AS A VIRULENCE-SPECIFIC MARKER | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2004-11-25 | — | — | WO | disclosed |
| US-20040235016-A1 | Nanocylinder-modified surfaces | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2004-11-25 | — | — | US | disclosed |
| WO-2004099307-A2 | NANOCYLINDER-MODIFIED SURFACES | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2004-11-18 | — | — | WO | disclosed |
| EP-1476180-A2 | INTERLEUKIN-2 MUTANTS WITH REDUCED TOXICITY | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2004-11-17 | — | — | EP | disclosed |
| EP-1466179-A1 | METHOD FOR THE DIAGNOSIS OF CANCERS BY MEASURING THE CHANGES OF GLYCOSYLATION OF PROTEINS RELATED TO TUMORIGENESIS AND METASTASIS AND KIT FOR DIAGNOSIS OF CANCERS USING THE SAME | Korea Research Institute of Bioscience and Biotechnology (KR) | 2004-10-13 | — | — | EP | disclosed |
| US-6803238-B1 | FOR DETECTING A LABELED SAMPLE MOLECULE BOUND TO AN IMMOBILIZED PROBE BY ELECTROCHEMILUMINESCENCE | SIGMA GENOSYS, L.P. | 2004-10-12 | — | — | US | disclosed |
| US-20040198703-A1 | Protecting groups for biological labeling | KECZER STEYE DE (US) | 2004-10-07 | — | — | US | disclosed |
| WO-2004074455-A2 | Fc REGION VARIANTS | APPLIED MOLECULAR EVOLUTION (US) | 2004-09-02 | — | — | WO | disclosed |
| WO-2004074836-A2 | METHODS FOR INVESTIGATING THE SPECIFICITY OF COMPOUNDS THAT INTERACT WITH RECEPTORS | PURELY PROTEINS LIMITED (GB) | 2004-09-02 | — | — | WO | disclosed |
| US-6783947-B1 | FOR DETECTING AMOUNT OF HOMOCYSTEINE IN SAMPLE; COMPRISES ALPHA-HALOKETONE AND DEPROTECTING AGENTS; FOR BIOASSAYS/CONJUGATION KITS | DADE BEHRING MARBURG GMBH (DE) | 2004-08-31 | — | — | US | disclosed |
| EP-1448978-A1 | INTEGRATED OPTOELECTRONIC SILICON BIOSENSOR FOR THE DETECTION OF BIOMOLECULES LABELED WITH CHROMOPHORE GROUPS OR NANOPARTICLES | National Center for Scientific Research Demokritos (GR) | 2004-08-25 | — | — | EP | disclosed |
| US-20040151626-A1 | Label-free high-throughput optical technique for detecting biomolecular interactions | X-BODY, INC. | 2004-08-05 | — | — | US | disclosed |
| US-20040146950-A1 | Phosphoprotein detection reagent and methods of making and using the same | THE UNIVERSITY OF NORTH CAROLINA | 2004-07-29 | — | — | US | disclosed |
| EP-0951480-A4 | METHOD AND NOVEL COMPOUNDS FOR USE THEREIN | BIOTA SCIENT MANAGEMENT (AU) | 2004-07-28 | — | — | EP | disclosed |
| EP-1436429-A2 | TARGETED NUCLEIC ACID CONSTRUCTS AND USES RELATED THERETO | THE GENERAL HOSPITAL CORPORATION (US) | 2004-07-14 | — | — | EP | disclosed |
| US-20040132214-A1 | Label-free methods for performing assays using a colorimetric resonant optical biosensor | SRU BIOSYSTEMS, LLC | 2004-07-08 | — | — | US | disclosed |
| US-20040132172-A1 | Optical apparatus comprising reflective two-dimensional grid for detecting biomolecular interactions; biosensors; medical diagnostics | X-BODY, INC. | 2004-07-08 | — | — | US | disclosed |
| US-20040115210-A1 | Imunogenic complex comprising ribosomes | BT PHARMA (FR) | 2004-06-17 | — | — | US | disclosed |
| EP-0769966-B1 | BIOTIN COMPOUNDS FOR TARGETTING TUMORS AND SITES OF INFECTION | THEJMDE TRUST (US) | 2004-06-02 | — | — | EP | disclosed |
| EP-1419393-A1 | TUMOR SPECIFIC OLIGOSACCHARIDE SEQUENCES AND USE THEREOF | Carbion OY (FI) | 2004-05-19 | — | — | EP | disclosed |
| EP-1418430-A2 | A homogeneous assay for determining analyte | Dade Behring Marburg GmbH (DE) | 2004-05-12 | — | — | EP | disclosed |
| EP-0821696-B1 | PEPTIDE ANTAGONISTS OF CELLULAR MITOGENESIS AND MOTOGENESIS AND THEIR THERAPEUTIC USE | PHARMACIA ITALIA SPA (IT) | 2004-05-06 | — | — | EP | disclosed |
| EP-1412471-A1 | APPARATUS AND METHOD FOR DETERMINING THE ONSET AND PRESENCE OF SEPSIS CONDITIONS | Webber, Robert (US) | 2004-04-28 | — | — | EP | disclosed |
| WO-2004017810-A2 | TUMOR SPECIFIC OLIGOSACCHARIDE EPITOPES AND USE THEREOF | BIOTIE THERAPIES CORP. (FI) | 2004-03-04 | — | — | WO | disclosed |
| US-20040023249-A1 | Multiplexed diagnostic and therapeutics | GENOMETRIX GENOMICS INCORPORATED | 2004-02-05 | — | — | US | disclosed |
| EP-1384078-A1 | QUANTITATIVE NON-INSTRUMENTAL IMMUNOASSAY AND DEVICE USING COLOURED PARTICLES | SUNDREHAGEN, Erling (NO) | 2004-01-28 | — | — | EP | disclosed |
| US-6680054-B1 | SIALIC ACID DERIVATIVE FUNCTIONALIZED VIA 7-POSITION; INFLUENZA ANTIVIRAL AGENT | BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) | 2004-01-20 | — | — | US | disclosed |
| US-20040002587-A1 | Fc region variants | APPLIED MOLECULAR EVOLUTION | 2004-01-01 | — | — | US | disclosed |
| US-6670194-B1 | Mass spectrometry; screening for changes in the expression of enzymatic activity of specific proteins induced by absence, deficiency or excess of a given protein | UNIVERSITY OF WASHINGTON | 2003-12-30 | — | — | US | disclosed |
| EP-1105517-B1 | RAPID QUANTITATIVE ANALYSIS OF PROTEINS OR PROTEIN FUNCTION IN COMPLEX MIXTURES | UNIV WASHINGTON (US) | 2003-10-29 | — | — | EP | disclosed |
| US-6632623-B1 | Use in improving process of differentiating patients with prostate cancer (PCa) from patients with benign prostatic hyperplasia (BPH) or healthy male subjects without PCa | STENMAN ULF-HAAKAN (FI) | 2003-10-14 | — | — | US | disclosed |
| EP-1347777-A2 | IMMUNOGENIC COMPLEX COMPRISING RIBOSOMES | Timmerman, Benedikt (FR) | 2003-10-01 | — | — | EP | disclosed |
| US-20030180293-A1 | Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody | AJINOMOTO CO. INC (JP) | 2003-09-25 | — | — | US | disclosed |
| US-20030180330-A1 | Method for identifying helicobacter antigens | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2003-09-25 | — | — | US | disclosed |
| US-20030170624-A1 | Single nucleotide polymorphisms and their use in genetic analysis | ORCHID CELLMARK INC. | 2003-09-11 | — | — | US | disclosed |
| US-6613328-B2 | For therapy of thrombotic disease or athelosclerosis | AJINOMOTO CO., INC. (JP) | 2003-09-02 | — | — | US | disclosed |
| US-20030148391-A1 | Monitoring interactions/adjustments in physical properties between G protein-coupled receptors and binding partners using surface-selective harmonic visualization/illumination | BIODESY LLC | 2003-08-07 | — | — | US | disclosed |
| WO-2003064991-A2 | METHOD AND APPARATUS USING A NONLINEAR OPTICAL TECHNIQUE FOR DETECTION OF PROBE-TARGET INTERACTIONS IN A FIELD | SALAFSKY JOSHUA S (US) | 2003-08-07 | — | — | WO | disclosed |
| EP-0984282-B1 | Particles having an incorporated composition comprising a chemiluminescent compound | DADE BEHRING MARBURG GMBH (DE) | 2003-07-30 | — | — | EP | disclosed |
| WO-2003060522-A1 | METHOD FOR THE DIAGNOSIS OF CANCERS BY MEASURING THE CHANGES OF GLYCOSYLATION OF PROTEINS RELATED TO TUMORIGENESIS AND METASTASIS AND KIT FOR DIAGNOSIS OF CANCERS USING THE SAME | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2003-07-24 | — | — | WO | disclosed |
| EP-1329513-A1 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON (US) | 2003-07-23 | — | — | EP | disclosed |
| US-20030124678-A1 | Interleukin-2 mutants with reduced toxicity | UNIVERSITY OF SOUTHERN CALIFORNIA | 2003-07-03 | — | — | US | disclosed |
| US-20030113766-A1 | Amine activated colorimetric resonant biosensor | SRU BIOSYSTEMS, LLC | 2003-06-19 | — | — | US | disclosed |
| US-20030112427-A1 | Refractometer and method for qualitative and quantitative measurements | RYAN THOMAS E (US) | 2003-06-19 | — | — | US | disclosed |
| WO-2003046527-A1 | INTEGRATED OPTOELECTRONIC SILICON BIOSENSOR FOR THE DETECTION OF BIOMOLECULES LABELED WITH CHROMOPHORE GROUPS OR NANOPARTICLES | NATIONAL CENTRE FOR SCIENTIFIC RESEARCH 'DEMOKRITOS' (GR) | 2003-06-05 | — | — | WO | disclosed |
| US-20030092075-A1 | Aldehyde chemical surface activation processes and test methods for colorimetric resonant sensors | SRU BIOSYSTEMS, LLC | 2003-05-15 | — | — | US | disclosed |
| US-20030087322-A9 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON | 2003-05-08 | — | — | US | disclosed |
| US-20030068657-A1 | Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor | SRU BIOSYSTEMS LLC (US) | 2003-04-10 | — | — | US | disclosed |
| EP-1299117-A2 | VACCINE AGAINST HELICOBACTER PYLORI | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2003-04-09 | — | — | EP | disclosed |
| US-20030064068-A1 | ANTITHROMBOTIC AGENT AND HUMANIZED ANTI-VON WILLEBRAND FACTOR MONOCLONAL ANTIBODY | AJINOMOTO CO., INC. (JP) | 2003-04-03 | — | — | US | disclosed |
| US-20030049203-A1 | Targeted nucleic acid constructs and uses related thereto | ENERGY, UNITED STATES DEPARTMENT OF | 2003-03-13 | — | — | US | disclosed |
| WO-2003020949-A2 | TARGETED NUCLEIC ACID CONSTRUCTS AND USES RELATED THERETO | THE GENERAL HOSPITAL CORPORATION (US) | 2003-03-13 | — | — | WO | disclosed |
| US-20030044772-A1 | Methods for identifying ligand specific binding molecules | APPLIED MOLECULAR EVOLUTION [FORMERLY IXSYS] | 2003-03-06 | — | — | US | disclosed |
| WO-2003015697-A2 | INTERLEUKIN-2 MUTANTS WITH REDUCED TOXICITY | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2003-02-27 | — | — | WO | disclosed |
| WO-2003016915-A1 | TUMOR SPECIFIC OLIGOSACCHARIDE SEQUENCES AND USE THEREOF | BIOTIE THERAPIES CORP. (FI) | 2003-02-27 | — | — | WO | disclosed |
| WO-2003012026-A1 | APPARATUS AND METHOD FOR DETERMINING THE ONSET AND PRESENCE OF SEPSIS CONDITIONS | WEBBER ROBERT (US) | 2003-02-13 | — | — | WO | disclosed |
| US-6517838-B1 | Protecting against infection with Borrelia burgdorferi, Lyme disease | THE TEXAS A&M UNIVERSITY SYSTEM | 2003-02-11 | — | — | US | disclosed |
| US-20030027327-A1 | Optical detection of label-free biomolecular interactions using microreplicated plastic sensor elements | SRU BIOSYSTEMS, LLC | 2003-02-06 | — | — | US | disclosed |
| US-20030027328-A1 | Guided mode resonant filter biosensor using a linear grating surface structure | SRU BIOSYSTEMS, LLC | 2003-02-06 | — | — | US | disclosed |
| EP-1278768-A1 | METHOD FOR IDENTIFYING HELICOBACTER ANTIGENS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2003-01-29 | — | — | EP | disclosed |
| EP-0769018-B1 | HELICOBACTER PROTEINS AND VACCINES | CHIRON CORP (US) | 2002-12-18 | — | — | EP | disclosed |
| EP-1264181-A1 | CARRIERS COATED WITH POLYSACCHARIDES, THEIR PREPARATION AND USE | Dade Behring Marburg GmbH (DE) | 2002-12-11 | — | — | EP | disclosed |
| WO-2002095409-A1 | QUANTITATIVE NON-INSTRUMENTAL IMMUNOASSAY AND DEVICE USING COLOURED PARTICLES | SUNDREHAGEN ERLING (NO) | 2002-11-28 | — | — | WO | disclosed |
| EP-1112085-A4 | ANTITHROMBOTIC AGENT AND HUMANIZED ANTI-VON WILLEBRAND FACTOR MONOCLONAL ANTIBODY | AJINOMOTO KK (JP) | 2002-11-20 | — | — | EP | disclosed |
| US-20020168295-A1 | For detecting the binding of one or more specific binding substances to their respective binding partners; optical device, transmission filters, biosensors | X-BODY, INC. | 2002-11-14 | — | — | US | disclosed |
| US-20020169288-A1 | Collagen-binding adhesin from staphylococcus epidermidis and method of use | TEXAS A&M UNIVERSITY SYSTEM, THE | 2002-11-14 | — | — | US | disclosed |
| US-6479301-B1 | Methods for fabricating an array for use in multiplexed biochemical analysis | GENOMETRIX GENOMICS INCORPORATED | 2002-11-12 | — | — | US | disclosed |
| US-20020160428-A1 | Quantitative non-instrumental immunoassay and device using coloured particles | SUNDREHAGEN ERLING (NO) | 2002-10-31 | — | — | US | disclosed |
| EP-1070255-A4 | ASSAY OF IGFBP COMPLEX | DIAGNOSTIC SYSTEMS LAB INC (US) | 2002-10-23 | — | — | EP | disclosed |
| EP-1249705-A2 | Multiplexed molecular analysis apparatus and its fabrication method | Genometrix Genomics Incorporated (US) | 2002-10-16 | — | — | EP | disclosed |
| US-20020146848-A1 | Separation particles | GLOBAL LIFE SCIENCES SOLUTIONS GERMANY GMBH (DE) | 2002-10-10 | — | — | US | disclosed |
| US-6462809-B1 | Refractomer and method for qualitative and quantitative measurements | LEICA MICROSYSTEMS, INC. | 2002-10-08 | — | — | US | disclosed |
| WO-2001023612-A9 | DETERMINING MUTATIONS BY SELECTIVE REACTION OF THE 2'-RIBOSE POSITION IN HYBRIDIZED OLIGONUCLEOTIDES | UNIV NORTH CAROLINA (US) | 2002-10-03 | — | — | WO | disclosed |
| EP-0753070-B1 | NOVEL NUCLEIC ACID/POLYMER COMPLEXES, METHOD FOR PREPARING SAME AND USE THEREOF FOR CELL TRANSFECTION | IDM IMMUNO DESIGNED MOLECULES (FR) | 2002-09-25 | — | — | EP | disclosed |
| US-20020127565-A1 | Biosensor for use in detecting and monitoring biopolymer activity in sample | SRU BIOSYSTEMS, LLC | 2002-09-12 | — | — | US | disclosed |
| US-6440723-B1 | SYNTHESIZED WITH COMPLEMENTARY BINDING UNIT SUCH AS AVIDIN OR BIOTIN ON SOLID SUPPORT; FOR ANALYSIS OF GENE EXPRESSION; DRUG SCREENING | OLIGOS ETC. INC. | 2002-08-27 | — | — | US | disclosed |
| EP-1224467-A2 | PROTECTING ALKYLATING REAGENTS USED FOR QUANTIFYING HOMOCYSTEINE | Dade Behring Marburg GmbH (DE) | 2002-07-24 | — | — | EP | disclosed |
| US-20020094525-A1 | METHODS FOR THE DETECTION OF MULTIPLE SINGLE NUCLEOTIDE POLYMORPHISMS IN A SINGLE REACTION | ORCHID BIOSCIENCES, INC. | 2002-07-18 | — | — | US | disclosed |
| WO-2002053178-A2 | IMMUNOGENIC COMPLEX COMPRISING RIBOSOMES | TIMMERMAN BENEDIKT (FR) | 2002-07-11 | — | — | WO | disclosed |
| EP-1219964-A1 | Assay method, in which the High-Dose-Hook-Effect is avoided, reduced or detected | Dade Behring Marburg GmbH (DE) | 2002-07-03 | — | — | EP | disclosed |
| US-6410692-B2 | SEPARATING LIQUID SAMPLE; INCUBATE SAMPLE WITH POLYPEPTIDE, INCUBATE MACROMOLECULE-POLYPEPTIDE COMPLEX WITH SECOND BINDING PARTICLE, DETECT COMPLEX | NOVADX, INC. | 2002-06-25 | — | — | US | disclosed |
| US-20020076739-A1 | Rapid quantitative analysis of proteins or protein function in complex mixtures | UNIVERSITY OF WASHINGTON | 2002-06-20 | — | — | US | disclosed |
| EP-1214317-A1 | ANTIVIRAL AGENTS | BIOTA SCIENTIFIC MANAGEMENT PTY. LTD. (AU) | 2002-06-19 | — | — | EP | disclosed |
| EP-1206288-A2 | TARGETED FIBERLESS RADIATIVE EFFECTORS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2002-05-22 | — | — | EP | disclosed |
| US-6383470-B1 | Microparticle preparations made of biodegradable copolymers | CEPHALON, INC. | 2002-05-07 | — | — | US | disclosed |
| EP-1190260-A2 | DETECTION OF VON-WILLEBRAND FACTOR (VWF) ACTIVITY | K.U. Leuven Research & Development (BE) | 2002-03-27 | — | — | EP | disclosed |
| US-20020028217-A1 | MICROPARTICLE PREPARATIONS MADE OF BIODEGRADABLE COPOLYMERS | CEPHALON, INC. | 2002-03-07 | — | — | US | disclosed |
| WO-2002002141-A2 | VACCINE AGAINST HELICOBACTER PYLORI | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2002-01-10 | — | — | WO | disclosed |
| US-6331441-B1 | FOR HIGH THROUGHPUT ANALYSIS OF MULTIPLE ANALYTES IN COMPLEX MIXTURES OF SAMPLE SUBSTANCES, COMBINATORIAL ANALYSIS | GENOMETRIX GENOMICS INCORPORATED | 2001-12-18 | — | — | US | disclosed |
| US-20010051380-A1 | REMOVAL OF ABUNDANT INTERFERING PROTEINS FROM A LIQUID SAMPLE USING A COLLAPSIBLE AFFINITY MATRIX | FISH AND RICHARDSON P.C. | 2001-12-13 | — | — | US | disclosed |
| WO-2001083531-A1 | METHOD FOR IDENTIFYING HELICOBACTER ANTIGENS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2001-11-08 | — | — | WO | disclosed |
| US-6312960-B1 | PREPARING APPARTUS FOR USE IN TESTING; POSITION BUNDLED CAPILLARY TUBES, POSITION CAPILLARY TUBES OVER SUPPLY CONTAINER, ACCURATELY POSITION TUBES OVER PATTERN, DEPOSIT LIQUID ONTO SUBSTRATE | GENOMETRIX GENOMICS, INC. | 2001-11-06 | — | — | US | disclosed |
| EP-0515194-B1 | Assay methods utilizing induced luminescence | DADE BEHRING MARBURG GMBH (DE) | 2001-10-31 | — | — | EP | disclosed |
| US-6303309-B1 | DECOMPLEXING BY CONTACT WITH AMINE | SEQUENOM, INC. | 2001-10-16 | — | — | US | disclosed |
| EP-1140736-A2 | POLYMER ARRAYS AND METHODS OF MAKING AND USING SAME | Oligos Etc. Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| EP-1105517-A4 | RAPID QUANTITATIVE ANALYSIS OF PROTEINS OR PROTEIN FUNCTION IN COMPLEX MIXTURES | UNIV WASHINGTON (US) | 2001-09-19 | — | — | EP | disclosed |
| WO-2001067105-A1 | CARRIERS COATED WITH POLYSACCHARIDES, THEIR PREPARATION AND USE | DADE BEHRING MARBURG GMBH (DE) | 2001-09-13 | — | — | WO | disclosed |
| US-20010010821-A1 | HELICOBACTER PROTEINS AND VACCINES | CHIRON CORPORATION | 2001-08-02 | — | — | US | disclosed |
| EP-1112085-A1 | ANTITHROMBOTIC AGENT AND HUMANIZED ANTI-VON WILLEBRAND FACTOR MONOCLONAL ANTIBODY | Ajinomoto Co., Inc. (JP) | 2001-07-04 | — | — | EP | disclosed |
| EP-1105737-A1 | IMMUNOASSAY FOR QUANTITATIVE DETERMINATION OF THE COMPLEX BETWEEN PROSTATE SPECIFIC ANTIGEN (PSA) AND ALPHA2-MACROGLOBULIN (A2M) IN A SAMPLE | Stenman, Ulf-Hakan (FI) | 2001-06-13 | — | — | EP | disclosed |
| EP-1105517-A1 | RAPID QUANTITATIVE ANALYSIS OF PROTEINS OR PROTEIN FUNCTION IN COMPLEX MIXTURES | UNIVERSITY OF WASHINGTON (US) | 2001-06-13 | — | — | EP | disclosed |
| US-6245742-B1 | ANTITUMOR, ANTICARCINOGENIC AND ANTIMETASTASIS AGENTS; VIRICIDES, PSORIASIS, ANTIINFLAMMATORY AGENTS, ANTIALLERGENS, PSORIASIS | PHARMACIA & UPJOHN S.P.A. (IT) | 2001-06-12 | — | — | US | disclosed |
| US-6228360-B1 | IMMUNOGLOBULINS BINDING TO HUMAN VON WILLEBRAND FACTOR WITH CHAINS | AJINOMOTO CO., INC. (JP) | 2001-05-08 | — | — | US | disclosed |
| WO-2001023612-A2 | DETERMINING MUTATIONS BY SELECTIVE REACTION OF THE 2'-RIBOSE POSITION IN HYBRIDIZED OLIGONUCLEOTIDES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2001-04-05 | — | — | WO | disclosed |
| WO-2001019822-A1 | ANTIVIRAL AGENTS | BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) | 2001-03-22 | — | — | WO | disclosed |
| WO-2001018548-A2 | PROTECTING ALKYLATING REAGENTS USED FOR QUANTIFYING HOMOCYSTEINE | DADE BEHRING MARBURG GMBH (DE) | 2001-03-15 | — | — | WO | disclosed |
| WO-2001008660-A2 | TARGETED FIBERLESS RADIATIVE EFFECTORS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2001-02-08 | — | — | WO | disclosed |
| EP-1070255-A1 | ASSAY OF IGFBP COMPLEX | Diagnostic Systems Laboratories, Inc. (US) | 2001-01-24 | — | — | EP | disclosed |
| WO-2001002853-A2 | DETECTION OF VON-WILLEBRANDFACTOR (vWF) ACTIVITY | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 2001-01-11 | — | — | WO | disclosed |
| WO-2000077041-A2 | PEPTIDES FROM DECORIN BINDING PROTEIN AND THEIR USES | THE TEXAS A & M UNIVERSITY SYSTEM (US) | 2000-12-21 | — | — | WO | disclosed |
| WO-2000029830-A9 | REFRACTOMETER AND METHOD FOR QUALITATIVE AND QUANTITATIVE MEASUREMENTS | LEICA MICROSYSTEMS INC (US) | 2000-11-09 | — | — | WO | disclosed |
| EP-1047929-A1 | REFRACTOMETER AND METHOD FOR QUALITATIVE AND QUANTITATIVE MEASUREMENTS | Leica Microsystems, Inc. (US) | 2000-11-02 | — | — | EP | disclosed |
| WO-2000040525-A2 | POLYMER ARRAYS AND METHODS OF MAKING AND USING SAME | OLIGOS ETC. INC. (US) | 2000-07-13 | — | — | WO | disclosed |
| US-6083763-A | DEVICE FOR PREPARING THE REACTION SUBSTRATE FOR THE ANALYSIS | GENOMETRIX INC. (US) | 2000-07-04 | — | — | US | disclosed |
| EP-1007967-A2 | METHODS FOR IDENTIFYING LIGAND SPECIFIC BINDING MOLECULES | Ixsys, Incorporated (US) | 2000-06-14 | — | — | EP | disclosed |
| WO-2000029830-A1 | REFRACTOMETER AND METHOD FOR QUALITATIVE AND QUANTITATIVE MEASUREMENTS | LEICA MICROSYSTEMS, INC. (US) | 2000-05-25 | — | — | WO | disclosed |
| EP-0994960-A1 | METHODS FOR THE DETECTION OF MULTIPLE SINGLE NUCLEOTIDE POLYMORPHISMS IN A SINGLE REACTION | Orchid Biocomputer, Inc. (US) | 2000-04-26 | — | — | EP | disclosed |
| EP-0984281-A2 | A homogeneous assay for determining analyte | Dade Behring Marburg GmbH (DE) | 2000-03-08 | — | — | EP | disclosed |
| EP-0984282-A2 | Particles having an incorporated composition comprising a chemiluminescent compound | Dade Behring Marburg GmbH (DE) | 2000-03-08 | — | — | EP | disclosed |
| WO-2000010601-A1 | ANTITHROMBOTIC AGENT AND HUMANIZED ANTI-VON WILLEBRAND FACTOR MONOCLONAL ANTIBODY | AJINOMOTO CO., INC. (JP) | 2000-03-02 | — | — | WO | disclosed |
| WO-2000011208-A1 | RAPID QUANTITATIVE ANALYSIS OF PROTEINS OR PROTEIN FUNCTION IN COMPLEX MIXTURES | UNIVERSITY OF WASHINGTON (US) | 2000-03-02 | — | — | WO | disclosed |
| US-6028170-A | Analogs of hirudin | BAXTER INTERNATIONAL INC. (US) | 2000-02-22 | — | — | US | disclosed |
| US-6022688-A | RELEASING A BIOTIN COMPOUND:BIOTIN-BINDING COMPOUND COMPLEX; CONTACTING COMPLEX WITH AMMONIA EFFECTIVELY CAUSING RELEASE OF COMPLEX | SEQUENOM, INC. (US) | 2000-02-08 | — | — | US | disclosed |
| WO-1999064583-A2 | COMPOSITIONS AND METHODS FOR MODULATING PROTEOLYTIC DEGRADATION OF INTRACELLULAR TARGETS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALT H AND HUMAN SERVICES (US) | 1999-12-16 | — | — | WO | disclosed |
| WO-1999061915-A1 | IMMUNOASSAY FOR QUANTITATIVE DETERMINATION OF THE COMPLEX BETWEEN PROSTATE SPECIFIC ANTIGEN (PSA) AND ALPHA2-MACROGLOBULIN (A2M) IN A SAMPLE | STENMAN ULF HAAKAN (FI) | 1999-12-02 | — | — | WO | disclosed |
| US-5985658-A | SEPARATING TARGET CELLS FROM A PLURALITY OF CELLS BASED ON A REVERSIBLE HIGH AFFINITY INTERACTION BETWEEN TWO MOLECULES, CALMODULIN AND A CALMODULIN BINDING PEPTIDE; SEPARATING BONE MARROW CELLS FROM T-CELLS, TUMOR CELLS FOR EXAMPLE | HEALTH RESEARCH INCORPORATED (US) | 1999-11-16 | — | — | US | disclosed |
| EP-0951480-A1 | METHOD AND NOVEL COMPOUNDS FOR USE THEREIN | BIOTA SCIENTIFIC MANAGEMENT PTY. LTD. (AU) | 1999-10-27 | — | — | EP | disclosed |
| WO-1999046597-A1 | ASSAY OF IGFBP COMPLEX | DIAGNOSTIC SYSTEMS LABORATORIES, INC. (US) | 1999-09-16 | — | — | WO | disclosed |
| EP-0941248-A1 | PLATELET SECRETORY TRANSPORT PROTEIN | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1999-09-15 | — | — | EP | disclosed |
| US-5939540-A | DNA WHICH CODES A BLOOD PROTEIN; DIAGNOSIS OF BLOOD CLOTS; FOR IN VITRO SCREENING OF MODULATORS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1999-08-17 | — | — | US | disclosed |
| WO-1999039204-A1 | REMOVAL OF ABUNDANT INTERFERING PROTEINS FROM A LIQUID SAMPLE USING A COLLAPSIBLE AFFINITY MATRIX | NOVADX (US) | 1999-08-05 | — | — | WO | disclosed |
| EP-0369000-B1 | MACROCYCLIC COMPLEXES OF YTTRIUM, THE LANTHANIDES AND THE ACTINIDES HAVING PERIPHERAL COUPLING FUNCTIONALITIES | VALLARINO LIDIA M (US) | 1999-04-21 | — | — | EP | disclosed |
| US-5888763-A | POLYPEPTIDE | THE ROCKEFELLER UNIVERSITY (US) | 1999-03-30 | — | — | US | disclosed |
| EP-0558732-B1 | PRODUCTION OF CHROMOSOME REGION SPECIFIC DNA SEQUENCES AND TRANSAMINATION | AMOCO CORP (US) | 1999-03-03 | — | — | EP | disclosed |
| WO-1999006834-A2 | METHODS FOR IDENTIFYING LIGAND SPECIFIC BINDING MOLECULES | IXSYS, INCORPORATED (US) | 1999-02-11 | — | — | WO | disclosed |
| WO-1998059066-A1 | METHODS FOR THE DETECTION OF MULTIPLE SINGLE NUCLEOTIDE POLYMORPHISMS IN A SINGLE REACTION | ORCHID BIOCOMPUTER, INC. (US) | 1998-12-30 | — | — | WO | disclosed |
| US-5846727-A | Microsystem for rapid DNA sequencing | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL & MECHANICAL COLLEGE (US) | 1998-12-08 | — | — | US | disclosed |
| WO-1998051435-A1 | FULLY-COATED, UNIFORM-SIZED METALLIC PARTICLES | TANG WEIXIN (US) | 1998-11-19 | — | — | WO | disclosed |
| US-5837808-A | ANTICOAGULANTS | BAXTER INTERNATIONAL INC. (US) | 1998-11-17 | — | — | US | disclosed |
| US-5824520-A | EUKARYOTIC EXPRESSION CONSTRUCT THAT CODES BINDING | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1998-10-20 | — | — | US | disclosed |
| US-5811246-A | Process for immobilization onto the surfaces of ELISA plates of a compound carrier complex and for immunization | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1998-09-22 | — | — | US | disclosed |
| WO-1998040487-A1 | ANGIOGENIN RECEPTOR, COMPOSITIONS AND METHODS RELATED THERETO | THE ENDOWMENT FOR RESEARCH IN HUMAN BIOLOGY, INC. (US) | 1998-09-17 | — | — | WO | disclosed |
| WO-1998021243-A1 | METHOD AND NOVEL COMPOUNDS FOR USE THEREIN | BIOTA SCIENTIFIC MANAGEMENT PTY. LTD. (AU) | 1998-05-22 | — | — | WO | disclosed |
| EP-0662005-B1 | MICROPARTICLE PREPARATIONS MADE FROM BIODEGRADABLE COPOLYMERS | SCHERING AG (DE) | 1998-04-29 | — | — | EP | disclosed |
| WO-1998016829-A1 | ORGANISM-SPECIFIC AND ALLERGEN-SPECIFIC ANTIBODY CAPTURE ASSAY AND COMPOSITIONS FOR DETECTION OF DISEASE-CAUSING ORGANISMS AND ALLERGENS | ENTERON, L.P. (US) | 1998-04-23 | — | — | WO | disclosed |
| WO-1998015576-A1 | PLATELET SECRETORY TRANSPORT PROTEIN | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1998-04-16 | — | — | WO | disclosed |
| US-5733762-A | CONJUGATED GLYCOPROTEINS FOR DRUG DELIVERY | I.D.M. IMMUNO-DESIGNED MOLECULES (FR) | 1998-03-31 | — | — | US | disclosed |
| EP-0707710-A4 | SURFACE PLASMON RESONANCE DETECTOR HAVING COLLECTOR FOR ELUTED LIGATE | SMITHKLINE BEECHAM CORP (US) | 1998-02-25 | — | — | EP | disclosed |
| US-5716594-A | CONJUGATING A THERAPEUTIC AGENT TO BIOTIN TO FORM A COMPOUND THAT HAS A SPECIFICITY FOR THE SITE OF INFECTION | THE JMDE TRUST (US) | 1998-02-10 | — | — | US | disclosed |
| EP-0821696-A1 | PEPTIDE ANTAGONISTS OF CELLULAR MITOGENESIS AND MOTOGENESIS AND THEIR THERAPEUTIC USE | PHARMACIA & UPJOHN S.p.A. (IT) | 1998-02-04 | — | — | EP | disclosed |
| US-5702892-A | GENETIC ENGINEERING; GLUCOSE-6-PHOSPHATE DEHYDROGENASEINHIBITION | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-12-30 | — | — | US | disclosed |
| EP-0726905-A4 | SINGLE NUCLEOTIDE POLYMORPHISMS AND THEIR USE IN GENETIC ANALYSIS | MOLECULAR TOOL INC (US) | 1997-12-17 | — | — | EP | disclosed |
| US-5696240-A | Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities | VALLARINO LIDIA M (US) | 1997-12-09 | — | — | US | disclosed |
| US-5683694-A | Method for the treatment of tumors with conjugated antibody A5B7 and a prodrug | CANCER RESEARCH CAMPAIGN TECH. LTD. & ZENECA LTD. (GB) | 1997-11-04 | — | — | US | disclosed |
| WO-1997030079-A1 | PEPTIDE ANTAGONISTS OF CELLULAR MITOGENESIS AND MOTOGENESIS AND THEIR THERAPEUTIC USE | PHARMACIA & UPJOHN S.P.A. (IT) | 1997-08-21 | — | — | WO | disclosed |
| US-5632990-A | LINKED TO CARBOXYPEPTIDASE OR NITROREDUCTASE; ANTICARCINOGENIC AGENTS | CANCER RESEARCH CAMPAIGN TECH. LTD. (GB) | 1997-05-27 | — | — | US | disclosed |
| EP-0769966-A1 | BIOTIN COMPOUNDS FOR TARGETTING TUMORS AND SITES OF INFECTION | Elmaleh, David, R. (US) | 1997-05-02 | — | — | EP | disclosed |
| EP-0769018-A1 | HELICOBACTER PROTEINS AND VACCINES | RICAN LIMITED (IE) | 1997-04-23 | — | — | EP | disclosed |
| EP-0769019-A1 | HELICOBACTER PYLORI ANTIGENIC PROTEIN PREPARATION AND IMMUNOASSAYS | RICAN LIMITED (IE) | 1997-04-23 | — | — | EP | disclosed |
| US-5595897-A | CATIONIC POLYMERS | I.D.M. IMMUNO-DESIGNED MOLECULES (FR) | 1997-01-21 | — | — | US | disclosed |
| EP-0753070-A1 | NOVEL NUCLEIC ACID/POLYMER COMPLEXES, METHOD FOR PREPARING SAME AND USE THEREOF FOR CELL TRANSFECTION | I.D.M. IMMUNO-DESIGNED MOLECULES (FR) | 1997-01-15 | — | — | EP | disclosed |
| US-5561069-A | Surface plasmon resonance detector having collector for eluted ligate | SMITHKLINE BEECHAM CORPORATION (US) | 1996-10-01 | — | — | US | disclosed |
| EP-0726905-A1 | SINGLE NUCLEOTIDE POLYMORPHISMS AND THEIR USE IN GENETIC ANALYSIS | MOLECULAR TOOL, INC. (US) | 1996-08-21 | — | — | EP | disclosed |
| EP-0707710-A1 | SURFACE PLASMON RESONANCE DETECTOR HAVING COLLECTOR FOR ELUTED LIGATE | SMITHKLINE BEECHAM CORPORATION (US) | 1996-04-24 | — | — | EP | disclosed |
| US-5506350-A | IN PRESENCE OF A TRIFLUOROACETATE CHAOTROPE | BITTNER MICHAEL L (US) | 1996-04-09 | — | — | US | disclosed |
| WO-1996001272-A1 | HELICOBACTER PROTEINS AND VACCINES | RICAN LIMITED (IE) | 1996-01-18 | — | — | WO | disclosed |
| WO-1996001273-A1 | HELICOBACTER PYLORI ANTIGENIC PROTEIN PREPARATION AND IMMUNOASSAYS | RICAN LIMITED (IE) | 1996-01-18 | — | — | WO | disclosed |
| WO-1995033491-A1 | BIOTIN COMPOUNDS FOR TARGETTING TUMORS AND SITES OF INFECTION | ELMALEH DAVID R (US) | 1995-12-14 | — | — | WO | disclosed |
| WO-1995030020-A1 | NOVEL NUCLEIC ACID/POLYMER COMPLEXES, METHOD FOR PREPARING SAME AND USE THEREOF FOR CELL TRANSFECTION | I.D.M. IMMUNO-DESIGNED MOLECULES (FR) | 1995-11-09 | — | — | WO | disclosed |
| EP-0662005-A1 | MICROPARTICLE PREPARATIONS MADE FROM BIODEGRADABLE COPOLYMERS | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-07-12 | — | — | EP | disclosed |
| WO-1995012607-A1 | SINGLE NUCLEOTIDE POLYMORPHISMS AND THEIR USE IN GENETIC ANALYSIS | MOLECULAR TOOL, INC. (US) | 1995-05-11 | — | — | WO | disclosed |
| EP-0294703-B1 | Bifunctional antibody constructs and method for selectively destroying cell populations | DANA FARBER CANCER INST INC (US) | 1995-05-10 | — | — | EP | disclosed |
| WO-1995007295-A1 | ANALOGS OF HIRUDIN | BAXTER INTERNATIONAL INC. (US) | 1995-03-16 | — | — | WO | disclosed |
| EP-0414741-B1 | FURTHER IMPROVEMENTS RELATING TO DRUG DELIVERY SYSTEMS | CANCER RES CAMPAIGN TECH (GB) | 1995-03-15 | — | — | EP | disclosed |
| US-5395587-A | Surface plasmon resonance detector having collector for eluted ligate | SMITHKLINE BEECHAM CORPORATION (US) | 1995-03-07 | — | — | US | disclosed |
| WO-1995002178-A1 | SURFACE PLASMON RESONANCE DETECTOR HAVING COLLECTOR FOR ELUTED LIGATE | SMITHKLINE BEECHAM CORPORATION (US) | 1995-01-19 | — | — | WO | disclosed |
| EP-0633029-A2 | Further improvements relating to drug delivery systems | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1995-01-11 | — | — | EP | disclosed |
| US-5374516-A | Covalently attached to polymer particles of ethylenically unsaturated monomers with reactive alkylsulfonyl or halogen groups; detecting hormones, drugs, steroids in urine, blood, saliva | EASTMAN KODAK COMPANY (US) | 1994-12-20 | — | — | US | disclosed |
| US-5373093-A | Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities | NEWPORT INSTRUMENTS | 1994-12-13 | — | — | US | disclosed |
| EP-0627488-A1 | Method for producing filamentous phages displaying on the surface of the capsid peptides capable of binding biotin, and filamentous phages and peptides thus obtained | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 1994-12-07 | — | — | EP | disclosed |
| EP-0430371-B1 | Dry immunoassay analytical element comprising monodispersed beads | EASTMAN KODAK CO (US) | 1994-11-17 | — | — | EP | disclosed |
| WO-1994023302-A1 | IMMUNOLOGICAL ASSAY OF OXIDATIVELY MODIFIED HUMAN LOW DENSITY LIPOPROTEINS IN PLASMA | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1994-10-13 | — | — | WO | disclosed |
| US-5340716-A | Assay method utilizing photoactivated chemiluminescent label | SNYTEX (U.S.A.) INC. (US) | 1994-08-23 | — | — | US | disclosed |
| WO-1994007539-A1 | MICROPARTICLE PREPARATIONS MADE FROM BIODEGRADABLE COPOLYMERS | SCHERING AKTIENGESELLSCHAFT (DE) | 1994-04-14 | — | — | WO | disclosed |
| EP-0368273-B1 | New method of assay for antigen | ISHIKAWA EIJI (JP) | 1994-03-30 | — | — | EP | disclosed |
| EP-0558732-A1 | PRODUCTION OF CHROMOSOME REGION SPECIFIC DNA SEQUENCES AND TRANSAMINATION | AMOCO CORPORATION (US) | 1993-09-08 | — | — | EP | disclosed |
| US-5236830-A | METHOD OF ASSAY FOR ANTIGEN | ISHIKAWA EIJI (JP) | 1993-08-17 | — | — | US | disclosed |
| US-5218102-A | Easily synthesized, hybridize well with target sequences | IMPROBIO (BE) | 1993-06-08 | — | — | US | disclosed |
| EP-0369000-A4 | MACROCYCLIC COMPLEXES OF YTTRIUM, THE LANTHANIDES AND THE ACTINIDES HAVING PERIPHERAL COUPLING FUNCTIONALITIES | — | 1993-06-02 | — | — | EP | disclosed |
| WO-1993006246-A1 | PRODUCTION OF CHROMOSOME REGION SPECIFIC DNA SEQUENCES AND TRANSAMINATION | AMOCO CORPORATION (US) | 1993-04-01 | — | — | WO | disclosed |
| WO-1993004082-A1 | ANALOGS OF HIRUDIN | BAXTER INTERNATIONAL INC. (US) | 1993-03-04 | — | — | WO | disclosed |
| US-5187107-A | Deactivation of denaturing agent | BIO-RAD LABORATORIES, INC. (US) | 1993-02-16 | — | — | US | disclosed |
| WO-1993000357-A1 | THERAPEUTIC POLYPEPTIDES BASED ON VON WILLEBRAND FACTOR | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1993-01-07 | — | — | WO | disclosed |
| EP-0515194-A2 | Assay methods utilizing induced luminescence | BEHRINGWERKE Aktiengesellschaft (DE) | 1992-11-25 | — | — | EP | disclosed |
| EP-0302715-B1 | AVIDIN- AND BIOTIN-IMMOBILIZED REAGENTS, ANALYTICAL ELEMENTS AND METHODS OF USE | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1992-04-22 | — | — | EP | disclosed |
| US-5089423-A | Quantitative analysis of immunoractive substances immobilized on solid phase | CYBERFLUOR INC. (CA) | 1992-02-18 | — | — | US | disclosed |
| EP-0460026-A1 | HIGH PERFORMANCE AFFINITY CHROMATOGRAPHY COLUMN COMPRISING NON-POROUS, MONODISPERSE POLYMERIC PACKING MATERIAL | EASTMAN KODAK COMPANY (US) | 1991-12-11 | — | — | EP | disclosed |
| US-5043062-A | Particles with surface reactive groups linked to biological ligands | EASTMAN KODAK COMPANY (US) | 1991-08-27 | — | — | US | disclosed |
| EP-0430371-A2 | Dry immunoassay analytical element comprising monodispersed beads | Johnson & Johnson Clinical Diagnostics, Inc. (US) | 1991-06-05 | — | — | EP | disclosed |
| EP-0414741-A1 | FURTHER IMPROVEMENTS RELATING TO DRUG DELIVERY SYSTEMS. | CANCER RES CAMPAIGN TECH (GB) | 1991-03-06 | — | — | EP | disclosed |
| WO-1990009832-A1 | HIGH PERFORMANCE AFFINITY CHROMATOGRAPHY COLUMN COMPRISING NON-POROUS, MONODISPERSE POLYMERIC PACKING MATERIAL | EASTMAN KODAK COMPANY (US) | 1990-09-07 | — | — | WO | disclosed |
| EP-0370694-A2 | Diagnostic kit and method using a solid phase capture means for detecting nucleic acids | EASTMAN KODAK COMPANY (US) | 1990-05-30 | — | — | EP | disclosed |
| EP-0369000-A1 | MACROCYCLIC COMPLEXES OF YTTRIUM, THE LANTHANIDES AND THE ACTINIDES HAVING PERIPHERAL COUPLING FUNCTIONALITIES | Vallarino, Lidia M. (US) | 1990-05-23 | — | — | EP | disclosed |
| EP-0368273-A2 | New method of assay for antigen | Ishikawa, Eiji (JP) | 1990-05-16 | — | — | EP | disclosed |
| WO-1989011868-A1 | MACROCYCLIC COMPLEXES OF YTTRIUM, THE LANTHANIDES AND THE ACTINIDES HAVING PERIPHERAL COUPLING FUNCTIONALITIES | COULTER ELECTRONICS, INC. (US) | 1989-12-14 | — | — | WO | disclosed |
| US-4879214-A | Differentiation of nucleic acid segments on the basis of nucleotide differences | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-11-07 | — | — | US | disclosed |
| WO-1989010140-A1 | FURTHER IMPROVEMENTS RELATING TO DRUG DELIVERY SYSTEMS | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1989-11-02 | — | — | WO | disclosed |
| EP-0334694-A1 | Nucleic acid probes with non-radioactive labels, and preparation processes | LA REGION WALLONNE (BE) | 1989-09-27 | — | — | EP | disclosed |
| EP-0302715-A1 | Avidin- and biotin-immobilized reagents, analytical elements and methods of use | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1989-02-08 | — | — | EP | disclosed |
| EP-0294703-A2 | Bifunctional antibody constructs and method for selectively destroying cell populations | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1988-12-14 | — | — | EP | disclosed |
| EP-0290269-A2 | Immunoassay methods and reagents and methods for producing the latter | CYBERFLUOR INC. (CA) | 1988-11-09 | — | — | EP | disclosed |
| EP-0290269-A2 | Immunoassay methods and reagents and methods for producing the latter | CYBERFLUOR INC. (CA) | 1988-11-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080166414-A1 | Drugs And Gene Carrier Particles That Rapidly Move Through Mucous Barriers | ABCB11, ABCB1, SLC47A2 | TDP1 3516/4885CA12 605/4885CA1 2864/4885 |
| US-20230331710-A1 | HETEROCYCLIC COMPOUND, PREPARATION METHOD AND USE THEREOF | C9, CFB, C5 | TDP1 4317/4885CA12 4220/4885CA1 4347/4885 |
| US-12590166-B2 | CD20 binding molecules and uses thereof | IGSF11, FCGR2A, FCGR3B | TDP1 2906/4885CA12 1320/4885CA1 2762/4885 |
| US-20230305002-A1 | PROTEIN FOR RAPID, EFFICIENT CAPTURE OF ANTIGENS | CD2BP2, HSPBP1, CD74 | TDP1 2527/4885CA12 1987/4885CA1 2880/4885 |
| US-20100092483-A1 | Compositions monovalent for CD40L binding and methods of use | CD40LG, CD40, FCGR1A | TDP1 1458/4885CA12 3918/4885CA1 4301/4885 |
| US-20260146087-A1 | REAGENTS AND METHODS FOR TREATING CANCER AND AUTOIMMUNE DISEASE | IKZF1, IGSF11, IKZF3 | TDP1 2575/4885CA12 3988/4885CA1 4482/4885 |
| US-20060062784-A1 | Compositions monovalent for CD40L binding and methods of use | CD40LG, CD40, TNFSF11 | TDP1 1369/4885CA12 4058/4885CA1 4608/4885 |
| US-20130164343-A1 | COMPOSITIONS AND METHODS FOR ENHANCING TRANSPORT THROUGH MUCUS | SLC26A4, SLC26A3, SLC10A2 | TDP1 4403/4885CA12 276/4885CA1 1135/4885 |
| US-20260116914-A1 | METHODS OF GENERATING NANOARRAYS AND MICROARRAYS | SPPL2B, SNAP29, SPPL2A | TDP1 340/4885CA12 3016/4885CA1 3130/4885 |
| US-12473285-B2 | DCN-1 modulating compounds and methods of use thereof | DCUN1D1, DCUN1D2, DCUN1D4 | TDP1 1230/4885CA12 4525/4885CA1 4691/4885 |
| US-12624378-B2 | Cell-free protein synthesis | AARS1, RNGTT, RNMT | TDP1 2613/4885CA12 4265/4885CA1 3845/4885 |
| US-11312749-B2 | Heterotandem bicyclic peptide complex | EPHA2, CD2BP2, TIMCC | TDP1 4430/4885CA12 1843/4885CA1 2749/4885 |
| US-20090297524-A1 | Compositions monovalent for CD40L binding and methods of use | CD40LG, CD40, FCGR1A | TDP1 1258/4885CA12 3925/4885CA1 4557/4885 |
| US-20170095566-A1 | Compositions and Methods for Enhancing Transport Through Mucus | SLC26A4, SLC26A3, SLC10A2 | TDP1 4403/4885CA12 276/4885CA1 1135/4885 |
| US-20020076739-A1 | Rapid quantitative analysis of proteins or protein function in complex mixtures | PRTN3, RPS27A, PA2G4 | TDP1 4040/4885CA12 3265/4885CA1 2941/4885 |
| US-12600767-B2 | Compounds and methods targeting epiregulin | HCRTR1, HCRTR2, NPY2R | TDP1 2719/4885CA12 2788/4885CA1 4488/4885 |
| US-20230096410-A1 | Innate Immunity Killer Cells Targeting PSMA Positive Tumor Cells | IFNG, IFNAR1, CD4 | TDP1 1745/4885CA12 1863/4885CA1 1779/4885 |
| US-20260070979-A1 | TIGIT ANTIBODIES, ENCODING NUCLEIC ACIDS AND METHODS OF USING SAID ANTIBODIES IN VIVO | IGSF11, IGLV6-57, FCGR3B | TDP1 792/4885CA12 941/4885CA1 2793/4885 |
| US-20100209946-A1 | USES OF WATER-DISPERSIBLE SILICA NANOPARTICLES FOR ATTACHING BIOMOLECULES | CD44, SELP, EPCAM | TDP1 3903/4885CA12 100/4885CA1 253/4885 |
| US-20100215580-A1 | Compositions and methods for enhancing transport through mucus | SLC26A4, SLC26A3, SLC10A2 | TDP1 4403/4885CA12 276/4885CA1 1135/4885 |
| US-12631645-B2 | Detection of BCL-2 family heterodimer complexes and use thereof | BCL2L10, BCL2L1, BCL2L2 | TDP1 3683/4885CA12 3203/4885CA1 3852/4885 |
| US-12287336-B2 | Protein for rapid, efficient capture of antigens | CD2BP2, HSPBP1, CD74 | TDP1 2527/4885CA12 1987/4885CA1 2880/4885 |
| US-20260063630-A1 | CAPTURE, PURIFICATION, AND RELEASE OF BIOLOGICAL SUBSTANCES USING A SURFACE COATING | EPCAM, SELL, CD47 | TDP1 4085/4885CA12 178/4885CA1 668/4885 |
| US-20260007657-A1 | PHARMACEUTICAL COMPOSITION FOR KERATOSIS AND USE THEREOF | KRT18, PRKDC, DPM1 | TDP1 1158/4885CA12 316/4885CA1 1669/4885 |
| US-20240150431-A1 | MHC Multimers, Methods for Their Generation, Labeling and Use | MICA, CD74, HLA-DRB1 | TDP1 2892/4885CA12 1696/4885CA1 3018/4885 |
| US-20250325660-A1 | IMMUNOMODULATOR COMPOUNDS AND METHODS OF USE | CD274, PDCD1LG2, PDCD1 | TDP1 4121/4885CA12 1267/4885CA1 2558/4885 |
| US-20260000773-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2 | EPHA2, EPHB2, EPHB1 | TDP1 849/4885CA12 1667/4885CA1 1803/4885 |
| US-20240110909-A1 | BIOANALYTICAL ANALYSIS OF SITE-SPECIFIC ANTIBODY DRUG CONJUGATES | GUSB, DNPEP, FUCA2 | TDP1 2709/4885CA12 215/4885CA1 850/4885 |
| US-20220072098-A1 | BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF | GFRA2, GFRA1, NGF | TDP1 2553/4885CA12 1507/4885CA1 1165/4885 |
| US-20230256115-A1 | CROSSLINKED HYDROGEL FOR IMMUNE CHECKPOINT BLOCKADE DELIVERY | IAPP, CD274, PDCD1 | TDP1 1648/4885CA12 3442/4885CA1 3439/4885 |
| US-20100168390-A1 | MHC MULTIMERS, METHODS FOR THEIR GENERATION, LABELING AND USE | MICA, CD74, HLA-DRB1 | TDP1 2928/4885CA12 1825/4885CA1 3203/4885 |
| US-20210177982-A1 | MUCUS-PENETRATING PEPTIDES, DELIVERY VEHICLES AND METHODS OF THERAPY | MUC1, VIP, CFTR | TDP1 3940/4885CA12 623/4885CA1 2386/4885 |
| US-20050255465-A1 | Novel fluorescent label compounds | TRPC6, CHERP, FIBP | TDP1 1793/4885CA12 1015/4885CA1 512/4885 |
| US-12534718-B2 | Separating polynucleotide fragments | DNASE1, TENT4B, TNS4 | TDP1 54/4885CA12 4665/4885CA1 4816/4885 |
| US-20260103533-A1 | ANTI-OPG ANTIBODIES | TNFSF11, TNFRSF9, ACVRL1 | TDP1 1488/4885CA12 3754/4885CA1 4339/4885 |
| US-12636307-B2 | In vitro heparin and heparan sulfate compositions and methods of making and using | TPST2, CSGALNACT1, B4GALT1 | TDP1 1361/4885CA12 2220/4885CA1 2192/4885 |
| US-20110172400-A1 | COMPOSITIONS MONOVALENT FOR CD40L BINDING AND METHODS OF USE | CD40LG, CD40, CD4 | TDP1 2958/4885CA12 3237/4885CA1 4163/4885 |
| US-11428694-B2 | Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies | CD2BP2, HAVCR2, FABP1 | TDP1 3526/4885CA12 1698/4885CA1 4531/4885 |
| US-20110059018-A1 | COVALENTLY BINDING IMAGING PROBES | CTSV, CTSL, CTSE | TDP1 825/4885CA12 428/4885CA1 209/4885 |
| US-11860156-B2 | Bioanalytical analysis of site-specific antibody drug conjugates | GUSB, DNPEP, FUCA2 | TDP1 2777/4885CA12 204/4885CA1 828/4885 |
| US-11696956-B2 | Bicyclic peptide ligands specific for EphA2 | EPHA2, EPHB2, ERBB2 | TDP1 3012/4885CA12 2852/4885CA1 3525/4885 |
| US-20190351071-A1 | STRUCTURES AND METHODS FOR GENE THERAPY | NCL, DCLRE1B, DNASE1L3 | TDP1 59/4885CA12 4477/4885CA1 4596/4885 |
| US-12545737-B2 | Antibodies that bind to AXL proteins | VSIG8, IGSF11, ERBB3 | TDP1 1609/4885CA12 2571/4885CA1 3530/4885 |
| US-20250346654-A1 | ANTI-AP2 ANTIBODIES AND ANTIGEN BINDING AGENTS TO TREAT METABOLIC DISORDERS | FABP4, FABP1, FABP3 | TDP1 4799/4885CA12 2033/4885CA1 3620/4885 |
| US-12552868-B2 | Antibodies that bind to AXL proteins | VSIG8, IGSF11, ERBB3 | TDP1 1611/4885CA12 2569/4885CA1 3531/4885 |
| US-20070299022-A1 | Antisense Oligonucleotide to Inhibit Melanoma Inhibitory Activity Mia | MCTS1, RNGTT, MSH2 | TDP1 542/4885CA12 727/4885CA1 729/4885 |
| US-20230108636-A1 | COMPOSITIONS AND METHODS FOR ENHANCING TRANSPORT THROUGH MUCUS | SLC26A4, SLC26A3, SLC10A2 | TDP1 4403/4885CA12 276/4885CA1 1135/4885 |
| US-20050085630-A1 | Photocleavable isotope-coded affinity tags | PTMS, DNPEP, ACP1 | TDP1 1392/4885CA12 3430/4885CA1 2984/4885 |
| US-11453703-B2 | Heterotandem bicyclic peptide complexes | TIMCC, TAP1, CD81 | TDP1 4216/4885CA12 887/4885CA1 1060/4885 |
| US-20260043816-A1 | Anti-TDP-43 Binding Molecules | TARDBP, TDP1, TDP2 | TDP1 2/4885CA12 4604/4885CA1 4480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.